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ABSTRACT 
Charles Robert Evans: Multidimensional Liquid Chromatography Coupled to Mass 
Spectrometry for the Analysis of Complex Mixtures of Proteins 
(Under the direction of James W. Jorgenson) 
 
 Proteomics – which is the analysis of the full complement of proteins produced by an 
organism – plays a crucial part in a variety of fields of research, including basic biological 
studies, pharmaceutical development, and clinical diagnostics.  Separations are a key element 
of proteomic analyses.  The traditional means of separating protein mixtures is two-
dimensional gel electrophoresis, which offers very high resolution.  Over the past several 
decades, alternative methods for protein separations based on liquid chromatography have 
been developed.  These methods have advantages over gel-based analyses, including reduced 
bias against certain classes of proteins, straightforward automation, and easier coupling to 
mass spectrometry.  However, in order to effectively manage the complexity of a proteome, 
the separation technique must be able to resolve a very large number of components.  
Multidimensional liquid chromatography (MDLC) is well-suited to this task.  Chapter 1 of 
this dissertation introduces the theoretical framework behind MDLC.  Previous work 
involving protein separations using comprehensive two-dimensional liquid chromatography 
(LC x LC), which is a form of MDLC, is also discussed. 
 Chapters 2 and 3 of the dissertation focus on the development of methods for intact 
protein separations using liquid chromatography.  Several separation modes were evaluated, 
including size exclusion, ion exchange, and reversed phase.  Two-dimensional separations of 
 
iv
E. coli proteins were performed which use anion exchange in the first dimension and ultra-
high pressure reversed-phase LC in the second dimension.  Although high peak capacities 
were demonstrated, the technique was limited in that proteins could not be identified solely 
based on the intact protein molecular weight data which was obtained. 
 The research presented in Chapters 4 and 5 use the same intact-protein LC x LC 
separations, but also incorporates enzymatic digestion of proteins followed by LC-MS 
analysis of the resulting peptides.  The resulting technique is a hybrid of “top-down” and 
“bottom-up” proteomics methods.  It allows proteins to be identified on the basis of tandem 
mass spectra of peptides, but retains the information gained from intact protein MS.  In 
Chapter 6, this technique was applied to study differential protein expression in yeast cultures 
grown under different conditions. 
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CHAPTER 1: Multidimensional separations and proteomics: theory, background and 
applications 
 
1.1 Proteomics 
The study of the expression, structure and function of proteins has always been at the 
center of efforts to understand the processes which enable life and which are responsible for 
the occurrence of disease.  Although the study of proteins is by no means a new endeavor, 
recent advances in analytical technology have enabled substantial changes in the means by 
which proteins can be studied.  In a conventional approach, a single protein of interest is 
selected, isolated, purified, and then studied using any of a variety of techniques, which 
might include amino acid analysis, Edman degradation, x-ray crystallography, NMR, or mass 
spectrometry.  This strategy of single-protein analysis is still widely employed, and is indeed 
often the only way by which detailed information regarding protein structure and function 
may be obtained.  Proteomics, however, describes a more global approach to the study of 
proteins.  Its aim is to characterize the entire complement of proteins – termed the proteome 
– produced by an organism.  It offers a broader picture, albeit at the expense of some detail, 
and is often able to reveal significant information regarding patterns of protein expression 
which might not be detected by more targeted analyses of individual proteins.  A major focus 
of this dissertation will be the development of analytical methods – particularly chemical 
separations – which are readily applied to proteomics. 
 
2
1.1.1 Challenges associated with proteomics 
The field of proteomics poses numerous analytical challenges.  First is the complexity 
of proteomes in terms of the sheer number of components.  Genetic data predicts that the 
prokaryotic bacterium E. coli, a relatively simple unicellular organism, is capable of 
producing in excess of 4,000 distinct proteins.1  The human proteome is substantially more 
complex.  Human genes encode an estimated complement of 20,000-30,000 proteins, while 
the actual number of distinct proteins is substantially higher due to the possibility of multiple 
proteins originating from a single gene and due to post-translational modifications (PTMs).2  
These modifications, such as phosphorylation, glycosylation, and ubiquitination, are known 
to have important effects on proteins such as regulating their activity, specifying their 
intended location within a cell, or targeting them for destruction.3  Therefore, PTMs must be 
considered in any thorough attempt to characterize the proteome of an organism.  
Furthermore, in any given organism, tissue or cell, different proteins are likely to be present 
at concentrations spanning six or more orders of magnitude.4  In multicellular organisms, the 
picture is also complicated by the heterogeneity of protein distribution – proteins expressed 
in one type of cell or tissue may differ dramatically from those expressed in others.  Finally, 
the proteome of an organism is not a static entity.  The proteins being produced and their 
relative abundance are likely to change in response to environmental conditions or other 
factors.  All of these factors make proteome analysis a formidable task. 
While no single analytical technique yet developed has all of the capabilities 
necessary to fully characterize the proteome of an organism, certain criteria are particularly 
important in selecting a workable strategy for proteome analysis.  Some of the major steps 
typically involved in proteomics include separation of a complex mixture of proteins into 
individual components or more manageable subsets, identification and study of the proteins 
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which are present, and quantification to assess their absolute or relative abundance. For the 
separation component of the analysis, high resolution is a requirement.  If the separation is 
not able to adequately resolve the components of the mixture, which is likely to contain 
hundreds or thousands of proteins or peptides, identification and quantification will be 
difficult or impossible.  After the separation, some technique must be used to detect and 
identify the proteins, and to study features of interest, such as post-translational 
modifications.  For identification, a criterion of great importance is sensitivity.  Enhanced 
sensitivity will improve both the number and the accuracy of the protein identifications 
which can be attained.  While numerous techniques have been investigated, the most 
versatile method for identifying proteins is mass spectrometry, which has, over the past 
twenty years, become an indispensable part of proteomics research.    Finally, to quantify 
proteins, a technique with a large dynamic range is required in order to ensure that a wide 
range of concentrations can be detected simultaneously.  Traditionally, some form of protein 
staining or radioisotope labeling followed by visualization of spots on a gel has been used, 
but in recent years mass spectrometry has gained some acceptance for relative quantification 
in proteomics.5, 6  
 Clearly, proteomics cannot be performed by relying exclusively on any one analytical 
aspect of the task – whether separation, identification, or quantification.  However, 
improvements in any one of these areas can enhance the capabilities of the method as a 
whole.  The focus of this dissertation will be on the development of high-resolution 
separation techniques, with a view toward their application to the field of proteomics. 
1.1.2 Choice of strategies: bottom up versus top down 
   Two major strategies exist for proteomic studies, which have been termed “bottom-
up” and “top-down”.7  In the bottom-up approach, the sample containing a mixture of 
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proteins is first subject to digestion using a proteolytic enzyme – most commonly trypsin, 
though others are also frequently used – which breaks down the proteins into peptides.  The 
mixture of peptides is then separated and these peptides are analyzed using a mass 
spectrometer, such that, in an ideal case, a mass spectrum or tandem mass spectra are 
obtained of each peptide.  From these data, the peptides can be sequenced manually or, more 
typically, sequenced and identified using probability-based database searching.  From the 
search results, a list of proteins likely to have been present in the original sample is also 
produced. 
In top down proteomics, no enzymatic digestion of the proteins is performed.  
Instead, the intact proteins are separated and then sent to the mass spectrometer.  If any 
information beyond the intact protein molecular weight is desired – which in itself is usually 
insufficient to identify the protein – then the proteins are subjected to gas-phase 
fragmentation inside the mass spectrometer.8  Patterns of fragmentation are then studied in 
order to identify the proteins. 
 Both approaches have distinct advantages and disadvantages.  From a separation 
standpoint, the bottom-up approach is typically regarded as more straightforward, since 
reversed-phase liquid chromatography (RPLC), which is a high resolution separation 
technique and is easily coupled to mass spectrometry, is well suited to the analysis of peptide 
mixtures.  Intact protein separations, particularly using reversed-phase liquid 
chromatography, are more prone to difficulties such as poor peak shape and sample 
carryover9-12.  Therefore, fewer proteins can be resolved in a single separation than is 
possible with peptides.  However, the proteolytic cleavage performed as a part of a bottom-
up analysis increases the difficulty of the separation, because when a mixture containing 
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several hundred proteins is digested, several thousand or even tens of thousands of peptides 
will be produced.   In intact protein separations, the complexity of the mixture is not 
increased by enzymatic digestion, so the separation does not need to be able to resolve as 
many components. 
In terms of data collection and analysis, the bottom-up approach involving tandem 
mass spectra (MS/MS) of peptides is well established, and numerous database searching 
programs exist which are routinely used to accurately identify proteins from these spectra.13  
However, since mass spectra are typically not obtained for every peptide predicted from the 
protein sequence, some low abundance proteins may be missed entirely, and certain 
information such as the location of post-translational modifications may not be obtained for 
even high abundance proteins.  An advantage of the top-down approach is that whole 
proteins are introduced into the mass spectrometer.  This allows the possibility of performing 
more thorough studies in terms of protein structure and analysis of post-translational 
modifications.14  Since gas-phase fragmentation of proteins produces very complex mass 
spectra, however, only high-resolution mass spectrometers such as Fourier transform – ion 
cyclotron resonance (FTICR) instruments are generally regarded as being well suited to the 
task.  Recently, there has been some interest in analyses which combine aspects of both 
bottom-up and top-down methods.15-17  To some extent, this allows the best characteristics of 
each technique to be shared in a single analysis.  Ultimately, the choice between a bottom-up 
and top-down approach is dictated by the type of information which is desired from the study 
and the instrumentation which is available to carry it out. 
1.1.3 Conventional separation methods for proteomics 
 Regardless of whether a top-down or bottom-up approach is used, separations are an 
important part of nearly all proteomic studies.  Historically, most separations of proteins have 
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been carried out using gel electrophoresis, a technique in which proteins are resolved by their 
different rates of migration through a polymeric gel in the presence of an applied electric 
field.  The most powerful gel electrophoresis technique for proteomics is known as 2D 
polyacrylamide gel electrophoresis, or 2D-PAGE.   First reported in 1975 by O’Farrell,18 2D-
PAGE resolves proteins into spots on a flat gel using two different separation mechanisms. 
First, proteins are separated according to their isoelectric point via isoelectric focusing (IEF).  
This is typically performed using a gel strip with an immobilized pH gradient.19  When a 
protein is introduced into the gel, it migrates to the location at which its isoelectric point 
matches the pH of the surrounding gel medium.  At this location the net charge of the protein 
is zero, so it is no longer influenced by the electric field, and its migration stops.  Once all 
proteins have been allowed to focus into bands according to their isoelectric point, the 
applied electric field is turned off.  To carry out the second separation, the IEF gel is then 
placed in contact with one side of a flat slab of polyacrylamide gel containing the surfactant 
molecule sodium dodecyl sulfate (SDS).  SDS is composed of a hydrophobic twelve-carbon 
alkane group, which tends to complex with proteins, and a hydrophilic sulfate group, which 
imparts all proteins with a negative charge.  An electric field is applied perpendicular to the 
orientation of the IEF gel, which causes the negatively charged SDS-coated proteins to enter 
the polyacrylamide gel and migrate toward the positive electrode.  Larger proteins migrate 
more slowly, due to greater frictional hindrance in moving through the gel matrix.  Thus the 
proteins are separated according to their size.  Once good separation has been achieved, the 
electric field is turned off, leaving proteins distributed at various spots throughout the gel.    
The protein spots are then made visible by exposing the gel to a visible or fluorescent stain 
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which binds to the proteins, or by exposure of the gel to photographic film if the proteins 
were labeled with radioactive isotopes.   
2D-PAGE is capable of producing very high resolution separations.  For a typical 
mixture, where proteins are randomly distributed throughout the 2D gel, it is estimated that 
over 2000 components can be resolved.19  Differential analyses are also possible with 2D-
PAGE, in which changes in levels of protein expression between two similar samples can be 
detected.   This is achieved by running two samples under identical conditions, then visually 
comparing the images to identify spots on the gels which differ substantially in terms of 
intensity from one run to the next.  More recently, computer software has become available 
to automate the process of comparing gel spot intensities. 
 Although 2D-PAGE is a very powerful technique for protein separations, it has 
certain fundamental limitations.  It is a labor-intensive analysis that usually requires at least 
two days to complete.  It cannot be coupled to mass spectrometry in an on-line fashion.  In 
order to obtain mass spectra of peaks of interest, protein spots must be excised from the gel 
manually or using robotics systems, after which the proteins must be extracted from the gel 
matrix and individually analyzed using MS.  2D-PAGE does not yield good separations of 
certain types of proteins, especially proteins that are extremely large or hydrophobic, which 
may not enter the gel, and proteins which are very acidic or basic, which tend to be poorly 
resolved.  Also, 2D-PAGE is only semi-quantitative, and proteins present at very low 
abundance may fall be below the detection limit of the staining techniques used to visualize 
the proteins.19  Given these shortcomings, there is ample reason to attempt to develop a 
technique which would offer some of the same capabilities of 2D-PAGE, with fewer of its 
limitations. 
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1.1.4 Application of liquid chromatography to proteomics 
Many of the limitations of 2D-PAGE are not shared by separation methods based on 
liquid chromatography.  When appropriate conditions are used, LC can separate a broader 
range of proteins than 2D-PAGE, including those that are large, hydrophobic, acidic or 
basic.20  Depending on the column and detection technique used, LC can have greater 
sensitivity to proteins present in small amounts than 2D-PAGE.  Perhaps most importantly, 
separation methods such as liquid chromatography can be fully automated and can be 
coupled with a variety of detection methods such as UV absorbance, laser-induced 
fluorescence or mass spectrometry.  Given these advantages, it is not surprising that 
researchers have looked to liquid chromatography and related techniques to provide an 
alternative to 2D-PAGE.  The ongoing challenge for separation scientists has been to devise 
LC-based separation methods and instrumentation that can equal 2D-PAGE in resolving 
power. 
 In order to develop LC methods which give separating power equivalent to 2D-
PAGE, several approaches are available.  One strategy is to use long columns and to increase 
the gradient length.  While this approach is straightforward and has been shown to be 
successful,21 to attain a desired increase in resolution using this method requires an 
exponential increase in run time.  Thus this approach quickly reaches a practical limit in 
terms of the time available to run the separation.  Another approach is to use LC columns 
packed with smaller particles.  Over the past ten years, it has been demonstrated that using 
columns packed with particles with diameters between 1-2 μm, as opposed to the 3-5 μm 
range which were the previous standard for HPLC, enables higher resolution separations to 
be achieved while simultaneously reducing run time.22-26  The tradeoff for these 
improvements is that much higher pressures are required to force mobile phase through the 
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packed bed of small particles.  Pump technology has been developed to meet these 
requirements; the resulting technique has been termed ultra-high pressure liquid 
chromatography (UHPLC), or more recently, ultra-performance liquid chromatography 
(UPLC).  Although UHPLC has been used to produce separations with peak capacities over 
one thousand27 and has been shown to be applicable to proteomics28, no single HPLC or 
UHPLC separation has yet demonstrated peak capacities as high as 2D-PAGE, especially for 
intact protein separations.  To achieve such truly high peak capacities, often the only option 
is to perform a multidimensional separation. 
1.2 Multidimensional separations 
A multidimensional separation involves the coupling of two or more separation 
mechanisms in order to carry out a single analysis.29, 30  Although simple in concept, 
multidimensional separations can be exceedingly powerful in terms of resolution.  The need 
for multidimensional separations arises from the inability of one-dimensional separation 
methods to adequately resolve highly complex samples, such as those encountered in 
proteomics, as has already been discussed.  
1.2.1 Background and theory 
In a multidimensional separation, a sample is first subjected to separation via one 
method, and then the separated components are further separated by at least one additional 
method.  Although there is no inherent limitation to the number of independent separation 
methods that can be coupled, practical constraints have limited the vast majority of the 
multidimensional separations reported to date to two dimensions.  Two dimensional 
separations provide enhanced resolution and peak capacity as compared to 1D separations, 
where peak capacity is defined as the maximum number of peaks that can fit into the 
accessible separation space side by side with a resolution of 1.0 from each neighboring 
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peak.31, 32  In an ideal case, the peak capacity of a 2D separation is given by Equation 1-1: 
 21 nnnc ×=   (Equation 1-1) 
where nc is the total peak capacity and n1 and n2 are the peak capacity of the first and second 
dimensions, respectively.30  Hypothetically, if two techniques with a peak capacity of 100 
each were used in a 2D separation, the resulting system would have a maximum peak 
capacity of 10,000.   Although this theoretically means that a maximum of 10,000 different 
components could be fully separated using this method, due to the usually random 
distribution of peaks and the statistical probability of peak overlap, the actual number of 
detectable components that can be expected to be fully resolved is substantially smaller than 
the peak capacity.33, 34  Thus, achieving very high peak capacities using 2D separations is 
clearly desirable, though it may not be a trivial task due to the challenges associated with 
selecting and coupling two appropriate separation methods. 
 Due to the large number of 2D separations reported in the literature, it is important to 
make clear distinctions between different classes of 2D separations.  One important concept 
is the difference between separations that are 2D-in-space versus 2D-in-time.  A separation 
which is 2D-in-space results in a separation of analytes over a physical two-dimensional 
(planar) surface.  2D-PAGE, which was described earlier in this chapter, is a prime example 
of a 2D-in-space separation.  Techniques that are 2D-in-time are carried out by first 
performing a 1D separation – for example, using a LC column – and then sequentially 
subjecting individual fractions from this first separation to a second 1D separation.  2D-LC, 
also known as LC x LC, is an example of a 2D-in-time method.  Among techniques that are 
2D-in-time, another distinction must be made between off-line and on-line multidimensional 
separations.  Off-line methods involve collecting fractions from the first dimension in tubes 
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or other containers, then later subjecting the contents of these fractions to separation on the 
second dimension.  On-line techniques employ switching valves or other instrumentation that 
allow the fractions from the first dimension to be transferred directly to and be separated by 
the second dimension, usually while the first dimensional separation continues 
simultaneously.   
 Certain theoretical considerations apply to all multidimensional separations, 
regardless of whether a technique is 2D in space or time, off-line or on-line.  Giddings 
established two such fundamental requirements for ideal multidimensional separations.29, 30  
First, the separation mechanisms must be orthogonal.  This means that there should be no 
correlation between the elution order of analytes in one dimension with their elution order in 
any subsequent dimension.  For a 2D separation, this yields a chromatogram in which the 
separated components are distributed randomly over the separation space, which maximizes 
peak capacity.  Hypothetical examples of orthogonal and non-orthogonal 2D separations are 
shown in Figure 1-1.  Often, orthogonal separations are achieved by ensuring that the 
chemical or physical property by which analytes are separated is different for each 
dimension.  For example, reversed phase liquid chromatography (RPLC), which separates 
based on hydrophobicity, is orthogonal to ion exchange chromatography (IEC), which 
separates according to coulombic interactions.  Interestingly, however, it has been shown that 
two separations can be orthogonal even when their separation modes are identical, if some 
chemical condition is changed which alters the selectivity of one of the dimensions.  Gilar et 
al. demonstrated a 2D reversed-phase / reversed phase separation of peptides which was 
orthogonal and generated high peak capacity when the two separations were carried out at 
substantially different pH values.35 
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 Giddings’ second criterion states that no resolution gained in the first dimension of 
the separation may be lost in any subsequent dimension.  For on-line, 2D-in-time separations, 
this requirement is satisfied by designing instrumentation that collects fractions or transfers 
them from the first dimension to the second at a frequency sufficient to ensure the resolution 
of the first dimension is not substantially diminished.  Therefore, in an on-line 2D separation 
the second dimension must be capable of completing separations very rapidly, in order to 
allow many second-dimension runs to occur within the time it takes for a single first-
dimension separation to finish.  The resulting need for high speed analyses in the second 
dimension represents an experimental challenge in carrying out 2D separations.  Exactly how 
frequently the first dimension must be sampled depends on the width of the first-dimension 
peaks.   Murphy et al. proposed that, in order to achieve optimal resolution, each peak in the 
first dimension should be sampled at least three times by the second dimension.36  More 
recently, Horie et al. reported that sampling the first dimension column 1 to 2 times over the 
width of a first dimension peak is typically preferable, because the reduced sampling rate 
prevents excessively short run times on the second dimension.37  This improves the total peak 
capacity of the 2D separation, even though the resolution contributed by the first dimension 
may be somewhat reduced.  In spite the challenges associated with two-dimensional 
separations, methods that satisfy Giddings’ criteria and produce good separations of complex 
mixtures have been demonstrated. 
1.2.2 Previous work in multidimensional liquid chromatography 
One multidimensional method that has been used commonly is an on-line, 2D-in-time 
technique called heart-cutting two-dimensional liquid chromatography.  In this approach, the 
first-dimension separation is carried out like a standard 1D analysis on a chromatography 
column.  A single desired segment of the first-column effluent is then transferred, typically 
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via a switching valve, to a second column for further separation via a different method.  
Heart-cutting is useful when extra resolution is needed to examine a small segment of peaks 
in a complex chromatogram, but it requires foreknowledge of the sample’s composition.  
Since heart-cutting does not subject the entire sample to two-dimensional separation, it is of 
little use when every component of a sample is an analyte of interest, as in proteomics.  The 
alternative to heart-cutting is known as “comprehensive” multidimensional separations, 
because all sample components are subjected to displacement on both dimensions.38  
Comprehensive multidimensional separations are more powerful than heart-cutting 
separations because they provide greater peak capacity. 
A wide variety of combinations of liquid chromatographic modes have been used in 
comprehensive LC x LC separations, including ion exchange-reversed phase (IEC x 
RPLC),39-45 size exclusion-reversed phase (SEC x RPLC),46-49 reversed phase-size exclusion 
(RPLC x SEC),36, ion exchange-size exclusion (IEC x SEC),38 and normal phase-reversed 
phase (NPC x RPLC).50  Although many different instrumental setups for LC x LC have been 
designed, most of the components used are similar, and include an injector, two isocratic or 
gradient LC pumps, a single column for the first dimension, one or more columns for the 
second dimension, one or more computer-controlled switching valves, and an appropriate 
detection system. 
 The first true comprehensive system for two-dimensional liquid chromatographic 
separation was reported in 1990 by Bushey and Jorgenson.38  This system was used to 
analyze a mixture of protein standards and a sample of human serum.  A cation exchange 
column operated in gradient elution mode for the first dimension is coupled to a size 
exclusion column used for the second dimension.  An eight-port switching valve is used to 
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interface the two columns and allows on-line fraction transfer from the first column to the 
second.  A diagram of the instrumental setup of this LC x LC system is provided in Figure 
1-2.  The effluent of the cation exchange column is directed to a storage loop.  When the 
valve is switched, the isocratic LC pump forces the contents of the loop onto the size 
exclusion column where they are further separated.  Meanwhile, the effluent of the first 
dimension is directed to the second storage loop.  The flow rates on the two columns are 
selected such that the analysis time of the second dimension exactly matches the amount of 
time it takes for the first dimension to fill the storage loop.  This allows all the effluent of the 
first column to be transferred to the second dimension.  A computer is used to control the 
switching of the valve and the acquisition of data from a UV absorbance detector at the end 
of the second column.  In this manner the SEC column can analyze a large number of 
fractions from the ion exchange column during the course of a run lasting a total of 2.5 to 6 
hours.  The chromatographic data are presented as a three-dimensional view of a 2D 
chromatogram as shown in Figure 1-3. The system was estimated to have a total peak 
capacity of approximately 130, which is the product of the peak capacities visually estimated 
for each dimension.  Other examples of column-switching LC x LC separations using dual 
storage loops have since been reported in the literature, some with greater peak capacity.36, 39, 
40, 51  A 2D anion exchange-reversed phase system that was used to analyze a tryptic digest of 
reduced porcine thyroglobulin gave a peak capacity over 2,000.43 
   A different approach, in which the effluent from the first column is not captured by 
storage loops but instead is transferred directly to the head of one of two parallel second-
dimension columns, was reported in 1997 by Opiteck, Jorgenson and Anderegg.47  This 
system was used to analyze the fragments produced by tryptic digests of the proteins 
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ovalbumin and bovine serum albumin.  The first dimension of their system consisted of six 
size-exclusion columns connected in series.  These were coupled via a pair of four-port 
valves to two parallel reversed phase LC columns, which serve as the second dimension.  
This study was also one of the first reports of on-line mass spectrometric detection used to 
analyze a two dimensional separation.  A diagram of the entire setup is shown in Figure 1-4.  
As sample elutes from the series of SEC columns, it is routed to RPLC column alpha.  Since 
the aqueous buffers used for SEC are weak eluents for RPLC, the sample material is 
concentrated in a narrow zone at the head of the column.  When the two four-port valves are 
switched simultaneously, a second LC pump starts a gradient to elute the sample from RPLC 
column alpha, while the effluent from the first dimension is loaded onto RPLC column beta.  
The effluent from the RPLC column being eluted is directed to a UV absorbance detector 
followed by a 10:1 flow splitter and an electrospray mass spectrometer.  The total peak 
capacity of this system was estimated to be about 500.  Other two-dimensional LC x LC 
techniques using parallel columns in the second dimension have been reported, many of 
which replace the two four-port switching valves with a single ten-port valve that 
accomplishes the same purpose.41, 42, 45, 52, 53 
1.2.3 Recent applications of multidimensional liquid chromatography to proteomics 
The most prominent recent technique in which multidimensional liquid 
chromatography has been applied to the field of proteomics is a bottom-up technique known 
as Multidimensional Protein Identification Technology (MudPIT), developed by Yates and 
colleagues.54-60  As opposed to comprehensive LC x LC systems, which use separate columns 
for each dimension coupled through a column switching valve, MudPIT uses a single 
capillary column packed with two different stationary phases, with a pulled tip at the outlet 
end for direct coupling to a mass spectrometer via electrospray ionization.  The end of the 
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capillary nearest the pulled tip is packed with several centimeters of reversed phase material, 
followed by several centimeters of strong cation exchange (SCX) material.  The column is 
connected to a polyetheretherketone (PEEK) microcross which splits the flow from a 
conventional quaternary LC pump, reducing it to 0.15-0.25 μL/min, and also provides a 
connection where the electrospray voltage is applied, as shown in Figure 1-5.  The 2D 
separation is carried out using a multi-step gradient elution profile, an example of which is 
shown in Figure 1-6.  To elute fractions of the sample from the ion-exchange portion of the 
column onto the reverse phase material, a step-gradient of buffer with increasing ionic 
strength is used. In between each of these incremental steps, a linear gradient of increasing 
organic content is used to separate the eluted fraction on the reversed phase segment of the 
column.  The outlet of the column is interfaced with an electrospray mass spectrometer.  
Typically the mass spectrometers used with MudPIT have tandem MS capabilities to enable 
the identification of proteins via “shotgun” analysis.  In this approach, the tandem mass 
spectra which are obtained are compared with a database containing known protein 
sequences using a probability-based searching method.  The results of this analysis are used 
to identify the proteins present in the sample. 
 The capabilities of MudPIT as a separation method for the purpose of proteomics 
have been assessed by several studies.  The peak capacity of the two-dimensional separation 
carried out in one 15-fraction MudPIT analysis was estimated to be approximately 3,200.56 
When the inherent peak capacity of the mass spectrometer was included, the estimated 
overall peak capacity increased to 23,000, which compares favorably with 2D-PAGE 
techniques.  In practice, MudPIT is capable of identifying over 1,000 proteins in a single 
sample.  Washburn and colleagues applied MudPIT to the analysis of the proteome of the 
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yeast S. cerevisiae and identified 5440 peptides using mass spectrometry, which were 
assigned via database searching to originate from 1484 unique proteins.55  Among these were 
a substantial number of low-abundance and trans-membrane proteins, which suggests that the 
technique is largely unbiased and gives a representative sampling of the yeast proteome.  
Lack of bias represents a significant advantage over 2D-PAGE, which has limited dynamic 
range and typically performs poorly with trans-membrane proteins since they are 
hydrophobic and do not easily enter into the gel. 
 Another report indicates that the number of protein identifications can be further 
improved by using a three-phase MudPIT column in which an additional section of RP 
material is added at the inlet of the column to provide on-line removal of salts from the 
sample.58  MudPIT has also been used for quantitative studies of proteomic samples via the 
use of 15N isotope labeling.57  An assessment of quantitative MudPIT suggests that the 
technique can provide useful data about relative levels of protein expression, but that 
experimental reproducibility could be improved by enhancing resolution in order to increase 
the number of peptides detected per protein.60 
 One of the greatest advantages of MudPIT is the relative simplicity of the 
instrumentation needed to carry out 2D separations.  Only a single quaternary gradient LC 
pump, an appropriately packed capillary column, and minimal interfacing components are 
required.  However, the simplicity of this arrangement also limits its flexibility.  The two 
separation modes coupled in tandem must both utilize gradient elution.  Further, the gradient 
in the first dimension must always be run in a step-wise fashion in order to elute concise 
fractions of sample onto the second column.  The resolution contributed by the first 
dimension is limited by the number of fractions transferred, which is equal to the number of 
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steps used in the first dimension gradient.  Each step requires substantial time, typically 
approximately 100 minutes, which includes periods for re-equilibration and washing of salts 
off the column.  A maximum of fifteen steps in the first-dimension salt gradient have been 
reported,55 which may suggest that the first dimension is under sampled in spite of long run 
times.  Notably, the only combination of separation modes that has been used thus far in 
MudPIT is strong cation exchange – reversed phase, perhaps because this is one of few 
arrangements where suitable gradients can be applied alternately to two different stationary 
phases in a single column in order to bring about an effective, orthogonal 2D separation. 
1.3 Scope of dissertation 
Given the importance of the field of proteomics and the increasing interest in using 
chromatography as an alternative to 2D-PAGE, there is ample motivation for ongoing 
research into advancing the capabilities of LC for protein separations.  Thus, although the 
research described in this dissertation involves many aspects of proteomics – including mass 
spectrometry and database searching for protein identification – the focus of the research will 
be on multidimensional liquid chromatography.  First, an evaluation of various 1D 
chromatographic methods and research directed toward improving their capabilities for 
protein separations will be described (Chapter 2).  Next, an off-line LC x LC separation using 
UHPLC for separation of intact proteins will be discussed (Chapter 3).  Then, two hybrid top 
down / bottom up approaches to analysis of the E. coli proteome using off-line (Chapter 4) 
and on-line (Chapter 5) LC x LC-MS will be presented.  Finally, the same hybrid top down / 
bottom up on-line LC x LC-MS technique will be applied to several samples of the proteome 
of the yeast S. cerevisiae grown under differing conditions, in order to detect differences in 
protein expression (Chapter 6). 
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1.6 Figures 
 
 
 
 
 
 
Figure 1-1: Hypothetical orthogonal (A) and non-orthogonal (B) two-dimensional 
separations.  Note that, in the orthogonal separation, sample components are randomly 
distributed over the entire separation space, which maximizes peak capacity.  The non-
orthogonal separation shows a strong correlation between retention on the two dimensions, 
which results in a substantially diminished peak capacity. 
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Figure 1-2: Schematic diagram of a 2D IEC-SEC instrument.  Effluent from the ion exchange 
column is directed onto one of the two sample loops via the 8-port switching valve (V2).  To 
separate the contents of the loop, valve 2 is switched, which sends the contents of the loop 
onto the size exclusion column.  Meanwhile, the other storage loop fills with effluent from 
the ion exchange separation.  Once the sample is fully separated on the size exclusion 
volume, V2 is switched and the process begins again. (Adapted from Ref. 38) 
 
26
 
 
 
Figure 1-3: 2D ion exchange-size exclusion chromatogram of protein sample.  Peak 
identities: (A) glucose oxidase, (B) ovalbumin, (C) β-lactoglobulin, (D) trypsinogen, (E) α-
lactoglobulin, (F) conalbumin, (G) ribonuclease A, (H) hemoglobin; (M) exclusion volume 
“pressure” ridge, (N) inclusion volume “salt” ridge.  Valve actuated every 6 minutes.  UV 
detection at 215 nm (Reproduced with permission from Ref. 38) 
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Figure 1-4: Schematic diagram of a 2D SEC-RPLC instrument with on-line mass 
spectrometric detection.  The two four-port valves are switched simultaneously, directing the 
effluent of the size exclusion column to one of two reversed-phase columns while the other 
column is eluted using a gradient LC pump.  After elution is complete, the valves switch 
again and the process repeats. (Adapted from Ref. 47) 
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Figure 1-5: Diagram of a MudPIT column and electrospray interface. The micro-cross serves 
as a flow splitter in conjunction with a split capillary, and as the location at which the 
electrospray voltage is described.  Further explanation can be found in the text.    (Adapted 
from Ref. 56).  
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Figure 1-6: An example 5-step MudPIT gradient profile.  The balance of the mobile phase at 
any time is made up of buffer A.  Buffer A is 5% acetonitrile (ACN), 95% H2O and 0.02% 
heptafluorobutyric acid (HFBA).  Buffer B is 80% ACN, 20% H2O and 0.02% HFBA.  
Buffer C is 250 mM ammonium acetate/5% ACN, 95% H2O and 0.02% HFBA.  Buffer D is 
400 mM ammonium acetate/5% ACN, 95% H2O and 0.02% HFBA.  A further description of 
the parameters used to perform a MudPIT experiment can be found in the text (Adapted from 
Ref. 55 
CHAPTER 2: Size exclusion and ion exchange chromatography of intact proteins 
 
2.1 Introduction 
The ability to separate mixtures containing proteins is crucial to a wide variety of 
chemical and biological research, including the study of cellular pathways, biomarker 
discovery, and development of biopharmaceutical agents.  Virtually the entire complement of 
available separation techniques is routinely applied to proteins, including dialysis, 
ultracentrifugation, isoelectric focusing, electrophoresis, and liquid chromatography.  Each of 
these methods has distinct advantages and disadvantages.  For instance, while dialysis offers 
an effective and inexpensive means of removing low or high molecular weight impurities 
from a solution containing a protein of interest, this technique cannot separate many proteins 
in a highly complex mixture.  Likewise, capillary electrophoresis can offer fast, high-
resolution separations, but would be impractical for preparative-scale protein purification.   
Among the strategies available for protein separations, liquid chromatography is 
relatively unique in that it can be used to separate a sample based on many different chemical 
properties, such as size, charge or hydrophobicity.  Thus, a wide range of selectivity can be 
achieved using the same fundamental technique: a sample is injected onto a column, and 
separation occurs as analyte molecules differentially partition between a liquid mobile phase 
and a stationary phase.  The fact that the method remains consistent regardless of the 
separation mechanism is important because it enables the user to choose a separation strategy 
tailored to the task at hand simply by switching from one column to another, without having 
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to invest in entirely new instrumentation when the task changes.  Additionally, the relative 
similarity of most LC separations makes it possible to couple one LC technique to another to 
perform a multidimensional separation.  Although multidimensional LC will be the primary 
focus of later chapters in this dissertation, proper selection and optimization of each 
individual dimension is essential in order to make a multidimensional separation successful.  
Thus, this chapter describes research performed in order to select and optimize 1D-LC 
separation methods for intact proteins, such that they may be incorporated into a 2D 
separation. 
2.1.1 Overview of LC methods available for intact protein separations 
 A wide variety of LC separation modes can be used to separate mixtures of proteins, 
including size-exclusion chromatography, ion exchange chromatography, hydrophobic 
interaction chromatography, hydrophilic interaction chromatography, and reversed-phase 
chromatography.1  Specialized methods such as affinity chromatography are also available 
for isolation of a particular protein or class of proteins, though these techniques are not 
applicable to a general separation of a complex mixture containing unknown components.  
Given the range of options which are available, the chromatographer must carefully consider 
the nature of the sample to be analyzed and the characteristics of the available techniques 
when selecting a separation mode. 
The easiest technique to implement for protein separations is size exclusion 
chromatography (SEC).  This method separates proteins based on their size, using a 
mechanism relatively unique compared to most forms of chromatography.  A size exclusion 
column consists of a packed bed of porous particles.  The diameter of the pores is chosen 
such that it is of the same order as the hydrodynamic radius of the proteins being separated 
(10-100 nm is typical).  Proteins or other molecules much smaller than the pore diameter are 
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easily able to enter and occupy the space within the pores.  Proteins with diameters larger 
than the pores are completely excluded from entering, whereas proteins close to the size of 
the pores are partially excluded.  To perform a chromatographic run, a sample is injected and 
analyte molecules are carried through the column by flow of a liquid mobile phase.  Proteins 
too large to enter the pores flow directly through the column and thus elute first, whereas 
smaller molecules spend a portion of their time within the stagnant mobile phase inside the 
pores, and thus elute later.  The result is a chromatogram with peaks arranged in order of 
size.  SEC is carried out under isocratic conditions –  the mobile phase composition remains 
the same throughout the run – which simplifies optimization of the separation but also limits 
its flexibility.  While effective, SEC is generally regarded as providing low resolution.  A 
well-optimized separation might have a peak capacity of 14 or less.2 
Ion exchange chromatography (IEC) separates proteins based on their charge.  The 
stationary phase consists of charged groups immobilized on the surface of a support particle.  
The immobilized charged groups are always associated with ions of opposite charge, which 
are not covalently bonded but remain attached due to electrostatic attraction.  When a sample 
containing ions is introduced into the column, the sample will displace the electrostatically 
bound ions already present and will bind to the stationary phase.  If the ionic strength of the 
mobile phase is low, the sample will remain bound since few ions are present in solution to 
displace it.  To carry out a separation, a gradient of increasing salt concentration is applied.  
This increases the concentration of counterions competing for the charged surface sites, 
which causes analyte molecules to be displaced by ions from the mobile phase.1  Proteins 
with greater charge density tend to be retained longer on the column.  IEC offers good 
flexibility in that a range of stationary phases are available.  Both positively charged (anion 
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exchange) and negatively charged (cation exchange) stationary phases can be used, and the 
separation can be adjusted by changing the pH of the mobile phase.  In general, ion exchange 
offers higher peak capacities than size exclusion chromatography.2  
Hydrophobic interaction chromatography (HIC) and hydrophilic interaction 
chromatography (HILIC) separate proteins based on their hydrophobicity and polarity, 
respectively.  HIC employs a gradient from high to low salt concentration.  The high salt 
concentration used at the beginning of the run causes proteins to bind to a mildly 
hydrophobic stationary phase – effectively, they are “salted out” of the mobile phase.  As the 
salt concentration in the mobile phase is gradually decreased, proteins begin to enter the 
mobile phase and separation occurs.  HILIC is analogous to normal phase liquid 
chromatography in that it uses a gradient of increasing solvent polarity, and more polar 
molecules are retained longer by the stationary phase.  The only significant difference from 
normal-phase LC is that HILIC uses some water in the mobile phase as opposed to entirely 
organic solvents, which makes it feasible for protein separations.3  
Reversed-phase liquid chromatography (RPLC) separates proteins based on their 
hydrophobicity.  It uses a gradient of increasing organic solvent concentration as opposed to 
a salt gradient.  At the start of a run, proteins are retained by interaction with a hydrophobic 
stationary phase, which might consist of C18, C8, C4 or phenyl groups immobilized on a bed 
of packed particles.  As the concentration of organic solvent in the mobile phase increases, it 
becomes more favorable for the protein to partition into the mobile phase.  Separation is 
achieved because more hydrophobic proteins are retained longer than less hydrophobic ones.  
Unfortunately, RPLC does have some disadvantages in terms of reproducibility and sample 
carryover from one run to the next when used for intact protein separations.4-7  Nevertheless, 
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if these difficulties can be managed, RPLC offers high peak capacities and relatively short 
run times. 
2.1.2 Considerations in selection of separation modes to be used for MDLC 
 When a multidimensional separation is to be performed, additional criteria become 
important in selecting and optimizing each LC dimension.  First, one must ensure that the 
two dimensions produce orthogonal separations.  For example, coupling of two reversed-
phase separations carried out under identical conditions would offer no benefit over a 1D-LC 
separation, as discussed previously (section 1.2.1).  Coupling of ion-exchange with reversed-
phase LC would be a better choice due to the difference in the selectivity of the separations.  
Alternatively, the selectivity of one of the dimensions could be changed, for example, by 
altering the pH of the mobile phase in one reversed-phase separation.  If the two dimensions 
are to be coupled in an off-line manner, by collecting fractions after the first dimension and 
then analyzing those fractions on the second dimension, then this may be the extent of the 
criteria that must be considered.  Each separation method can be run under whatever 
conditions give the best performance within the desired run-time, and steps such as solvent 
evaporation or desalting can be carried out on the fractions that are collected if desired. 
If an LC x LC separation is to be performed using on-line coupling between the 
dimensions, the criteria for selecting and optimizing the individual separations are more 
complex.  First, the mobile phase from the first column must be miscible with that used for 
the second column, and any buffers or salts to be used must be soluble in both mobile phases.  
It is also desirable for the first dimension mobile phase to be a weak eluent on the second 
dimension.  This is because it is preferable for all components in a fraction to concentrate at 
the head of the second column, to reduce the effects of band broadening and improve 
resolution.  Finally, since it is necessary to sample the effluent from the first separation many 
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times using the second dimension, the second dimension separation must be run very rapidly 
compared to the first.   This ensures that resolution gained on the first dimension is 
maintained in the second dimension, as stipulated by Giddings’ second criterion (see section 
1.2.1).   
Certain combinations of separation modes satisfy these criteria better than others for 
online LC x LC of proteins.  Solvent miscibility is seldom a problem, since mobile phases 
used for protein separations generally contain water.  Buffer and salt solubility can be a 
concern, however, if high-salt techniques like HIC or ion exchange are coupled to techniques 
where substantial amounts of organic solvent are used in the mobile phase, like RPLC or 
HILIC.  Eluent strength may also be an issue – if the effluent from an ion exchange column, 
which uses a low-to-high salt gradient, were directed onto a HIC column, which uses a high-
to-low salt gradient, sample components would not be retained initially on the second 
column, and resolution would be diminished.  The most significant challenge, however, is the 
difference in speed required between the two dimensions.  The first dimension must typically 
be configured such that a single run lasts several hours.  The second dimension runs must be 
much more rapid, typically lasting only for a period of a few minutes.  These criteria dictate 
differences in the columns that should be used for each dimension.  In the first dimension, 
resolution is optimized by using long columns, which may be packed with relatively large (5 
μm or greater) support particles.  The second dimension columns must be short to minimize 
dead time, and may benefit from the use of smaller (3 μm or less) support particles in order to 
allow high resolution separations at fast flow rates.  The choice of separation modes is also 
important – reversed-phase LC is typically well-suited for use as the second dimension, since 
it can be run quickly and still provides relatively high peak capacity.  Size exclusion and ion 
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exchange are more ideal for the first dimension, since commercially available columns using 
these separation modes suffer too much loss of resolution when used for short runs. 
In the research presented in this chapter, size exclusion and ion exchange LC modes 
were evaluated for separation of intact proteins.  Both commercially available and custom-
packed columns were assessed in order to optimize their performance and to determine if and 
how they should be used as a first dimension of a multidimensional LC separation.  As 
pertaining to the second separation dimension, the choice between separation modes was 
significantly more straightforward.  Few other techniques have the advantages of reversed 
phase liquid chromatography for use as a second dimension in a LC x LC separation, such as 
its capability of fast run times and its ability to be directly coupled to electrospray mass 
spectrometry.  These advantages have lead to its widespread use in multidimensional liquid 
chromatography – of the 13 publications on original LC x LC research cited in Chapter 1, 
only 2 used a separation mode other than RPLC in the second dimension.  RPLC is not 
evaluated for 1D protein separations in this chapter; its use is described in the context of 
multidimensional separations presented later in this dissertation. 
2.2 Size exclusion chromatography 
As discussed previously, size exclusion chromatography is a good technique for 
protein separations since it is simple to implement and works well with most samples.  It is 
also a good candidate for use as a first dimension of LC x LC.  It can be run slowly without 
loss of resolution, and it uses aqueous mobile phases which are weak eluents for reversed-
phase columns.  Unfortunately, it is generally considered to be a low-resolution technique.8  
This preconception may not be due not to fundamental limitations of the method, but rather 
to the lackluster performance of standard columns.  To assess this assumption, the 
performance of a commercially available size exclusion column was tested for the separation 
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of protein mixtures.  Custom size exclusion columns were also prepared by packing fused 
silica capillaries with both commercial and custom-bonded porous particles.  The 
performance of the commercial and custom size exclusion columns was compared in order to 
determine the best option for use in a 2D separation. 
2.2.1 Experimental 
2.2.1.1 Mobile phases and chemicals 
 Three different mobile phases were used for size exclusion separations.  The first, a 
denaturing mobile phase, consists of 50 mM dibasic sodium phosphate (Fisher Scientific, 
Fair Lawn, NJ) and 3M urea (Fisher) in deionized water, adjusted to pH 7 with phosphoric 
acid (Fisher).  The second, a non-denaturing mobile phase, consists of 50 mM dibasic sodium 
phosphate (Fisher) and 100 mM sodium sulfate (Sigma-Aldrich, St. Louis, MO) in deionized 
water, adjusted to pH 7 with phosphoric acid.  The third, a non-denaturing mobile phase with 
a volatile buffer, consists of 400 mM ammonium acetate (Sigma-Aldrich) in deionized water, 
adjusted to pH 7 using ammonium hydroxide (Fisher) or acetic acid (Fisher).  Deionized 
water was purified using a Barnstead Nanopure water system (Boston, MA).  The reagents 
used for preparation of custom-bonded size exclusion particles were hydrochloric acid 
(Fisher), 3-glycidoxypropyltrimethoxysilane (Gelest, Morrisville, PA), acetone (Fisher), and 
diethyl ether (Fisher).  All chemicals were ACS grade or higher and were used as received. 
2.2.1.2 Protein standards and E. coli protein extract preparation 
 Samples used for size exclusion separations included mixtures of standard proteins 
and proteins extracted from the bacterium E. coli.  Standard proteins used were thyroglobulin 
(MW 660 kDa), immunoglobulin G (MW 160 kDa), bovine serum albumin (MW 66 kDa), 
ovalbumin (MW 43 kDa) and myoglobin (MW 17 kDa).  Typical concentrations injected 
were 0.1-0.2 mg/mL per protein, in a solvent of the mobile phase being used to carry out the 
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separation.  The peptides leucine enkephalin (MW 556 Da) and tetraglycine (MW 228) were 
used as low MW standards at a typical concentration of 0.05 mg/mL.  All proteins and 
peptides were purchased from Sigma-Aldrich and were used as received.   
To obtain a more complex sample representative of the proteome of an organism, 
soluble proteins were extracted from a culture of the bacterium E. coli by Eric Hamlett in the 
Giddings research group in the department of Microbiology and Immunology at the 
University of North Carolina – Chapel Hill.  The procedure he used is described below. 
 A single colony-forming unit of Escherichia coli K12 (strain MG1655 wild type) 
was isolated from a Luria-Bertani (LB) broth agar plate culture.  The colony was aseptically 
transferred into 50% glycerol as a stock culture and stored at -80ºC until needed.  An 
inoculation loop from the glycerol stock was transferred to 3mL of autoclaved LB broth and 
grown for 18 hours at 37ºC at a rotation of 250 rpm.  100 μL of this primary growth was 
transferred to 1.0 L of autoclaved LB broth and grown for 18 hours at 37ºC at a rotation of 
250 rpm, after which point the growth had reached stationary phase – the point at which the 
cells had saturated the growth medium.  The LB broth media was centrifuged at 5000 rpm for 
20 minutes in order to pellet the cells, after which point the supernatant was poured off.  To 
cleanse the cells of LB broth, the cell pellet was re-suspended in 20 mL of 0.1M phosphate 
buffer-saline (PBS) and then centrifuged at 5000 rpm for 20 minutes; this wash step was then 
repeated.  The cleansed cell pellet was then re-suspended in 20 mL of lysis buffer.  The lysis 
cell suspension was sonicated using a Fisher Dismembrenator model 300, using several 
bursts at 30% power.  The suspension slurry was then centrifuged at 10,000 rpm for 20 
minutes to re-pellet the cell debris.  The golden-colored supernatant was transferred to a 
sterile ultracentrifuge tube.  Non-solubilized proteins were pelleted (an oily droplet) by 
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centrifuging at 35,000 rpm for 45 minutes.  Supernatant was transferred to a sterile tube.  
Benzonase, a nuclease, was added to the supernatant to digest chromosomal DNA.  The 
digestion was performed on ice for a period of 20 minutes using 8 units of benzonase per mL 
of supernatant.  The nuclease-treated extract was then concentrated and low MW components 
were partially removed using UltraFree centrifuge filters with a 5000 Da MW cutoff.  20 mL 
of supernatant was concentrated to 1.2 mL by centrifuging through the filters at 2000 rpm.  
This solution was then ready for analysis using size-exclusion LC. 
2.2.1.3 Particle bonding 
 To prepare custom size exclusion columns, silica particles were chemically bonded 
with an inert surface coating containing diol functional groups to prevent chemical 
interactions with proteins.  The starting material was 2 μm porous silica particles with 145 Å 
pores, provided by Waters Corporation (Milford, MA).  To perform the chemical 
modification, the procedure set forth by Regnier et al.,9 adapted by the recommendations of 
Porsch,10 was followed.  First, the particles were re-hydroxylated by refluxing 3 g of particles 
in 200 mL of 1.5 N hydrochloric acid in a round-bottomed flask for several hours.  The slurry 
was allowed to cool, and the particles were washed with deionized water until the pH of the 
slurry was neutral.  The particles were then boiled in deionized water for 30 minutes, after 
which they were again washed with deionized water.  They were then dried for several hours 
in a vacuum oven at room temperature. 
 After drying, the re-hydroxylated particles were ready to be chemically modified 
using 3-glycidoxypropyltrimethoxysilane (GPTMS).  A simplified diagram of the chemical 
bonding procedure is shown in Figure 2-1.  45 mL of a 10% (v/v) solution of GPTMS in 
water was prepared by adding the silane drop-wise to water.  The pH of the solution was 
monitored using a pH meter while the silane was added, and was maintained at 8.5 by adding 
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drops of 10-3 to 10-1M solutions of aqueous potassium hydroxide as needed.  The GPTMS 
solution was added to a round bottomed flask containing the re-hydroxylated particles, and 
the flask was sealed and swirled to mix its contents.  The particles were left in the sealed 
flask for 24 hours at room temperature to allow the bonding reaction to occur.  After the one-
day reaction period, the particles were collected over a 0.2 μm filter, and were washed with 
deionized water.  To open the epoxide ring of the oxirane now bonded to the particle surface, 
the particles were transferred to a flask and 50 mL of 10-3M hydrochloric acid were added.  
The flask was swirled periodically to mix the slurry.  After one hour, the particles were 
collected by filtration and washed with deionized water, acetone, and diethyl ether.  The 
particles were dried overnight on a watchglass at room temperature, then in a convection 
oven at 85ºC for 3 hours.  The particles were then ready to be packed into capillary columns 
and used for size exclusion LC. 
2.2.1.4 Column selection and column packing 
To assess the capabilities of a commercially available size exclusion column for 
protein separations, a column was purchased from Tosoh Bioscience LLC (Montgomeryville, 
PA).  The column, model number G2000SWXL, has an inner diameter of 7.8 mm, a length of 
30 cm, and is packed with 5 μm diameter silica particles with 125 Å diameter pores.  Like the 
custom-bonded particles, these particles are derivatized with ligands containing diol 
functional groups.  The manufacturer specifies that the column is useful for separations of 
globular proteins ranging in size from 5 kDa – 150 kDa.  As an intermediate option between 
the commercial size exclusion column and custom-bonded particles, size exclusion packing 
material was also purchased from Tosoh Bioscience.  The particles obtained are identical to 
those in the G2000SWXL column, except their pore diameter is 250 Å instead of 125 Å.  This 
changes the useful size range for protein separations to 10-500 kDa.   
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Packing of fused-silica capillaries (Polymicro Technologies, Phoenix, AZ) with SEC 
particles was carried out using a high pressure slurry method, which has been described in 
detail elsewhere.11  In short, the capillary to be packed is cut to the desired final column 
length plus approximately 40 cm.  An outlet frit is formed by tapping one end of the capillary 
in a vial containing non-porous silica particles, then placing that end of the column into an 
electrical arc in order to sinter the particles and fix them in place.  The open end of the 
capillary is placed into a high-pressure fitting, which is tightened into a packing reservoir 
containing the packing slurry.  The slurry is prepared by adding approximately 20 mg of 
particles to 4 mL of deionized water, then placing the slurry in an ultrasonic bath for 20 
minutes to fully suspend the particles.  Packing is initiated by applying approximately 1000 
psi of liquid pressure to the reservoir using a pneumatic amplifier pump (Haskel 
International, Burbank, CA).  As the bed of packed particles in the capillary lengthens, the 
pressure is increased in order to keep the rate of packing approximately constant.  For 5 μm 
particles, typically no more than 6000 psi of liquid pressure is required to pack a column to a 
length of approximately 50 cm within about one hour.  Somewhat longer packing times and 
higher pressures were needed to pack the 2 μm particles.  
Once the column has packed to the desired length, the pressure is turned off and 
residual pressure is released gradually through a valve.  The column is cut to remove any 
excess capillary from the inlet end, and is hung vertically, inlet end up, to allow the bed to 
dry overnight.  After drying, an inlet frit is added in the same manner as the outlet frit.  To 
create a transparent “window” in the capillary to enable on-column UV absorbance detection, 
a small section of the polyimide is burned away in the area a few centimeters from the outlet 
end of the capillary.  This can be accomplished before packing the column by passing the 
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desired region of the capillary through an electrical arc, or after packing by dripping a small 
amount of fuming sulfuric acid over the desired area. 
2.2.1.5 Instrumentation and run conditions 
 Runs were performed using a Waters 600E Multisolvent Delivery System, which is a 
low-pressure-mixing gradient HPLC pump capable of flow rates from 0.01 – 20 mL/min at a 
maximum backpressure of 6000 psi.  The pump outlet is connected to a 6-port computer-
controlled injector valve (VICI Valco Instruments, Houston, TX).  For runs using the 
G2000SWXL column, the outlet of the injector valve is connected directly to the column, and 
the column outlet is connected to an Applied Biosystems Model 785A programmable 
absorbance detector (Foster City, CA).  For most size exclusion runs on the G2000SWXL 
column, a flow rate of 0.5 mL/min and sample injection volumes of 5-50 μL were used.  All 
runs were performed under isocratic conditions. 
For runs using capillary columns, a pre-column dynamic split is used, as depicted in 
Figure 2-2.  Typically, the LC pump is operated at a flow rate of 0.2 mL/min.  The majority 
of the flow from the pump is diverted to waste through a splitter capillary, while a small 
portion enters the packed column.  The length and diameter of the splitter capillary 
determines the backpressure which is generated, which in turn determines the flow rate 
through the packed column.   If a splitter capillary were configured to generate 500 psi of 
backpressure, the flow rate through a typical SEC column with an inner diameter of 75 μm 
and a length of 50 cm packed with 5 μm particles would be approximately 50 nL/min.  Thus 
the split ratio would be approximately 4000:1.  Typical on-column injection volumes are 1-
10 nL.  On-column UV absorbance detection was performed through the packed bed using a 
Linear 200 UVIS variable wavelength detector (Linear Instruments, Reno, NV) equipped 
with a capillary flow cell. 
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2.2.2 Results and discussion 
 The motivation for performing 1D SEC separations was to develop a method which 
could be used as a first dimension in a 2D separation of intact proteins.  To achieve this goal, 
several parameters needed to be assessed.  One major question was whether better results 
could be obtained using a commercially available column or with a custom-packed column.  
Additionally, appropriate mobile phase and run conditions needed to be selected.  Finally, the 
selected technique needed to be tested with a complex sample representative of the proteome 
of an organism. 
The first step in evaluating SEC for protein separations was to compare the 
performance of a standard, commercially available size exclusion column to a column 
packed in-lab.  At first, certain difficulties were experienced in packing size exclusion 
columns. For the 5 μm SEC particles from Tosoh Bioscience, it was noted that if the column 
was allowed to pack gradually, the rate of packing would decrease dramatically – even to the 
point of coming to a complete halt – over the course of a few hours.  It was suspected that 
this phenomenon was due to clogging of the column with small particulate matter, which 
impedes flow and prevents packing from proceeding.  This hypothesis was verified by 
observing SEM images of particles before and after being placed in the packing reservoir, 
shown in Figure 2-3.  These images demonstrate that newly-prepared slurry contains only 
whole, spherical particles, whereas slurry removed from the packing reservoir after several 
hours has many small, irregular-shaped particle fragments.  The explanation for this 
degradation is relatively straightforward: the packing reservoir contains a magnetic stir-bar, 
which constantly stirs the slurry to prevent particles from settling out of suspension.  
Evidently, the highly porous size exclusion particles are vulnerable to fragmentation from 
physical impact with the stir-bar.  The difficulty is reduced by packing columns as quickly as 
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possible, typically in less than 1 hour, before substantial fragmentation has time to occur.  
Unfortunately, this limited the useful length of the columns which could be packed to 
approximately 50 cm.  Interestingly, the problem of particle fragmentation was not as 
significant with the 2 μm custom-bonded particles, which seem to be mechanically stronger 
than the 5 μm particles. 
Once well-packed size exclusion columns were obtained, their performance was 
compared to that of the commercial size exclusion column.  Figure 2-4 shows 
chromatograms from two SEC separations of four protein standards plus a low MW peptide 
standard.  The first separation was performed on the G2000SWXL column containing 5 μm 
particles with 125 Å pores. The second chromatogram was generated using a capillary 
column packed with the 5 μm SEC particles with 250 Å pores.  Note that while elution order 
is identical, resolution of most components is slightly higher on the capillary column.  This 
can be attributed to the fact that it is nearly twice the length of the commercial column (55 
cm as opposed to 30 cm).  Also, the larger pore size of the particles in the capillary column 
would be expected to more effectively separate larger proteins; this explains the greater 
resolution between thyroglobulin and BSA (and the BSA dimer peak) on the capillary 
column.  Peak capacities are estimated as 7 for the commercial column and 10 for the 
capillary column.  Thus, both columns offer relatively mediocre separating power, although 
within a typical range for size exclusion chromatography.8 
Based on standard chromatographic theory, substantial gains in separation efficiency 
can be achieved by using particles of smaller diameter, which results in higher peak capacity 
for a given column length.1  To assess whether such improvements could be attained for size 
exclusion separations, capillary columns were packed with 2 μm porous silica particles 
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modified in-house with GPTMS.  Figure 2-5 shows separations performed on this type of 
column compared with a column packed with Tosoh 5 μm SEC particles.  The column 
packed with 2 μm particles was slightly longer (55 cm as opposed to 49 cm) and the mobile 
phase flow rate was slightly higher; otherwise, run conditions were identical.  Visual 
comparison of the chromatograms suggests that the 2 μm particles give somewhat sharper 
peaks.  This would suggest that improved resolution can be obtained by using smaller 
diameter particles for size exclusion separations. 
Although SEC columns packed with 2 μm particles did produce somewhat higher 
resolution separations for proteins under 50 kDa than columns with 5 μm particles, they did 
not perform well with larger proteins, such as IgG or thyroglobulin.  When such proteins 
were injected on the column, typically either no peak was seen or the resulting peak was very 
broad and tailed.  This suggests that the bonding procedure used to deactivate the surface of 
the silica particles is inadequate to prevent undesirable interactions with large proteins.  This 
limitation ruled out the use of the custom-bonded size exclusion particles for intact protein 
separations.  Capillary columns packed with the 5 μm SEC particles from Tosoh Bioscience 
gave better results; however, the low flow rates used in capillary LC would make coupling of 
this separation method to another LC separation difficult.  Therefore, we returned to the 
conventional-diameter commercial size exclusion column as the most practical option for 
intact protein separations. 
The G2000SWXL column was evaluated for separation of an E. coli soluble protein 
extract.  Figure 2-6 shows a chromatogram for a separation of 1mg of total E. coli protein 
which was generated with the SEC column using 400 mM ammonium acetate (pH 7) as the 
mobile phase.  The chromatogram suggests the presence of many co-eluting peaks, which 
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appear within a relatively narrow window of retention time.  Clearly, a technique to be used 
as the first dimension of a 2D separation would not be expected to completely resolve a 
sample with this many components.  However, the relatively broad peaks and limited 
window of time in which peaks were observed suggests that SEC may not provide adequate 
peak capacity to effectively separate the sample into as many distinct fractions as desired.  
One option to address this issue would be to link many commercial SEC columns in series to 
increase resolution, as has been demonstrated successfully in the past.12, 13  However, 
doubling column length is expected to increase peak capacity by only 40%,14 so substantial 
expense would be involved in order to obtain significant improvements in performance.  
Therefore, it seemed more practical to investigate other separation modes as possible first 
dimensions for a 2D-LC separation of proteins. 
2.3 Ion exchange chromatography 
 Ion exchange is another logical candidate for use as a first dimension separation of 
intact proteins.  Like SEC, it uses entirely aqueous eluents, so it is compatible with on-line 
coupling to RPLC as a second dimension.  Unlike SEC, ion exchange separations have many 
parameters which must be selected and optimized.  First, there is the choice between anion 
exchange and cation exchange, which dictates the charge of the proteins which can be 
retained and separated by the column.  Next, one must select between a “weak” or “strong” 
ion exchanger.  Strong ion exchangers retain their charge regardless of pH, whereas for weak 
exchangers the extent of the surface charge is affected by the pH of the mobile phase.  
Changes in pH also affect the charge of the proteins being analyzed, which influences their 
retention on the column.  Thus, the choice of pH and selection of an appropriate buffer are 
crucial to optimizing ion exchange separations.  Finally, since ion exchange of proteins is 
carried out using gradient elution – typically by increasing the concentration of salt in the 
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mobile phase over the course of a run – the gradient must be optimized in order to obtain the 
best separation.  
2.3.1 Experimental 
2.3.1.1 Mobile phases and sample preparation 
Both anion exchange and cation exchange separations were performed using binary 
gradients.  The gradient profiles and composition of the mobile phases were changed as 
needed between runs to obtain the best separations possible.  Therefore, precise mobile phase 
compositions and gradient parameters are specified along with the relevant chromatogram or 
description of a run in the text of the chapter; a typical mobile phase composition is specified 
here.  For anion exchange separations, mobile phase A consisted of 50 mM ammonium 
acetate (Sigma-Aldrich) in deionized water, adjusted to pH 9 with ammonium hydroxide 
(Fisher).  Mobile phase B was 1M ammonium acetate, adjusted to pH 9 with ammonium 
hydroxide.  For cation exchange separations, mobile phase A was 50 mM ammonium 
formate (Sigma-Aldrich), adjusted to pH 3.5 with formic acid (Sigma-Aldrich).  Mobile 
phase B was 1M ammonium formate, adjusted to pH 3.5 with formic acid.  The E. coli 
protein extract sample used to evaluate the anion and cation exchange columns was the same 
as that used for evaluation of size exclusion columns; its preparation is described in section 
2.2.1.2. 
2.3.1.2 Column selection 
Due to the wide range of columns available for ion exchange chromatography, 
selection was performed based on several criteria.  Since it was unknown whether anion 
exchange or cation exchange would produce better separations of the E. coli proteome, both 
modes were investigated in order to compare their performance.  Strong ion exchangers were 
selected, since it was deemed preferable to be able to perform separations over a wide range 
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of pH values without altering the charge of the stationary phase.  Since working above pH 7 
is typical of many ion exchange separations, the support particles needed to be able to 
withstand high pH.  This ruled out most columns packed with silica particles.  Fortunately, 
many commercially available ion exchangers are based on polymeric support particles and 
can be used even at the extremes of the pH scale.  A final criterion was that the column 
needed to be usable as the first dimension in a 2D separation.  Since off-line coupling of 
dimensions was to be employed, this stipulated a column with an inner diameter which 
would allow operation at a flow rate between 0.1-1 mL/min so that fractions of a reasonable 
volume could be collected.   
 Two columns which satisfied the above criteria – one anion exchange and one cation 
exchange – were obtained from Waters Corporation.  The anion exchange column is the 
Biosuite Q 10 μm AXC.  It is a stainless steel column 7.5 cm in length with an inner diameter 
of 7.5 mm.  It is packed with 10 μm methacrylate-based polymeric particles with 1000 Å 
pores.  The particles are bonded with quaternary amine functional groups, which give the 
surface a positive charge.  The cation exchange column is the Waters Biosuite SP 10μm 
CXC.  Its dimensions and support particles are the same as the AXC column, except the 
stationary phase is coated with sulfopropyl functional groups, which carry a negative charge. 
2.3.1.3 Column packing 
In addition to the commercial columns described above, a custom-packed anion 
exchange column was also prepared.  The particles to be packed were identical to those in the 
Biosuite Q 10 μm AXC column, except they were 13 μm in diameter as opposed to 10 μm.  
These particles were obtained by emptying the particles from a semi-preparative scale 
column, the Waters Biosuite Q 13 μm AXC (15 cm x 21.5 mm ID).  This was performed by 
removing one endfitting from the column, then pumping deionized water into the other end 
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of the column while it was held with its open end facing down above a clean glass beaker.  
Once all particles had been extruded from the column, they were transferred to a glass vial, 
which was sealed and stored at 4ºC until needed. 
A slurry reservoir was designed and constructed to contain the particles and allow 
them to be packed into analytical LC columns with a conventional inner diameter (2-10 mm).  
This reservoir is pictured in Figure 2-7.  The slurry reservoir was machined from clear 
polycarbonate.  Its internal volume is approximately 150 mL.  The seal between the lid and 
base is made with a Viton o-ring, which fits into a groove machined into the lid.  The bottom 
portion of the internal chamber is tapered, which prevents particles from settling on a 
horizontal surface, and directs the slurry toward the outlet fitting at the base of the reservoir.  
The reservoir is pressurized using an HPLC pump through a connection for 1/16” tubing 
located in the lid.  Although the maximum pressure of the reservoir has not been determined, 
it is typically not used above 200 psi due to the large internal volume and limitations in the 
strength of the polycarbonate.  Also, due to limited chemical resistance, most organic 
solvents cannot be used with the reservoir. 
Empty glass columns purchased from Omnifit (Cambridge, UK) were packed with 
the anion exchange particles.  The columns have an inner diameter of 6.6 mm and are 40 cm 
long.  One end has an adjustable endfitting, which allows the column to be used with a bed 
length from 32 - 40 cm.  The maximum operational pressure is 900 psi.  For packing, the 
outlet endfitting was fitted with a 10 μm polyethylene frit and the inlet frit was removed to 
allow the particles to enter the column.  20% (v/v) slurry of the anion exchange particles was 
prepared and added to the packing reservoir.  The slurry solvent was 1M ammonium acetate 
(Sigma-Aldrich), adjusted to pH 8.5 with ammonium hydroxide (Fisher).  It is important to 
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use a relatively high salt concentration when packing polymeric ion exchange particles, since 
the particles swell when the ionic strength of the buffer is low, which can cause gaps to form 
in the packing when the column is used.1 
The reservoir was connected to the inlet of the column using 1/16” ID Teflon tubing.  
Packing was initiated by applying flow to the top of the reservoir at a rate of 5 mL/min using 
a Waters 600 HPLC pump.  The backpressure was monitored as packing proceeded and flow 
was reduced as needed to keep the pressure below 200 psi (a safe limit for the pressure 
reservoir).  The column packed to a length of 37 cm within a period of about 1 hour.  Once 
packing was complete, flow was turned off and the column was allowed to depressurize.  A 
frit was then added to the inlet endfitting, and its position was adjusted to remove any gap 
between the endfitting and the packed bed.  A total of three Omnifit glass columns were 
packed using this procedure, each to a bed length of 37 cm.  At this point, each column was 
tested chromatographically with standard proteins to ensure that it gave peaks which were 
symmetrical and as sharp as expected.  Once all columns had been tested, they were 
connected in series using 0.005” ID PEEK tubing, which was positioned directly next to the 
frits to minimize void volume.  A picture of the three packed anion exchange columns 
connected in series is shown in Figure 2-8.  The connected columns are used as a single AXC 
column, with an effective bed length of 111 cm. 
2.3.1.4 Instrumentation and run conditions 
Runs were performed with the same HPLC pump, injector and detector as was used 
for the separations on the conventional-diameter SEC column, which are described in section 
2.2.1.4.  The flow rate used for the Biosuite columns was 0.5 mL/min. The custom-packed 
anion exchange column was operated at 0.39 mL/min in order to maintain the same linear 
mobile phase velocity, since its inner diameter is smaller (6.6 mm as opposed to 7.5 mm).  
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Injection volumes varied from 5-50 μL.  All runs were carried out using binary gradient 
elution; specific gradient programs are specified along with the data in the results section. 
2.3.1.5 Bradford protein quantification assay 
The Bradford protein quantification assay15 was used to measure the amount of 
protein in fractions collected from the ion exchange columns.  The Bradford reagent was 
prepared as follows: 10 mg of Coomassie Brilliant Blue G-250 (Sigma) were dissolved in 5 
mL of ethanol (Aaper, Shelbyville, KY) in a 100 mL volumetric flask; a deep blue solution is 
produced.  10 mL of 85% phosphoric acid (Fisher) were added to the flask and the solution 
was swirled to mix; the solution turned a red-brown color.  The solution was diluted to mark 
with deionized water; the solution became a brown-green color.  The solution was filtered 
using a 1 μm syringe filter into a dry flask.  The filtrate, dark brown in color, is the ready-to-
use Bradford reagent. 
To use the Bradford reagent, the protocol for the microprotein assay15 was followed.  
1.5 mL of Bradford reagent was added to a centrifuge tube containing 0.1 mL of the buffer 
solution to be assayed for protein.  The tube was mixed by vortexing.  After an incubation 
period of 5 minutes, the absorbance of the solution was ready to be measured using a 
spectrophotometer.  A Spectronic 401 (Milton Roy, Rochester, NY) was set to a wavelength 
of 595 nm and was zeroed using a blank solution prepared by adding 1.5mL of Bradford 
reagent to 0.1mL of buffer solution with no protein.  The absorbance of the solution to be 
assayed was then measured.  Standard curves were generated using the protein bovine 
immunoglobulin G over a concentration range of 5-250 μg/mL; separate curves were 
generated for the buffers used in anion exchange chromatography (50 mM ammonium 
acetate, pH adjusted to 9.0 using ammonium hydroxide) and cation exchange 
chromatography (50 mM ammonium formate, pH adjusted to 3.5 using formic acid). 
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The Bradford assay was used to determine the quantity of protein found in ion 
exchange separations of the E. coli protein extract.  Anion and cation exchange separations of 
the E. coli protein extract were carried out as described in section 2.3.1.4.  The effluent from 
the column was collected in fractions using microcentrifuge tubes, which were switched 
every 2 minutes.  The fractions were then lyophilized in order to remove the mobile phase 
and allow the proteins to be concentrated.  To perform lyophilization, after all fractions were 
collected, the tubes were capped and frozen by immersion in liquid nitrogen for 
approximately 1 minute.  The tube caps were opened, and all tubes were placed in a vacuum 
centrifuge (SpeedVac Concentrator, Savant, Farmingdale, NY).  The centrifuge was turned 
on and vacuum was applied.  The tubes were left under vacuum until all mobile phase had 
been removed; typically, this took about 4-8 hours.  After lyophilizing, the contents of the 
fractions were re-suspended in 0.1 mL of 50 mM buffer solution, which represents 10-fold 
concentration of the proteins as compared to before lyophilization.  The fractions were then 
analyzed for protein using the Bradford reagent using the protocol described above. 
2.3.2 Results and discussion 
The motivation for switching from size exclusion to ion exchange chromatography 
was to obtain better resolution of complex protein mixtures, such as the E. coli protein 
extract sample, for use in a multidimensional separation.  Therefore, experimental efforts 
were directed at optimizing separations of these samples, rather than first performing 
separations of standard proteins.  The first attempt at separating the E. coli protein extract on 
the anion exchange column was performed using standard mobile phases recommended by 
the column manufacturer.  A 20-minute gradient from 0 to 0.5M sodium chloride was used, 
with a buffer of 50 mM Tris-HCl (pH 8.5) present in the mobile phase throughout the run.  
Detection was performed using UV absorbance at a wavelength of 215 nm.  A chromatogram 
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from this separation is shown in Figure 2-9.  Peaks are observed to be spread over an 18-
minute window of retention time; the estimated peak capacity of the separation was 20.  
Thus, even using a relatively short gradient and without extensive optimization, this approach 
demonstrated better separation capabilities than size exclusion chromatography. 
Although the sodium chloride gradient produced a reasonable anion exchange 
separation, the use of a non-volatile salt posed difficulties in terms of the plan to collect and 
lyophilize fractions in order to remove the mobile phase prior to analysis by a second 
chromatographic dimension.  The simplest solution was to use a mobile phase consisting of 
only components which are volatile under vacuum. Therefore, an anion exchange separation 
of the E. coli protein extract was performed using a gradient from 50 to 500 mM ammonium 
acetate, pH adjusted to 9.0 using ammonium hydroxide.  Ammonium acetate, a volatile salt, 
serves as both the pH buffer and as the elution salt in this gradient.  Likewise, a cation 
exchange separation was performed using ammonium formate, with the pH adjusted to 3.5 
using formic acid.  It was found that the background absorbance from ammonium acetate or 
formate was too strong to permit detection at 215 nm, so the wavelength was changed to 280 
nm.  At this wavelength, detection of proteins is based on absorbance of the side chains of 
the aromatic amino acids, as opposed to the peptide backbone.16  Therefore, detection is not 
as universal nor is quantitatively equivalent for all proteins, although the traces still provide 
an idea of when proteins elute from the column. 
Chromatograms of the ion exchange separations of the E. coli protein extract are 
shown in Figure 2-10.  The anion exchange chromatogram appears to show good separation 
of the sample, with peaks spread relatively evenly over 30 minutes of separation space.  
Peaks in the chromatogram from the cation exchange separation, however, are much sparser.  
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A very large peak is observed to elute near the dead time of the column; further into the 
gradient only three, substantially smaller peaks are observed.  Thus it seems that cation 
exchange chromatography, under the conditions used in this run, does not separate the E. coli 
protein extract effectively. 
In order to attempt to improve the cation exchange separation of the E. coli proteins, 
four different buffer compositions with pH values ranging from 2.5 to 7.0 were investigated.  
No separations above neutral pH were attempted, since alkaline pH favors the conversion of 
ionizable molecules such as proteins to anions rather than cations.  Chromatograms from 
these runs are shown in Figure 2-11.  Although small peaks appear throughout the 
chromatograms, the majority of the sample seems to elute near the dead time of the column 
(approximately 4 minutes) in all of the runs.  Decreasing the pH of the buffer did cause 
increased retention of some components in the sample.  This is particularly notable with pH 
2.5 citrate buffer, and to a lesser extent at pH 3.5 with the ammonium formate buffer.  In 
these cases, there is some resolution between the components eluting near the dead time.  
Another substantial reduction in the pH might result in a better cation exchange separation, 
but this was not possible since the manufacturer of the column recommends against using it 
at a pH below 2.0. 
The detection method which was used for these separations – UV absorbance at 280 
nm – is not selective to proteins alone.  Thus, a chromatogram which appears to have 
numerous peaks spread over a reasonable range of retention time is not a certain indication of 
a successful protein separation.  Therefore, a quantitative assay of protein concentration in 
fractions collected from the ion exchange columns was performed.  The assay was carried 
out using the Bradford method, which is based on the dye molecule Coomassie Brilliant Blue 
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G-250.15  At acidic pH, the dye binds with proteins and undergoes a characteristic absorbance 
wavelength shift from 465 nm to 595 nm.  The magnitude of this shift is proportional to the 
concentration of protein in solution, and can be measured using a visible-light 
spectrophotometer. 
Standard curves for the Bradford protein assay were generated using bovine IgG and 
are shown in Figure 2-12.  Separate curves were generated using protein solutions in buffers 
at different pH values, to match the buffers used in the ion exchange and cation exchange 
separations.  The curves demonstrate that the response of the Bradford assay is generally 
linear over the range of protein concentrations assayed (5-250 μg/mL).  The response was not 
notably different in one buffer compared to the other. 
Results of assays performed on fractions collected from anion and cation exchange 
separations of the E. coli protein extract are shown in Figure 2-13.  Bradford assay data is 
shown in terms of the raw absorbance value at 595 nm; these values are directly proportional 
to protein concentration.  The “LB” and “HB” data shown in the figures are the results from 
control experiments performed to ensure that solutions containing no protein give little or no 
reaction with the Bradford assay.  The LB (low salt blank) tube contained 100% mobile 
phase A, whereas HB (high salt blank) contained 100% mobile phase B.  Both of these tubes 
were treated identically to the actual ion exchange fractions, including all lyophilization and 
reconstitution steps.    Although the LB and HB solutions showed some absorbance, the 
levels were low compared to fractions containing actual protein.  This confirms that the 
Bradford assay does not experience substantial interference from residual salts from the ion 
exchange mobile phase. 
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The Bradford assay data are shown on the same graph as the UV absorbance 
chromatogram in order to assess the correlation between peaks that are observed and the 
presence of protein in the fractions.  For the anion exchange separation, fractions 1-10 appear 
to contain significant quantities of protein.  Interestingly, the UV chromatogram shows peaks 
in fractions 11-16 as well, while the Bradford assay detects no significant amount of protein 
in these fractions.  This suggests that the later peaks in the UV chromatogram are non-protein 
components, perhaps small molecules with absorbance at 280 nm.  Nonetheless, the assay 
does show that proteins are spread over a reasonable number of fractions, which validates the 
method as a means of separating mixtures of intact proteins.  The results from the Bradford 
assay of the cation exchange fractions are less encouraging.  No substantial absorbance at 
595 nm was detected in any fraction, even though the same amount of protein was injected 
onto the column.  It is suspected that some part of the cation exchange separation, fraction 
collection and lyophilization procedure interferes with the accuracy of the Bradford assay.  
Regardless, the assay did not provide convincing evidence that cation exchange 
chromatography separates the protein mixture effectively.  Therefore it was determined that 
anion exchange chromatography was the best option for use as a first dimension in a 
multidimensional separation of intact proteins. 
Once anion exchange was determined to be the preferred method, the separation of 
the E. coli protein extract was optimized further by lengthening the gradient.  Figure 2-14A 
shows a separation of the E. coli protein extract performed using the Biosuite Q 10um AXC 
column.  The 60 minute gradient described in the figure caption gives a peak capacity of 
approximately 35.  This column was then used as the first dimension in 2D separations of 
intact proteins; the details of these 2D separations will be described in later chapters. 
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  Although the Biosuite column was effective for 2D protein separations, ultimately, 
higher resolution separations than it could provide were desired.  Thus, a custom-packed 
anion exchange column with 111 cm of total bed length was prepared and tested as described 
in section 2.3.1.3.  The new column was used to perform separations of the same E. coli 
protein extract; an example of such a separation is shown in Figure 2-14B.  Due to the 
increased length of the column, the gradient needed to be lengthened.  A general rule is that, 
when attempting to improve resolution or peak capacity in an already-optimized separation 
by increasing column length, the quantity given by the expression:  
 ( )
umecolumn vol
rate flowimegradient t ×  (Equation 2-1) 
should be held constant.17  In even simpler terms, if the linear mobile phase velocity is kept 
constant, then the gradient length should be increased directly proportional to the increase in 
column length.  Since the linear flow rate was indeed the same on the short and long ion 
exchange columns, and the length of the long anion exchange column is 14.8 times greater 
than that of the short column, a 360 minute gradient on the long column is roughly equivalent 
to a 24 minute gradient on the short column.  This is not to say that the resolution would be 
equivalent in these two hypothetical runs – clearly the long column will produce much higher 
resolution separations.  Instead, it indicates that the long column can benefit from much 
longer run times than the short column.  Just as increasing the gradient length on the short 
column from 30 minutes to 60 minutes improved peak capacity, lengthening the gradient on 
the long column from 360 to 720 minutes should also do the same, although this was not 
experimentally verified.  
As expected, the result of the increased column and gradient length was substantially 
higher resolution separations.  The peak capacity of the separation shown was estimated to be 
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85.  As with the shorter column, the long anion exchange column was used as the first 
dimension in several multidimensional protein separations, which are described in 
subsequent chapters of this dissertation. 
2.4 Conclusions 
Size exclusion and ion exchange chromatography were evaluated as potential first 
dimensions for a LC x LC separation of intact proteins.  Although size exclusion 
chromatography successfully separated mixtures of protein standards, its peak capacity was 
not as high as desired and fractionation of a complex sample such as the E. coli protein digest 
was poor.  Capillary columns packed with commercial and custom-bonded size exclusion 
columns did offer better resolution, but the magnitude of the improvement was not 
substantial.  Anion exchange chromatography produced significantly higher resolution 
separations of the E. coli sample.  Cation exchange chromatography, however, did not appear 
to separate most of the proteins.  The Bradford quantitative protein assay confirmed the 
presence of proteins in many fractions from an anion exchange separation of the E. coli 
sample, while proteins were not found in cation exchange fractions.  Further improvement in 
anion exchange peak capacity was attained by packing a longer column and increasing the 
gradient time.  Of the techniques investigated, it was concluded that anion exchange 
chromatography is the best option for use as the first dimension in an LC x LC separation.    
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Figure 2-1: Scheme for surface modification of a silica particle with a diol phase using 3-
glycidoxypropyltrimethoxysilane (GPTMS) 
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Figure 2-2: Diagram of instrumentation used to perform capillary LC separations.  The 
capillary SEC column passes entirely through the flow-splitter tee and is sleeved by the 
PEEK tubing connected to the outlet of the 6-port injector, such that its inlet end is located as 
near as possible to (but not touching) the valve rotor.  This ensures minimum delay volume 
between the HPLC pump / injector and the capillary column.  A second tee connects the 
splitter capillary and a flush valve.  When runs are being performed, the flush valve is closed 
so that flow is directed through the splitter capillary, which determines the backpressure at 
the column head.  To flush the pump at high flow rates, as when changing mobile phase, the 
flush valve can be opened. 
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Figure 2-3: SEM images of 5 μm size exclusion particles from Tosoh Bioseparations, LLC.  
The top image shows particles as received; the bottom image shows particles retrieved from 
slurry which had been inside the stirred packing reservoir for several hours. 
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Figure 2-4: Size exclusion separations of protein standards.  Chromatogram A was generated 
using a Tosoh Bioscience G2000SWXL column containing 5 μm particles with 125 Å pores. 
Chromatogram B was obtained using a capillary column packed with 5 μm particles with 250 
Å pores.  Note that while elution order is identical, resolution of most components is slightly 
higher on the capillary column. 
Tosoh G2000SWXL  
7.8 mm i.d. x 30 cm 
B Capillary column  100 μm i.d. x 55 cm 
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Figure 2-5: Comparison of performance of capillary columns packed with (A) commercial 5 
μm SEC particles, and (B) 2 μm silica particles bonded in-house with GPTMS.  Both 
separations were carried out using denaturing mobile phase (50 mM phosphate + 3M urea, 
pH 7) 
75 mm i.d. x 49.5 cm 
Commercial 5 μm SEC particles A 
75 mm i.d. x 55 cm 
2 μm in-house GPTMS bonded particles B 
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Figure 2-6: Size exclusion separation of the E. coli protein extract on the G2000SWXL 
column. 
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Figure 2-7: Polycarbonate slurry reservoir used to pack anion exchange columns.  The green 
PEEK tubing at the top of the reservoir connects to a HPLC pump, which generates the flow 
used to pack the column.  The metal valve at the bottom controls the flow of slurry into the 
column to be packed, which is connected using the tan PEEK fitting at the bottom of the 
image.
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Figure 2-8: Photograph comparing conventional anion exchange column (7.5 cm long x 7.5 
mm ID) and the custom-packed anion exchange column series (111 cm total length x 6.6 mm 
ID). 
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Figure 2-9: Anion exchange separation of the E. coli protein extract.  Mobile phase A 
contained 50 mM Tris-HCl (pH 8.5); mobile phase B contained 50 mM Tris-HCl (pH 8.5) 
plus 500mM sodium chloride.  A 20 minute linear gradient from 0 to 100%B was used. 
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Figure 2-10: (A) anion exchange and (B) cation exchange separations of E. coli protein 
extract.  The red trace is the UV absorbance chromatogram.  The blue line represents the 
profile of the gradient in terms of percent of mobile phase B; the balance of the mobile phase 
was made up of mobile phase A. 
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Figure 2-11: Cation exchange separations of the E. coli protein extract performed using four 
different buffer and pH conditions. 
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Figure 2-12: Standard curves for the Bradford assay.  For the top curve, IgG was dissolved in 
50 mM ammonium acetate, pH 9.0.  In the bottom curve, IgG was dissolved in 50 mM 
ammonium formate, pH 3.5.
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Figure 2-13: Results of the Bradford protein assay used to assess the quantity of proteins 
present in fractions collected from (A) anion exchange and (B) cation exchange separations 
of E. coli protein extract.  The blue bars represent the measured absorbance of each fraction 
at 595 nm after mixing with the Bradford reagent, which is proportional to protein 
concentration.  The red trace is the corresponding UV absorbance chromatogram. 
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Figure 2-14: Comparison of separations of the E. coli protein extract on two anion exchange 
columns.  Chromatogram (A) was obtained with the 7.5 cm Biosuite Q 10um AXC column 
using a 60 minute gradient from 25-500 mM ammonium acetate (pH 8.5).  Chromatogram 
(B) was obtained using the custom-packed 111 cm anion exchange column using a 360 
minute gradient from 25-500mM ammonium acetate (pH 8.5).  In both chromatograms the 
final peak is shown off-scale to allow the detail of the remainder of the peaks to be seen.
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CHAPTER 3: Off-line LC x UHPLC-MS separations of E. coli proteins 
 
3.1 Introduction 
The research described in this chapter falls within the field of top-down proteomics.  
In general terms, the goal of this method is to separate a complex mixture of intact proteins 
and to analyze them using mass spectrometry.  Although still in development, top-down 
proteomics shows substantial promise for enabling identification of proteins and study of 
post-translational modifications without the need for enzymatic digestion.1  The emphasis of 
most research in top-down proteomics to date has been within the field of mass spectrometry, 
especially development of gas-phase fragmentation techniques and methods for interpreting 
the resulting complex spectra.  Separations are also important, however, since no mass 
spectrometer is able to simultaneously analyze all the proteins produced by an organism.  
Multidimensional liquid chromatography is a logical candidate, due to the high resolution it 
provides and the ease with which it can be coupled to mass spectrometry via electrospray 
ionization. 
The focus of this chapter is the development of an LC x LC separation method for 
intact proteins.  Anion exchange and reversed phase were chosen as the first and second 
dimensions for the separation, respectively, as presented in Chapter 2.  Beyond the selection 
of the separation modes, however, numerous steps were necessary to develop a functional LC 
x LC method.  First, the strategy for coupling the two dimensions was determined.  Second, 
the parameters of the reversed-phase separation were selected and optimized.  Third, since 
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MS is an essential part of any proteomic analysis, the separation method was coupled to a 
mass spectrometer.  Finally, a procedure for analyzing the chromatographic and mass 
spectral data was developed.  Once all aspects of the 2D separation were in place, the method 
was applied to the study of the E. coli proteome. 
Before describing the experimental methods used to perform the research, several 
aspects of the techniques reported in this chapter require further introduction.  One is the 
selection of a method of coupling one dimension to the other in LC x LC.  Second is ultra-
high pressure liquid chromatography, the technique to be used for the second dimension 
separation.  Finally, since mass spectrometry plays an important role in the method, 
electrospray ionization MS of intact proteins is briefly introduced. 
3.1.1 Off-line vs. on-line coupling in multidimensional LC 
Although apparently simple, the selection of a method used to couple dimensions in a 
2D separation merits consideration from a conceptual standpoint.  The majority of previous 
research in the Jorgenson group involving LC x LC has employed on-line coupling of 
dimensions, in which fractions from the first column are loaded directly onto to the second 
column using automated switching valves.  An alternative is off-line coupling, where the 
effluent of the first column is physically collected as fractions that are later injected 
individually onto the second column.  Although off-line coupling may seem to be a less 
sophisticated approach, both methods have noteworthy advantages and disadvantages which 
must be weighed when designing a 2D separation. 
The primary advantages of the on-line approach are automation and speed.  An entire 
2D separation can be carried out with no user intervention beyond the initial injection of the 
sample.  This is very advantageous for the purpose of routine, high-throughput analyses.  The 
entire run can be finished in essentially the time that it takes for the first dimension 
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separation to complete; therefore, the technique can be made quite rapid, especially 
compared to 2D gel electrophoresis.  However, these advantages impose certain limitations.  
Most significantly, the second dimension separation must be configured such that it is very 
rapid compared to the first.  This is necessary so that many second-dimension runs can be 
carried out during the time it takes to complete a single run on the first dimension in order to 
adequately sample the column.  This usually means that the resolution contributed by the 
second dimension must be compromised to improve the analysis speed.  Secondly, the on-
line approach requires relatively complex instrumentation.  Two LC pumps must be operated 
simultaneously, and operation of the switching valves used to connect the two dimensions 
must be timed precisely so that all of the effluent from the first column is transferred to and 
analyzed by the second column.   
Off-line LC x LC is a comparatively simple approach.  When minimally configured, 
it requires only a single LC pump, two separation columns of different types, and suitable 
containers for collecting fractions.  A greater degree of automation can be achieved if a 
fraction collector is used to collect the fractions from the first column and an autosampler is 
used to inject the fractions onto the second column.  There is no limit to the number of 
fractions that can be collected, so off-line coupling can be just as thorough in sampling the 
first dimension as on-line coupling.  Fraction collection also permits sample manipulation 
between separation dimensions – for example, fractions could be concentrated via 
lyophilization, and reconstituted in a solvent more appropriate for analysis on the second 
dimension.  Another major advantage of the off-line approach is that there is no need for the 
second dimension separation to be run faster than the first, because fractions can be stored 
and run when time permits.  Therefore both separations can be optimized to provide the 
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highest possible resolution, which could allow the second dimension to contribute a much 
higher peak capacity to the overall 2D method.  Offline LC x LC also allows flexibility in the 
amount of each fraction that is transferred to the second dimension.  This amount could be 
increased to improve sensitivity, decreased to prevent second-dimension column overload, or 
a fraction could be skipped altogether if the detector monitoring the first-dimension column 
effluent indicates that no analytes are present.  Finally, an off-line 2D separation allows the 
flexibility of analyzing any fraction multiple times on the second dimension without 
repeating the entire 2D separation, should the sample prove of particular interest or if an 
instrument failure occurs. 
Of course, off-line sampling also has numerous disadvantages.  Foremost is speed – 
off-line sampling is certain to take longer than an on-line approach because the fractions are 
usually run after the first dimension separation is complete, rather than as it is in progress.  
An additional factor is that the operator of the instrument may need to spend more time 
performing manual tasks such as setting up for fraction collection, collecting the fractions, 
and manipulating the fractions such that they are ready to be analyzed on the second 
dimension.  Finally, since the liquid fractions come in contact with more tubes and surfaces 
when fraction collection is performed than when on-line coupling is used, there is a greater 
possibility of sample losses with off-line coupling. 
In the case of the 2D separation to be described in this chapter, it was decided to use 
off-line coupling of dimensions, for two main reasons.  First, the goal of the separation was 
to generate as high of a peak capacity as possible in order to analyze the E. coli proteome.  
Since the speed of the separation was not a primary concern, off-line coupling could be used 
to allow both dimensions to be optimized without concern as to run time.  Second, it was 
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desired to use ultra-high pressure liquid chromatography (UHPLC) for the second dimension 
of the separation.  UHPLC is an enhancement of HPLC which offers improved 
chromatographic performance without long run times.2-6  A description of UHPLC and an 
explanation as to why it could not be used with on-line coupling are provided in the next 
section. 
3.1.2 UHPLC in multidimensional separations: benefits and challenges 
In two dimensional separations, as in any other form of chromatography, it is 
desirable to generate very high peak capacity in as short a time as possible.  In reality, some 
compromise between speed and resolution must be made, the specifics of which depend on 
the nature of the sample to be analyzed.  UHPLC has the potential to substantially enhance 
either the speed or the peak capacity of LC x LC, or even both simultaneously to some 
extent.  The basis for this potential improvement is briefly described below, in terms of 
standard one-dimensional chromatographic theory. 
3.1.2.1 UHPLC theory 
The efficiency of a chromatographic separation can be described by the height 
equivalent of a theoretical plate (H), where lower values of H correspond to more efficient 
separations.  The Van Deemter equation describes the relationship between H and mobile 
phase flow velocity (u) as the sum of three major terms, A, B and C, each of which represent 
a different contribution to band-broadening in a chromatographic column.   
 Cu
u
BAH ++=  (Equation 3-1) 
The A-term corresponds to Eddy diffusion, the B-term to longitudinal diffusion, and the C-
term to resistance to mass transfer.  For more efficient separations, it is advantageous to 
minimize the value of all of these terms.  The magnitude of two of the terms is known to be 
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related to the diameter of the particles (dp) with which the column is packed: A is 
proportional to dp and C is proportional to dp2.  Therefore, it is desirable to use the smallest 
possible particles in order to achieve the highest efficiency.  An added benefit of smaller 
particles is that the optimum linear velocity – that is, the value of u that gives the most 
efficient separation – increases as particle diameter decreases.  Therefore by decreasing 
particle diameter, it is possible to perform both faster and more efficient separations. 
The drawback to small particles is that they have higher flow resistance than 
conventional-sized particles when packed in a column, and therefore generate greater 
backpressures.  Conventional LC pumps are limited to a maximum operating pressure around 
400 bar (6,000 psi), which can quickly be exceeded with particles of 1-2 μm in diameter.  
One option is to decrease the column length to a few centimeters or less; this results in faster 
separations.7  However, due to the loss of column length no gain in separation efficiency is 
achieved.  An alternative is to use specialized pumps capable of producing substantially 
higher pressures in order to overcome the increased flow resistance.  The resulting 
technology is termed ultra-high pressure liquid chromatography (UHPLC) or ultra 
performance liquid chromatography (UPLC).  Runs have been successfully performed at 
pressures up to 6900 bar (100,000 psi) using packed capillary columns.6  UHPLC has 
demonstrated plate counts over 350,000 for isocratic reversed-phase separations4 and peak 
capacities over 1,000 using gradient elution.8 
3.1.2.2 UHPLC for LC x LC: high speed vs. high peak capacity 
If the main goal for a 2D separation is a short total analysis time, UHPLC is 
theoretically quite attractive.  If on-line coupling of dimensions can be used, the limiting 
factor for the speed of a 2D separation is the time it takes to complete each second-dimension 
run.  If this time is decreased, the first column can be sampled at shorter intervals and 
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therefore can be run faster, thus reducing the total analysis time.  The high pressure 
capabilities of UHPLC pumps can be devoted to generating very fast runs in relatively short 
columns.  With the small particles used in UHPLC, fast runs do not result in excessive 
compromise in terms of chromatographic efficiency, so relatively high performance can be 
maintained.  Therefore fast UHPLC is potentially well-suited to use as the second dimension 
of an on-line 2D separation.  At the time when the research presented in this chapter was 
performed, however, a practical difficulty prevented UHPLC from being used in this manner.  
Automated switching valves with low internal volumes – a necessary component for on-line 
coupling – were not compatible with use at ultra-high pressures.  Very recently, some 
manufacturers have introduced valves which support operation at up to 1,400 bar (20,000 
psi) and even some specialized valves which can be used up to 2800 bar (40,000 psi).9  As 
the use of UHPLC becomes more widespread, a greater variety of such valves will become 
available.  It is therefore reasonable to anticipate that on-line LC x LC separations using 
UHPLC will be feasible in the near future. 
Another important benefit of UHPLC in the context of LC x LC is its potential to 
generate very high resolution separations.  As previously discussed, the peak capacity of a 
multidimensional separation is equal to the product of the peak capacities of each dimension 
as long as all separations are orthogonal and no resolution gained using one dimension is lost 
in any subsequent dimension.10  Since reversed-phase UHPLC can give peak capacities well 
into the hundreds as a 1D technique, it is easy to conceive that extremely powerful 
comprehensive 2D separations could be performed if UHPLC is appropriately combined with 
a second, orthogonal separation method.  As already discussed, off-line coupling is a good 
option for LC x LC separations when the main goal is to maximize resolution.  For this 
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reason, the research reported in this chapter uses off-line coupling to interface the first 
dimension to the second. 
3.1.3 Electrospray ionization mass spectrometry of proteins 
Within the past two decades, mass spectrometry has revolutionized the field of 
proteomics by enabling rapid, accurate identification and characterization of proteins.  One 
crucial development which made these advances possible was the introduction of 
electrospray11 and MALDI12 ionization techniques.  These methods allow large molecules 
such as proteins to be ionized and converted to the gas phase without undergoing degradation 
or fragmentation.  Electrospray ionization is of particular interest in the present study because 
of the ease with which it can be coupled to liquid chromatography. 
In electrospray ionization, a solution containing the sample to be analyzed is passed 
through a capillary with a narrow-diameter tip.  In the case of LC-MS, this solution can be 
the effluent of a separation column.  A high electric potential (typically several kV) is applied 
either to the capillary or to the solution, which causes a very fine spray of charged droplets to 
form at the capillary tip due to electrostatic forces.  As the droplets pass through the air, 
solvent molecules evaporate, decreasing the size of the droplet and leaving it with a higher 
charge density.  Once the charge density becomes too great – termed the Rayleigh limit – the 
droplet fissions to produce multiple droplets in a process called Coulombic explosion.13  This 
process repeats, yielding progressively smaller droplets.  Ultimately, the analyte molecules 
become completely free of solvent, while retaining the charge originally carried by the 
droplets.  The precise mechanism by which the analyte molecules transition to the gas phase 
is still under debate, and may depend on the properties of the analyte.13  Proteins tend to form 
multiply-charged protonated molecular ions, [M+nH]n+,  during electrospray.  Regardless of 
the mechanism, the gas-phase ions enter the mass spectrometer through an orifice in a 
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sampling cone.  Inside the mass spectrometer, the ions are placed under vacuum and are 
accelerated using an electric field.  They are then separated based on their mass-to-charge 
ratio (m/z) using any of a variety of mass analyzers, and subsequently detected. 
 In this experiment, electrospray-time of flight mass spectrometry (ESI-TOF-MS) was 
used to detect proteins eluting from a reversed-phase LC column.  Much of the work in top-
down proteomics to date has used higher resolution mass analyzers, such as Fourier 
transform - ion cyclotron resonance (FTICR) instruments, in order to enable gas phase 
fragmentation of proteins.1  In general, however, TOF analyzers provide adequate resolution 
to measure intact protein molecular weight within a few Daltons, as was the goal for this 
experiment. In addition to the information gained by measuring protein MW, mass 
spectrometry has the advantage of being a very sensitive detection method.  When low flow 
rates are used, as in the capillary LC separations described in this chapter, its sensitivity 
easily surpasses that of optical detection methods such as UV absorbance. 
3.2 Experimental  
3.2.1 Overview 
A general diagram of the instrumentation and procedure used for LC x UHPLC is 
shown in Figure 3-1.  Conventional-pressure anion exchange chromatography is used to 
separate proteins in the sample according to their charge in the first dimension.  Interfacing 
between the two dimensions is accomplished by fraction collection after dimension 1, 
followed by lyophilization of the volatile mobile phase and reconstitution of the fractions in 
order to concentrate the proteins.  All fractions are then analyzed on the second dimension, 
ultra-high pressure reversed-phase liquid chromatography, which separates based on 
hydrophobicity.  The outlet of the reversed-phase capillary column is directly interfaced with 
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a mass spectrometer to carry out on-line electrospray time-of-flight MS, which provides 
intact molecular weight information for all detectable proteins. 
3.2.2 Samples and reagents 
Ammonium acetate and formic acid (ACS reagent grade) were purchased from 
Sigma-Aldrich (St. Louis, MO).  Ammonium hydroxide (ACS reagent grade) and acetonitrile 
(HPLC grade) were purchased from Fisher Scientific (Fair Lawn, NJ).  Deionized water was 
purified using a Barnstead Nanopure System (Boston, MA). 
The samples analyzed in these experiments were an extract of the soluble proteins of 
the bacterium Escherichia coli.  Two different samples were used.  The first is from E. coli. 
K12 strain MG1655 wild type, and was prepared by Eric Hamlet in the Giddings lab in the 
Department of Microbiology and Immunology at the University of North Carolina at Chapel 
Hill, using the procedure described in Section 2.2.1.2.  The second extract was prepared from 
E. coli strain DH5α (Q-BIOgene, Irvine, CA) by researchers at Waters Corporation (Milford, 
MA), using the procedure set forth by Millea et al.14 
3.2.3 Dimension 1: anion exchange chromatography 
3.2.3.1 Columns and instrumentation 
The first dimension of the 2D separation was performed using an anion exchange 
column.  Initially, the column used was the Waters Biosuite Q 10 μm AXC (7.5 cm x 7.5 mm 
ID), referred to hereafter as the short AXC column.  In order to improve resolution, a 
custom-packed anion exchange column (111 cm x 6.6 mm ID) was also used; it is referred to 
hereafter as the long AXC column.  For a more detailed description of the preparation of this 
column, see section 2.3.1.3.  The anion exchange gradient was generated by a Waters 600E 
quaternary gradient LC pump.  The pump is connected to a Valco 6-port valve (VICI, 
Houston, TX) with a 100 μL sample loop, which is used to inject sample onto the column.  
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Detection was performed using an Applied Biosystems 785A UV absorbance detector 
(Foster City, CA) set at 280 nm. 
3.2.3.2 Chromatographic conditions 
For anion exchange separations, mobile phase A was 25 mM ammonium acetate, 
adjusted to pH 8.5 with ammonium hydroxide.  Mobile phase B was 1M ammonium acetate, 
adjusted to pH 8.5 with ammonium hydroxide.  The gradient program is as follows: after 
sample injection, a linear gradient from 0% to 50% B was run over 30, 60 or 120 minutes 
(for the short AXC column) or 360 minutes (for the long AXC column).  The mobile phase 
was then ramped to 75% B over 5 minutes and was held at this composition for 15 minutes 
(short AXC column) or 45 minutes (long AXC column) to ensure complete elution of all 
proteins.  The mobile phase was then returned to 100% A.   The flow rate for the short AXC 
column was 0.5 mL/min; for the long AXC column it was 0.39 mL/min. 
3.2.4 Fraction collection and lyophilization 
After passing through the UV detector, the effluent from the anion exchange column 
was sent to a Waters Fraction Collector II, which automated collection of fractions in 2 mL 
polypropylene centrifuge tubes.  For the runs with the short AXC column, fractions were 
collected every 3 minutes, beginning as soon as the sample was injected, for a volume of 1.5 
mL per fraction.  For the long column, fractions were collected every 5 minutes, beginning 
50 minutes after the sample was injected (the dead time of the column); each fraction had a 
volume of 1.95 mL.  The total number of fractions varied depending on the length of the 
gradient: 15 were collected for the 30 minute gradient, 25 for the 60 minute gradient, 40 for 
the 120 minute gradient, and 80 for the 360 minute gradient.  After collection, fractions were 
flash-frozen using liquid nitrogen and were then placed in a SpeedVac Concentrator 
(Thermo-Electron, Bellefonte, PA), which was pumped down to pressures between 10-2 to 
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10-3 Torr using an Edwards double-stage rotary vacuum pump (Wilmington, MA).  Once the 
fractions had been lyophilized to dryness, they were reconstituted in 100 μL of a solution of 
10% acetonitrile and 90% water (v/v).  The fractions were then ready for analysis on the 
second dimension. 
3.2.5 Dimension 2: ultra-high pressure reversed phase liquid chromatography 
3.2.5.1 Columns and instrumentation 
The second dimension RPLC separations were performed using capillary columns 
prepared in lab.  The columns are packed with 1.5 μm diameter bridged ethyl hybrid (BEH) 
particles with a C18 stationary phase.  A typical column used for the separations reported in 
this chapter was 45 cm long and had an ID of 50 μm.  A detailed characterization of the BEH 
particles, including a description of the procedure used to pack them in capillary columns, 
has been reported previously.5  These particles have also been successfully used for intact 
protein separations at ultra-high pressures.15, 16   
A custom-built LC system was used to perform gradient reversed phase separations at 
ultra-high pressures.15  The system was designed and constructed by Geoff Gearhardt and 
Keith Fadgen at Waters Corporation.  A photograph of the instrument is shown in Figure 3-2; 
a schematic diagram is shown in Figure 3-3.  The instrument consists of two separate pumps.  
The first is a Waters CapLC, which is a conventional gradient pump with a 350 bar (5,000 
psi) pressure limit.  It also has an integrated autosampler.  This pump is responsible for 
injecting the sample and generating the reversed phase gradient to be run on the column. The 
second pump is actually a hybrid of a Waters 1525 HPLC which has been modified to pump 
automotive brake fluid, and a custom-designed hydraulic-amplifier which amplifies the 
fluidic pressure produced by the 1525 to generate the ultra-high pressures used to carry out 
the separation.  It is capable of generating pressures up to 3100 bar (45,000 psi).  The outlet 
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of the CapLC and hydraulic amplifier pumps are connected to a 4-port stainless steel high-
pressure union, as are the capillary column and an open-tubular split flow capillary (1.3 m 
long, 10 μm ID).  The hydraulic amplifier pump connects to the 4-port union through the 
gradient storage tubing, which is a 5 meter long length of 0.020” ID stainless steel tubing 
used to store the gradient loaded by the CapLC pump.  After loading, the gradient is sent 
onto the column by the hydraulic amplifier pump.  Also in the fluidic flow-path are two air-
actuated on/off pin valves, model ASFVO, from Valco.  One valve is located between the 
CapLC and the 4-port union; the second is located at the outlet of a pressure release vent on 
the hydraulic amplifier pump.  Although the valves are only rated for use up to pressures of 
700 bar (10,000 psi), we have found that they give many months of reliable service at 
pressures up to 1700 bar (25,000 psi), and can tolerate occasional use at pressures up to 2800 
bar (40,000 psi).  All of the instrumentation is controlled via a PC, using both the software 
package MassLynx 4.0 (Waters) and a custom-written software program for the hydraulic 
amplifier pump. 
A schematic diagram of the instrument which illustrates the process of performing a 
run is shown in Figure 3-3.  A vial containing the sample to be injected is placed in the 
autosampler tray of the CapLC.  With valves 1 and 2 in the open position, the CapLC 
generates an acetonitrile/water gradient, which travels through the 4-port union and onto the 
gradient storage tubing.  Since the gradient will later be forced onto the column by the ultra-
high pressure pump, which is located on the opposite end of the storage tubing, the gradient 
must be loaded in reverse – that is, beginning with the highest desired acetonitrile content 
and ending with the lowest.  The CapLC is typically set to load the gradient at a flow rate of 
40 μL/min, whereas the ultra-high pressure pump operates at 2 μL/min when a run is in 
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progress.  Therefore, a gradient that will run for 60 minutes only takes 3 minutes to load onto 
the gradient storage tubing.  Once loading of the gradient is complete, the CapLC loads a 
plug of the sample, typically 0.1-10 μL in volume, onto the storage tubing in the same 
manner.  Although the column and splitter are not blocked while the gradient and sample are 
being loaded, they both have a very high flow resistance compared to the gradient storage 
tubing, so only a miniscule amount of flow enters the column before the run begins. 
Once the sample has been loaded, the ultra-high pressure run is ready to begin, so 
valve 1 is closed in order to isolate the CapLC pump from ultra-high pressures.  Valve 2 is 
also closed, and then the ultra-high pressure pump is activated in order to bring the system to 
the desired run pressure – 1600 bar (23,000 psi) is typical.  Once this pressure is reached, the 
pump operates at a constant flow rate of 2 μL/min.  The splitter capillary diverts most of the 
flow from the gradient storage tubing and maintains appropriate pressure at the head of the 
column.  The flow rate through the separation capillary depends on this pressure, as well as 
the length and diameter of the column and the size of the packing material.  For a 50 μm ID 
capillary column, a flow rate of about 100 nL/min is typical, which means the split ratio is 
approximately 20:1.  The sample in the gradient storage tubing is the first liquid which enters 
the column.  Next, the column experiences the stored gradient, which is transferred to the 
column in the normal manner of low to high acetonitrile concentration. 
3.2.5.2 Chromatographic conditions 
For reversed phase separations, mobile phase A was deionized water with 0.2% (v/v) 
formic acid (ACS reagent grade, Sigma-Aldrich).  Mobile phase B was acetonitrile (HPLC 
grade, Fisher) with 0.2% (v/v) formic acid.  Runs were performed using a linear gradient 
from 10% to 60% MP B over 60 minutes, followed by a 10 minute hold at 60%B, and then a 
return to initial conditions. 
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3.2.6 Electrospray – time of flight MS detection 
The outlet of the separation column was coupled using a Teflon sleeve to a fused 
silica PicoTip nano-electrospray emitter purchased from New Objective (Woburn, MA).  The 
emitter, which is model #FS360-20-5-CE, has an inner diameter of 20 μm which tapers to 5 
μm at the tip.  It has a conductive coating, which allows electrospray voltage to be applied by 
placing a light-weight wire loop around the emitter, then connecting the other end of the wire 
to the capillary voltage power supply on the mass spectrometer.  The tip of the emitter was 
placed a few millimeters away from the sample cone of the mass spectrometer and was 
oriented perpendicular to its orifice.  The emitter-to-cone distance was manually optimized to 
give the best signal. 
On-line positive ion mode electrospray - time of flight MS was performed using a 
Micromass Q-TOF Micro instrument (Waters).  A capillary voltage of 2000 V, a sample cone 
voltage of 40 V, and an extraction cone voltage of 3 V were used for runs in this experiment.  
The source temperature was set at 100 ºC; no desolvation gas was necessary for stable 
electrospray at the flow rates used.  Mass spectra were acquired at a frequency of 2 Hz over a 
mass range from 450-1600 Da for the duration of the run.  Although the instrument is 
capable of tandem mass spectrometry, it was operated in TOF-only mode for the experiments 
reported in this chapter.    All mass spectra were acquired using the software package 
MassLynx 4.0. 
3.2.7 Data analysis 
2D chromatograms were prepared by loading total ion current data from each 
reversed-phase chromatogram into the data analysis software program Igor Pro 
(Wavemetrics, Lake Oswego, Oregon).  In Igor Pro, the data from all fractions in an anion 
exchange run were combined into a two-dimensional data set. The data was plotted as an 
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image to generate a 2D chromatogram.  The upper limit of the intensity scale was usually set 
by the most intense peak in the chromatogram, although in some cases the most intense peaks 
were intentionally set off-scale in order to allow lower intensity components to be seen. 
In the case of the run performed using the long AXC column, an additional method is 
used to generate an enhanced 2D chromatogram.  All of the LC-MS data from the second-
dimension runs were processed using AutoME, a software program written by Ignatius Kass 
at Waters Corporation.  Figure 3-4 illustrates the steps AutoME uses.  First, it divides a 
chromatogram up into time segments, typically 6 seconds wide, as indicated by the dashed 
vertical lines on the chromatogram in Figure 3-4A. All mass spectra acquired within each 
time segment are combined into a single spectrum, an example of which is illustrated in 
Figure 3-4B.  An iterative mathematical process called maximum entropy (MaxEnt) is used 
to de-convolute the experimental data, which contains ions in multiple charge states, to give a 
model spectrum in which all components have zero charge.17  An example of a mass 
spectrum before and after MaxEnt de-convolution is shown in Figure 3-4B and C.  Various 
parameters can be specified which affect the manner in which de-convolution is performed.  
For this experiment, these parameters were set such that the resolution of the output spectrum 
is 1 Da, the time segment width is 6 seconds, the range of masses in the output spectrum is 
3,000-60,000 Da, and the maximum number of iterations used is 50.  Once all data from a 
chromatogram is processed using AutoME, a custom-written Igor Pro function is used to 
determine the most intense peak (termed the “base peak”) in each time segment.  The 
intensity of this peak is then plotted against the original retention time of the time segment; 
the result is called a base peak intensity (BPI) chromatogram.  An example is shown in 
Figure 3-4D.  When all of the base peak chromatograms for the RPLC runs in a 2D 
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separation are combined using Igor Pro, a 2D base peak intensity chromatogram can be 
produced. 
To determine the molecular weight of the proteins in the E. coli sample, two different 
methods are possible.  For those chromatograms processed using AutoME, a list of the de-
convoluted protein masses is automatically generated as a part of data processing.  However, 
AutoME processing could not be used on the runs performed using the short AXC column 
because the MS data were acquired with an intensity threshold to reduce noise, which 
precludes MaxEnt processing.  Therefore, a manual de-convolution approach was employed.  
All chromatograms were thoroughly surveyed for peaks that gave a detectable charge 
envelope.  When such a peak was found, all MS scans under the peak were summed, and the 
resulting mass spectrum was background subtracted, smoothed and centered according to 
MassLynx default parameters to convert the spectrum from continuum data to a line 
spectrum.  Then an adjacent pair of ions from the same charge envelope in the mass spectrum 
was identified visually.  Using the MassLynx “Find Manual” dialog, the ion pair’s m/z values 
were used to discover all remaining ions in the same series and calculate the actual molecular 
weight of the intact protein.  If more than one charge envelope was present in the same mass 
spectrum, all other detectable protein masses were also measured.  This procedure was 
repeated in the same manner for all peaks in all of the chromatograms, and protein mass data 
were recorded in tabular form.   
Identification of the proteins based on their molecular weight was not attempted 
because mass accuracy was not sufficient to distinguish between the thousands of proteins 
known to be produced by E. coli.  Instead, the data were used to determine the number of 
probable unique protein masses detected in each fraction and in each 2D run.  To generate 
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this list, two steps were required.  First, multiple forms of the same protein must be 
disregarded.  Within a mass spectrum of a chromatographic peak, often one main component 
is present along with several other less intense components with a higher or lower mass, 
typically within a few hundred Da of the most intense component.  Potential explanations for 
these additional components include different post-translational modifications of the same 
protein, or the formation of non-covalent adducts between proteins and ions other than H+ 
(e.g., Na+, K+, or other metals) during electrospray ionization.  Regardless of the origin of 
these extra masses, since their retention time is identical to the main component, they are 
interpreted as being different forms of the same protein.  Therefore only the most abundant 
mass in the spectrum was counted as a unique protein; all additional masses within a set 
range of this mass (typically +/-500 Da) were disregarded.  Second, duplicate masses 
between fractions needed to be removed.  If the same protein mass (within an error of +/- 5 
Da) appeared in more than one fraction in a 2D run, it was counted as being found only in the 
fraction where its intensity was the greatest.  Once duplicates and multiple forms of the same 
protein were eliminated from the list, it was considered complete and the total number of 
proteins detected was tallied. 
3.3 Results and discussion 
3.3.1 Anion exchange separations 
Two different E. coli protein extracts, described in section 3.2.2, were analyzed in the 
experiments reported in this chapter.  Although both samples are derived from the same 
species, differences between the strains and the procedures used to produce the extracts are 
likely to result in differences in the proteins which are present in each of the samples.  To 
perform a simple comparison of the two protein extracts, anion exchange separations of both 
samples were run under identical conditions, using a 30 minute gradient from 25 to 500 mM 
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ammonium acetate (pH 8.5).  UV absorbance chromatograms from both separations are 
shown in Figure 3-5.  It is immediately apparent that there are substantial differences 
between the samples.  Peaks appear to be spread over the same range of retention time, but 
prominent peaks present in one sample are often absent in the other.  It appears that the strain 
DH5α E. coli sample prepared by Waters Corporation produces more total peaks.  It is 
impossible to determine from these chromatograms how the samples differ in terms of 
protein identities and quantities.  Nevertheless, it is clear that the two samples cannot be 
considered equivalent for the purpose of comparing runs performed under different 
chromatographic conditions.  For the remaining runs reported in this chapter, runs performed 
using the short AXC column analyzed the protein extract from the MG1655 strain, whereas 
the long column was used to analyze the DH5α strain. 
Figure 3-6 shows the UV absorbance chromatograms from three anion exchange 
separations of the MG1655 strain E. coli protein extract.  The goal of these separations was 
to study the effect of changing the anion exchange gradient length on peak capacity and total 
number of proteins detected in the 2D separations.  The sample is too complicated to be fully 
resolved by any of the anion exchange separations, as indicated by the presence of 
overlapping peaks throughout all of the chromatograms.  Nevertheless, by extending the 
gradient from 30 minutes to 60 minutes or 120 minutes, some additional resolution is gained.  
Although it is difficult to assign a peak capacity to these separations without fully-resolved 
peaks, rough estimates for the peak capacity are 20, 30, and 42, for the 30, 60, and 120 
minute gradients, respectively. 
A chromatogram from a 360-minute gradient separation of the E. coli DH5α strain 
protein extract using the long AXC column is shown in Figure 3-7.  As explained previously, 
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a direct comparison between the peaks observed in this separation and those from the short 
AXC columns is not possible due to the differences in the samples.  However, it is clear that 
the peak capacity is substantially higher in this separation than in any of the runs performed 
on the short AXC column – 80 is a reasonable estimate.     
3.3.2 UHP – RPLC separations 
After being lyophilized and reconstituted, fractions from the anion exchange 
separations were analyzed on the second dimension, UHP-RPLC.  For each anion exchange 
separation, a series of reversed-phase chromatograms are produced.  A representative 
chromatogram of a reversed-phase separation of one anion exchange fraction is shown in 
Figure 3-8.  The chromatogram is a plot of the total ion current (TIC) measured by the mass 
spectrometer as a function of retention time.  Peaks typically do not appear until after 15-30 
minutes in most of the reversed-phase chromatograms, mainly because of the delay 
associated with transferring the sample from the gradient storage tubing onto the reversed 
phase column.  Further inspection of the chromatogram reveals that there is a great deal of 
variability in peak shape.  Some peaks are sharp and symmetrical, having base widths as 
small as 10 seconds.  Some proteins co-elute, causing overlapping peaks and distorted peak 
shape.  Some non-overlapping peaks, particularly those appearing late in the chromatogram, 
are also broad and asymmetrical, having notable tailing and widths as large as several 
minutes. Assuming an average peak width of 20 seconds and an elution window of 33 
minutes, an estimated peak capacity for this separation would be 100, which is a relatively 
high number for a 1D intact protein separation.   
Although the observed inconsistency in peak shape is clearly not desirable, it is not 
atypical of reversed-phase protein separations due to non-ideal interactions between proteins 
and the stationary phase.18-21  Another factor which contributes to the large width of some 
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peaks is column overloading.  In order to be able to detect minor components of the sample, 
a relatively large volume of sample must be injected onto the column.  This high loading 
saturates the stationary phase with the most abundant proteins and causes them to elute as 
intense, broad peaks.  One option to remedy this problem is to reduce column loading and 
use a more sensitive mass spectrometer with a wider dynamic range.  Due to the expense of 
cutting-edge mass spectrometers, this is not often feasible, so another means to combat the 
dynamic range issue is with higher chromatographic peak capacity.  Although increasing 
peak capacity does not diminish column overloading, the chances of a broad peak 
overwhelming smaller adjacent peaks are reduced when the peaks are spread over a larger 
field of separation space.  The high total resolving power of the UHP-RPLC separation is 
beneficial in this regard.  This is also a significant argument in favor of 2D separations.  The 
multiplicative peak capacity provided by 2D separations greatly increases separation space, 
which reduces the probability of peak overlap even when sample loading is high. 
3.3.3 2D Chromatograms 
Two-dimensional chromatograms can be generated by displaying a series of the 1D 
RPLC chromatograms side by side.  Figure 3-9A is an example of such a plot, created using 
chromatograms from the RPLC separations of fractions from the 60 minute gradient AXC 
separation of the E. coli protein extract.  The chromatograms are offset from one another 
both horizontally and vertically, so that the baselines of all of the traces can be seen.  A 
different color is also used for each chromatogram to make them easier to distinguish.  The 
result is a rudimentary “3D” visualization of the 2D separation.  The figure does reveal the 
complexity of the sample and the distribution of its components over the both separation 
dimensions.  One disadvantage of this type of plot, however, is that high intensity 
components which appear in chromatograms toward the front obscure the peaks that appear 
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further back.  An alternate means of visualizing the data is to plot it on a planar 2D surface as 
shown in Figure 3-9B.  First dimension retention time is plotted on the Y-axis, and second-
dimension retention time is shown along the X-axis.  Intensity is indicated by color rather 
than by peak height.  Although the color scale is arbitrary, it allows simple visual comparison 
of peak intensity within a chromatogram and between chromatograms.  In general, this 
method of visualization is more useful than a 3D plot, since all of the data is clearly visible in 
a single figure.   
In Figure 3-10, 2D chromatograms are shown for separations of the E. coli protein 
extract performed using 30, 60 and 120 minute gradients on the short AXC column.  The data 
are scaled such that the maximum peak intensity is represented by the color at the top of the 
scale (black).  It is possible to estimate a peak capacity for the 2D separations by multiplying 
the peak capacity of each dimension.  Although the peak capacities of the AXC separations 
were already determined from their UV chromatogram, these estimates are not valid for the 
2D separation, since the maximum effective peak capacity from the first dimension cannot be 
greater than the total number of fractions collected.  Since some, but fewer than half, of the 
peaks appear to be split between two fractions, it is reasonable to use 2/3 of the total number 
of fractions that contained protein peaks as a conservative estimate for the first-dimension 
peak capacity.  If the second dimension peak capacity is taken to be 100 for all of the RPLC 
separations, the resulting total peak capacities of the 2D separations are approximately 900 
for the 30 minute separation, 1200 for the 60 minute separation, and 1900 for the 120 minute 
separation.  If the anion exchange column had been sampled by a greater number of 
fractions, these peak capacities would have been substantially higher 
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In comparing the three chromatograms, it is apparent that the general pattern of the 
elution profile is similar for all three runs.  Numerous peaks appear within the first 12 
minutes of anion-exchange retention time in all three 2D chromatograms.  These correspond 
to the proteins that were un-retained or very lightly retained on the anion exchange column, 
which implies that they are the most basic proteins in the sample.  There is then a gap of 
several minutes where few peaks appear; the gap is longer for the shallower anion exchange 
gradient and shorter for the steep one.  The time after this gap at which peaks reappear 
corresponds to the point on the gradient when the salt concentration is high enough to begin 
eluting proteins that were retained on the anion exchange column.  Peaks are spread over a 
fairly wide portion of the available separation space, although certain areas of the 2D plot 
clearly contain greater concentrations of protein than others.  Additionally, there seems to be 
a weak correlation between retention on the two dimensions – proteins that elute early from 
the anion exchange column (the most basic proteins) also tend to elute earlier in the reversed-
phase runs.  This correlation is expected, however, since many of E. coli’s most basic 
proteins are ribosomal proteins, which also tend to be fairly hydrophilic and thus are 
expected to be lightly retained on the reversed-phase column.  In general, however, the two 
separation methods appear to be relatively orthogonal in that peaks are spread over a 
relatively wide range of the available 2D separation space. 
As the anion exchange gradient is lengthened, more detail becomes visible in the 2D 
chromatograms.  Regions that appear laden with many overlapping, high intensity bands in 
the chromatogram from the steepest anion exchange gradient begin to separate into resolved 
peaks with the longer gradients.  Another trend is that the intensity of all peaks seems to 
diminish as the anion exchange gradient is lengthened.  This is most apparent in Figure 
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3-10C, which is the 2D chromatogram generated from the 120 minute anion exchange 
gradient.  Not only is the maximum peak intensity lower, but also the peaks which elute late 
in the gradients (those in the upper right of the chromatogram) seem to be lower in intensity 
relative to other peaks.  The notable decrease in sensitivity as the gradient is made shallower 
is consistent with previous observations from gradient reversed-phase and ion exchange 
separations of proteins.22  Additionally, it has been shown that, for a given column length, the 
peak capacity of a separation will reach a maximum at some gradient length, and that making 
the gradient shallower beyond this point will result in no further improvement of peak 
capacity.23, 24  Both of these factors emphasize that there is a point of diminishing returns 
when attempting to improve resolution by lengthening the gradient. 
If the column length is increased, however, the potential exists to take advantage of 
much longer gradients, as discussed in section 2.3.2.  A 2D chromatogram from a separation 
of the DH5α strain E. coli protein extract performed using the long AXC column is found in 
Figure 3-11.  A total of 80 fractions were transferred to the second dimension, although only 
about the first 56 fractions contained detectable protein peaks, so only these fractions are 
displayed in the chromatogram.  The data are scaled such that a few of the most intense peaks 
are off scale, in order to allow peaks of low intensity to be seen more clearly.  In general, it is 
apparent that this separation has substantially higher peak capacity than any of the 
separations performed using the short AXC column.  Using 2/3 of the number of fractions 
containing proteins as the AXC peak capacity, and 100 as that of the second dimension gives 
a total peak capacity of 3700.  Another notable feature in the chromatogram is the “stripe” of 
peaks running throughout all fractions at a reversed-phase retention time of 35 minutes.  
Based on its mass spectrum, it was determined to be a non-protein component with an m/z of 
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679.  Although its origin was initially unknown, it served as a convenient “alignment” 
marker which allowed retention times to be adjusted to compensate for retention time drift, 
which is a problem with the stored gradient UHP-RPLC pump.  It was later determined that 
the source of this peak was a contaminant originating from nylon membrane filters used to 
prepare the LC-MS mobile phase;25 eliminating this step removed the contaminant peak. 
 A second chromatogram was produced for the same 2D separation using the data de-
convoluted by AutoME as described in section 3.2.7.  The chromatogram, shown in Figure 
3-12, is a plot of base peak intensity – that is, the intensity of the single most intense 
component at each point in the chromatogram.  Also, only components within the mass range 
specified for de-convolution (3,000-60,000 Da) are considered, so non-protein components 
do not appear in the chromatogram.  In general, the BPI chromatogram is substantially 
“cleaner” in appearance than the 2D TIC chromatogram.  The contaminant peak seen in all 
fractions is gone, many areas in the TIC chromatogram which were filled with low intensity 
noise are completely empty, and some peaks which appeared to be tailed are more 
symmetrical.  These improvements make it easier to distinguish actual protein peaks, and 
would facilitate comparisons of different chromatograms.   
3.3.4 Protein mass spectrometry data 
Many of the trends that can be visually observed by examining the 2D 
chromatograms are also supported by the mass spectrometry data.  Figure 3-13 presents 
graphs of the number of probable unique protein masses found in each fraction of the three 
2D runs performed using the short AXC column.  As was noted in the chromatograms, in all 
of the runs there is a spike in the number of proteins detected in the second fraction, which 
corresponds to proteins not retained by the anion exchange column.  This is followed by a 
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gap of several fractions where few proteins are detected.  After the gap, the majority of the 
proteins elute over a range of the next 10 to 25 fractions, depending on the gradient length. 
Several differences between the three runs are also apparent in the MS data.  For one, 
lengthening the anion exchange gradient does spread the proteins over a greater number of 
fractions, as anticipated.  For the 30 minute gradient all proteins elute within 15 fractions, 
whereas they are spread over 31 fractions for the 120 minute gradient.  Also notable is the 
fact that the number of proteins detected in each fraction is substantially less for the 120 
minute anion exchange gradient run than for the 30 or 60 minute gradients.  As the gradient 
is lengthened, many of the proteins that elute in only one fraction in the shorter gradients are 
spread over two or more fractions in the longest gradient, and thus are more dilute.  This 
reduces their MS signal intensity and causes some proteins to fall beneath the detection limit, 
which prevents them from being counted. Just as is the case for the trend observed from 
visual inspection of the 2D chromatograms, the decrease in the number of proteins detected 
is consistent with expected drop-off in sensitivity as gradient length is increased.22 
A plot of the proteins found by fraction for the separation performed using the long 
anion exchange column is shown in Figure 3-14A.  It is immediately apparent that the single 
largest concentration of proteins was found in the first fraction; this is probably because a 
substantial portion of the proteins were not significantly retained by the anion exchange 
column.  The proteins which are retained, however, are spread over a relatively large number 
of anion exchange fractions.  Since a different sample was analyzed, a specific comparison of 
the number of proteins found using the two AXC columns would not be valid. 
Another means of examining the data is by looking at the molecular weight of the 
proteins found in the E. coli samples.  Figure 3-14B and Figure 3-15 show MW distribution 
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histograms for the proteins detected using the long AXC column and the short AXC column, 
respectively.  Proteins were observed over a mass range from 3 to 78 kDa in all of the three 
runs on the short AXC column; on the long column no proteins were observed above 60 kDa 
because this was the upper limit set for the AutoME de-convolution program used to 
determine protein MW for this run.  Clearly, the majority of the proteins detected fall toward 
the low end of the mass range; the bin with the largest number of proteins is 9-12 kDa in all 
separations except the one performed on the long column.  For the long column, the most 
proteins were found in the 3-6 kDa range, which contrasts with the short column runs in 
which relatively few proteins were detected in this range.  This is explained by the fact that 
the sample analyzed on the short column – E. coli strain MG1655 – was depleted of proteins 
below 5 kDa using a MW cutoff filter.  The DH5α strain protein extract was not prepared in 
this manner, so the smaller proteins remain.  Otherwise, all four protein distributions for all 
of the samples look relatively similar, with substantial differences only in the number of 
proteins detected in each size range.   
It is also possible to compare the observed MW distribution data to that which would 
be expected based on known E. coli proteins.  Using the SwissProt database, accessible at 
http://ca.expasy.org/srs5/, the average MW of an E. coli K12 strain MG1655 protein was 
determined to be 35.1 kDa, and the median was 30.6 kDa.  In comparison, for the data from 
the 2D separation using a 60 minute gradient on the short AXC column, the average MW 
was 21.9 kDa and the median was 18.1 kDa.  This indicates that the methods used in this 
study were biased significantly toward detection of smaller proteins.  This is not surprising, 
since electrospray ionization is known to give better results with smaller proteins than with 
larger ones.  Additionally, the theoretical average and median protein MW do not take 
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abundance into account.  It is likely that many of the most abundant E. coli proteins have a 
relatively low MW; these proteins are more likely to be detected than the less abundant 
proteins, many of which may have a higher MW. 
The data from all four 2D runs are summarized in Table 3-1.  The total number of 
unique protein masses found in all fractions increased from 209 to 247 for the 30- and 60-
minute anion exchange gradients, respectively.  This suggests that the increased peak 
capacity contributed by lengthening the anion exchange gradient allows more proteins to be 
resolved and detected.  This trend did not continue when the gradient was lengthened further, 
however, as the number of proteins detected decreased to 176 for the 120 minute anion 
exchange gradient.  This drop-off probably results from the fact that the proteins become too 
dilute when spread over several fractions.  The resulting diminished signal intensity offsets 
any gain in resolution achieved by lengthening the anion exchange gradient beyond a certain 
point.  Therefore, of the separations performed on the short AXC column, the 60 minute 
gradient gave the best results.  A total of 422 probable unique proteins were detected in the 
2D run performed using the long AXC column.  Although direct comparisons with the short 
column are not valid because a different strain of E. coli was used, the improved peak 
capacity generated by the 2D separation using the long column does seem to enable the 
detection of a greater number of proteins. 
3.4 Conclusions 
The peak capacity achieved using the long AXC column as part of a 2D separation, 
estimated as 3700, is one of the highest reported to date for an LC x LC separation of intact 
proteins.  This peak capacity could be increased substantially if the first dimension were 
sampled more frequently, so that no resolution was lost between dimensions.  Also, much 
potential exists to further enhance the capabilities of the system through optimization of both 
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the anion exchange and UHP-RPLC separations.  Although the peak capacity of this system 
still falls substantially short of the capabilities of 2D gel electrophoresis, it is free from many 
of the cumbersome problems that plague gel-based separations.  As further refinements are 
made, it is expected that multidimensional LC using ultra-high pressures will become a 
practical technique for separation of complex samples. 
From a proteomic standpoint, the results of the study were somewhat less 
encouraging.  The total number of probable unique proteins detected – 422 using the long 
anion exchange column – is only approximately 10% of the roughly 4400 proteins predicted 
by the E. coli genome.  It is worth noting that other more exhaustive studies of the E. coli 
proteome have successfully characterized only about 1600 E. coli proteins.26, 27  Therefore, it 
is possible that some proteins predicted by the genome are not transcribed or are produced in 
such small quantities as to render them undetectable to presently available techniques.  Still, 
the present study only detected about 25% of those proteins that have been characterized 
previously.  There are several factors that may contribute to why this percentage is low.  
First, the technique by which proteins were extracted from E. coli was intended to recover 
only proteins in the cytosol; thus all membrane-bound proteins would be excluded from the 
sample.  Secondly, electrospray MS favors detection of small proteins; proteins above 30 
kDa may be under-represented in the proteins detected in this study.  Perhaps the most 
significant challenge, however, is the fact that the concentration of different proteins in the 
sample spans many orders of magnitude.  To see the less abundant proteins requires injecting 
a large amount of sample, but doing so causes column overloading with the most abundant 
proteins.  To remedy this situation would require a mass spectrometer with improved 
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sensitivity and dynamic range, a column with higher loading capacity, or a 2D separation 
with a peak capacity high enough to compensate for the effects of overloading. 
It is also important to note that none of the proteins detected in this study were 
identified.  For true proteomics, this is a critical limitation.  Various techniques could be 
applied to attempt to identify the proteins.  Top-down proteomics involving gas-phase 
fragmentation would be possible; however, it generally requires the use of a mass 
spectrometer with higher resolution than the TOF analyzer used in these studies.  An 
alternative is to incorporate a step involving enzymatic digestion followed by MS/MS and 
database searching into or after the intact protein LC x LC separation.  This concept of a 
hybrid top down / bottom up approach to proteomics will be the focus of the following 
chapter. 
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3.6 Tables 
 
 
 
 
 
 
 
Anion 
exchange 
column 
E. coli strain 
analyzed 
Anion exchange 
gradient length 
# of probable 
unique 
proteins found 
# of fractions with 
probable unique 
proteins 
     
Short MG1655 30 min 209 15 
Short MG1655 60 min 247 21 
Short MG1655 120 min 176 31 
     
Long DH5α 360 min 422 47 
 
Table 3-1: Summary of data from four LC x UHPLC separations of an E. coli protein extract 
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3.7 Figures 
 
 
 
 
 
Figure 3-1: Overview of instrumentation and procedure used for off-line LC x UHPLC-MS 
separations 
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Figure 3-2: Photographs of the pre-loaded gradient UHPLC instrument. (A) shows the entire 
instrument; (B) shows a close-up view of the 4-port high pressure union 
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Figure 3-3: Diagram illustrating the operation of the preloaded gradient UHPLC system.  In 
“LOAD” mode, both pin valves are open.  The CapLC generates a gradient and injects the 
sample, both of which pass through the 4-port union (labeled “injection block”) and are 
loaded into the gradient storage tubing.  In “RUN” mode, both pin valves are closed and the 
hydraulic amplifier pump pressurizes the gradient storage tubing, forcing the pre-loaded 
sample and gradient onto the column.  More details regarding the operation of the instrument 
are found in the text. 
RUN 
LOAD 
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Figure 3-4: Process of generating a BPI chromatogram for intact proteins using maximum 
entropy de-convolution.  Full details are explained in Section 3.2.7 of the text. 
 
111
 
 
Figure 3-5: Comparison of anion exchange separations of E. coli protein extracts prepared 
from strain MG1655 wild type (A) and strain DH5α (B).  Both samples were separated on the 
short AXC column using a 30 minute gradient from 25 to 500 mM ammonium acetate. 
A 
B 
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Figure 3-6: Anion exchange separations of the E. coli protein extract on the short AXC 
column.  The separations were carried out using a gradient from 25 to 500 mM ammonium 
acetate over 30 min (A), 60 min (B), and 120 min (C). Fractions were switched at intervals 
indicated by the dashed vertical lines on the chromatograms. 
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Figure 3-7: Anion exchange separation of the E. coli protein extract on the long AXC 
column.  The separation was carried out using a gradient from 25 to 500 mM ammonium 
acetate over 360 min. 
 
114
 
 
 
 
 
 
 
120x103
100
80
60
40
20
0
TI
C
 s
ig
na
l
605550454035302520151050
Retention time (min)  
 
Figure 3-8: UHP-RPLC separation of one anion exchange fraction of an E. coli protein 
extract on a capillary LC column using nano-ESI-MS detection.  The gradient used was a 
linear ramp from 10 to 65% acetonitrile (with 0.2% formic acid throughout) over 60 minutes. 
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Figure 3-9: LC x LC data displayed in different formats.  In (A), 1D chromatograms are 
displayed side-by-side with a horizontal and vertical offset, which gives a rudimentary 3D 
visualization of the separation.  In (B), the same data is displayed on a planar 2D surface, and 
intensity is represented by a color scale as opposed to peak height.
A
B
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Figure 3-10: 2D chromatograms of the E. coli extract generated using the short AXC column 
with three gradients.  All separations used a linear gradient from 25-500 mM ammonium 
acetate.  The gradient length was 30 min for (A), 60 min for (B) and 120 min for (C).  Peak 
intensity is based on TIC signal. 
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Figure 3-11: Total ion current (TIC) 2D chromatogram of the E. coli extract separated using 
the long AXC column.  The gradient was a linear ramp from 25-500 mM ammonium acetate 
over 360 minutes. 
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Figure 3-12: Base peak intensity (BPI) 2D chromatogram of the E. coli extract separated 
using the long AXC column.  The chromatogram is from the same separation as Figure 3-11, 
except data were de-convoluted using AutoME, and the base peak intensity of components 
within the mass range of 3,000-60,000 Da were plotted. 
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Figure 3-13: Number of proteins found in each anion exchange fraction for 2D separations of 
the E. coli protein extract using the short AXC column. Plots (A), (B), (C) represent the 30, 
60, and 120 minute gradients, respectively. 
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Figure 3-14: (A) Number of proteins found in each anion exchange fraction for 2D separation 
of the E. coli protein extract using the long AXC column; (B) MW distribution histogram for 
proteins found for the 2D separation using the long AXC column 
B 
A 
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Figure 3-15: MW distribution histograms for proteins found in the E. coli protein extract for 
the 2D separation using the short AXC column.  Plots (A), (B), (C) represent the 30, 60, and 
120 minute gradients, respectively. 
CHAPTER 4: Analysis of E. coli proteins and protein digests using off-line LC x 
UHPLC-MS: a hybrid top-down/bottom-up approach to proteomics  
 
4.1 Introduction 
In Chapter 3, a top-down technique for protein analysis using LC x UHPLC-MS was 
reported.  Although the separation generated high peak capacity, a major disadvantage was 
that it was not possible to identify the proteins which were detected because only their intact 
molecular weight was measured using MS.  In this chapter, a method is presented which uses 
top-down intact-protein analysis, but also allows proteins to be identified by incorporating 
elements of a bottom-up approach.  This hybrid strategy is then applied to analysis of the E. 
coli proteome. 
4.1.1 Bottom-up proteomics: overview  
Before presenting research related to combined top-down / bottom-up proteomics, it 
is important to have a well-established theoretical understanding of both methods as 
independent techniques.  Up to this point in the dissertation, substantial emphasis has already 
been placed on top-down proteomics, since all of the separations and mass spectra presented 
have pertained to intact proteins.  Bottom-up proteomics1, 2 – which is also commonly termed 
shotgun proteomics – has only been explained in general terms.  Since it plays a critical part 
in the research presented in this chapter, it is important to introduce some of its theoretical 
and practical aspects. 
Like a top-down experiment, bottom up proteomics begins with a sample containing a 
mixture of proteins, which is subjected to one or more stages of separation and is analyzed 
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using mass spectrometry.  The distinguishing feature which all bottom-up analyses have in 
common is that, at some point before the sample is analyzed by MS, the proteins are 
enzymatically digested to produce peptides.  Once peptide MS data are acquired, they are 
analyzed and used to identify the proteins in the original sample.   
There are two main methods used to identify proteins from peptide MS data: peptide 
mass fingerprinting (PMF) and tandem mass spectrometry (MS/MS).2  A diagram showing 
an overview of a PMF experiment is shown in Figure 4-1.  In this example, the sample 
consists of a single protein which was digested to peptides using trypsin.  The sample is 
separated using RPLC coupled to ESI-TOF-MS, which produces the chromatogram shown in 
Figure 4-1A.  The mass spectra of individual peaks are then examined (Figure 4-1B), and the 
m/z and charge state of all detected components are recorded in a peak list table (Figure 
4-1C).  The peak list is input into a database searching program (Figure 4-1D), which 
compares the peptide masses from the MS data with calculated peptide masses which would 
be expected if known proteins stored in the database were digested using trypsin.  Based on 
the comparison, the program predicts the identity of the protein(s) which were present in the 
sample.  Some limitations of PMF include the fact that many peptides must be detected from 
each protein to ensure accurate identification, and that it works best with samples containing 
only a single protein or a relatively simple mixture. 
The alternative to PMF is tandem MS (MS/MS).  An overview of this method is 
shown in Figure 4-2.  As in PMF, a sample containing enzymatically digested protein(s) is 
separated using LC (Figure 4-2A) and mass spectra of the peptides are obtained (Figure 
4-2B).  Unlike PMF, multiple stages of mass spectrometry are also performed during the 
course of the analysis.  Individual peptide ions are selected using a mass analyzer and are 
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then subjected to fragmentation via collision induced dissociation (CID) or some other 
method.  Fragmentation typically occurs predominantly along the peptide backbone, although 
the mechanism can be complex and has been reviewed in detail elsewhere.3  Mass spectra of 
the fragment ions (Figure 4-2C) allow can then be compared with a database containing 
known protein sequences using a probability-based searching method in order to identify the 
proteins in the sample (Figure 4-2D).  MS/MS has the advantage of being a more selective 
process than PMF; thus proteins can be identified based on mass spectra of just a few – or 
even one – peptide.  It also is generally more successful than PMF with mixtures of greater 
complexity.  A disadvantage of MS/MS is that the duty cycle is low since the instrument is 
constantly being cycled between MS survey and MS/MS modes. 
4.1.2 Top-down and bottom-up proteomics: complementary techniques 
Although it is a well-established method of identifying proteins, there are substantial 
disadvantages inherent to all forms of bottom-up proteomics.  For one, the complexity of the 
sample is increased when an already complex mixture of proteins is digested to peptides.  
This makes the separation more difficult.  Also, sequence coverage of any given protein is 
often low.  Thus, any unknown post-translational modifications on portions of the protein 
which were not detected will not be discovered. 
Top-down proteomics offers an advantage over bottom-up in that it allows the intact 
molecular weight of all proteins to be measured, which is useful for study of protein 
processing or detection of post-translational modifications.4  Its major problem, however, is 
that identification of proteins is not often straightforward.  Identification has been 
demonstrated by using MS/MS of intact proteins to search for patterns of fragmentation 
which can uniquely identify a protein.  However, high-cost mass analyzers such as an  
FTICR5 or Orbitrap6 are required to attain the needed high resolution and mass accuracy.  An 
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alternative is to use a charge-state reduction method, in which ion-ion reactions are used to 
convert multiply charged ions to singly charged ions.7, 8  This allows intact protein MS/MS to 
be performed using lower resolution mass analyzers, such as a quadrupole ion trap.  
Although this method has gained some acceptance, further development will be required to 
make charge state reduction a practical mainstream technique.  Thus, protein identification 
using the top-down approach remains difficult. 
Clearly, there are distinct limitations associated with both top-down and bottom-up 
proteomic methods.  Fortunately, the weaknesses of one technique tend to be strengths of the 
other.  Simpler separations and better ability to detect post-translational modifications are 
advantages of the top-down approach, whereas well-established methods of identifying 
proteins favor bottom-up.  Therefore, it is logical to consider using both methods in order to 
gain a more complete picture of the proteome being studied.  Performing two entirely 
separate complex analyses on a single sample is inefficient, however.  Thus, development of 
a method in which both top-down and bottom-up proteomics are integrated into a single 
analysis is a worthwhile goal. 
4.1.3 Prior work in combining top-down and bottom-up workflows 
In the past, selecting between top-down and bottom-up was treated as an “either-or” 
choice.  As the field of proteomics has developed, however, there has been increased 
recognition of the complementary nature of the two techniques.  One of the first steps toward 
combining elements of both techniques was separation of the sample into fractions at the 
intact protein level preceding digestion.  A wide variety of techniques have been used to 
fractionate intact proteins before bottom-up analysis, including gel electrophoresis,9 off-gel 
electrophoresis,10 and many different modes of chromatography.11-13  Multi-dimensional 
fractionation, including LC x LC, has also been used.14  Fractionation reduces the complexity 
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of the protein mixture to be digested, which improves the outcome of the peptide separation 
and enhances the likelihood of successful protein identification using MS or MS/MS.  
Although protein fractionation incorporates the separation aspect of the top-down approach, 
intact proteins are not introduced into a mass spectrometer.  Since all information about the 
identity and composition of the proteins is obtained from mass spectra of peptides, 
techniques which use protein fractionation before digestion are still bottom-up analyses. 
Several examples of true hybrid top-down / bottom-up proteome analyses have been 
reported in the literature.15-20  Unlike bottom-up methods that use protein fractionation, these 
involve acquiring mass spectra of both intact proteins and protein digests.  One of the first 
studies demonstrating the use of this strategy for the characterization of the complete 
proteome of an organism was published in 2002 by VerBerkmoes et al.15  Their research 
pertained to proteins extracted from Shewanella oneidensis, a metal-reducing bacterium of 
interest in the field of bioremediation.  Various stages of centrifugation were used to separate 
membrane and cytosolic proteins.  The proteins were then fractionated using anion exchange 
chromatography.  A portion of each fraction was analyzed directly using FTICR-MS, while a 
second portion was digested using trypsin and then analyzed using LC-MS/MS.  A total of 
868 proteins were identified using the bottom-up approach, though only 70 proteins were 
detected using top-down, and only 20 of these were identified.  The relatively low number 
identified by the top-down approach was attributed to matrix ionization effects in performing 
ESI-MS of the fractions, which each contain numerous proteins. 
Berger et al. reported a further refined hybrid top down / bottom up technique which 
they termed “middle-out” proteomics.18, 19  In their approach, intact proteins were 
fractionated using on-line LC x LC, with anion exchange as the first dimension and reversed-
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phase as the second.  Using a flow split, a portion of the second dimension effluent was 
directed to an ESI-TOF mass spectrometer to measure intact protein MW, while the majority 
was diverted to a fraction collector.  The fractions were digested using trypsin and analyzed 
using MALDI-Q-TOF-MS/MS.  The technique was applied to both yeast ribosome proteins19 
and to E. coli cytosol.18  In the yeast ribosome protein study, approximately 85% of the 
known 80 unique ribosomal subunit proteins were detected by either the top down or bottom 
up approach.  In the study of E. coli cytosol – a much more complex sample – a total of 46 
proteins were detected and identified by top-down and bottom-up approaches, 55 were 
identified using bottom-up only, and 57 were detected using top-down alone.  In both studies, 
numerous post-translational modifications were identified on many of the proteins found, 
including N-terminal methionine removal or addition, N-terminal acetylation, and 
phosphorylation. 
Most recently, Sharma et al. reported a proteomic profiling method for S. oneidensis 
using AXC fractionation.20  One portion of the fractions was analyzed using RPLC-FTICR-
MS, while another portion was digested with trypsin and analyzed using RPLC-ion trap 
MS/MS.  A total of 715 intact proteins were detected using the top-down approach, and 447 
proteins were identified using the bottom-up peptide analysis.  Approximately 12% of the 
intact proteins were identified by correlating the intact protein MW with the predicted MW 
of proteins identified from the bottom up approach, after considering mass shifts due to 
PTMs. 
4.2 Experimental methods 
4.2.1 Overview 
 
Figure 4-3 gives an overview of the instrumentation and procedure used to perform a 
hybrid top-down / bottom up analysis of the E. coli cytosol proteome.  The sample, which 
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contains a complex mixture of proteins, is separated into fractions using anion exchange 
chromatography.  The fractions are then lyophilized and reconstituted in a smaller volume of 
buffer.  The reconstituted fractions are divided into two equal parts.  One part of each 
fraction is separated and analyzed “as is” using gradient ultra-high pressure RPLC-MS.  This 
provides intact protein molecular weight data.  The second part of each fraction is digested 
using trypsin to produce a mixture of peptides.  The peptides are then separated and 
analyzed, also using UHP-RPLC-MS.  Proteins are identified by searching the acquired 
peptide LC-MS data against the SwissProt database. 
4.2.2 Samples and reagents 
Reagents used for LC mobile phase were ammonium acetate and formic acid (ACS 
reagent grade), which were purchased from Sigma-Aldrich (St. Louis, MO), and   ammonium 
hydroxide (ACS reagent grade) and acetonitrile (HPLC grade), which were purchased from 
Fisher Scientific (Fair Lawn, NJ).  Deionized water was purified using a Barnstead Nanopure 
System (Boston, MA).  Reagents used in the trypsin digest procedure were ammonium 
bicarbonate (Sigma-Aldrich, St. Louis, MO), RapiGest SF acid-labile surfactant (Waters 
Corporation, Milford, MA), dithiothreitol (Research Products International, Mt. Prospect, 
IL), iodoacetamide (Sigma-Aldrich), TPCK-modified trypsin (Pierce, Rockford, IL), and 
trifluoroacetic acid (Sigma-Aldrich). 
The sample analyzed in this experiment was an extract of the soluble proteins of the 
bacterium Escherichia coli.  It was prepared from E. coli strain DH5α (Q-BIOgene, Irvine, 
CA) by researchers at Waters Corporation using the procedure set forth by Millea et al.18  
The total protein concentration in the sample was measured as approximately 100 mg/mL 
using a modified Coomassie dye-binding assay (BioRad, Hercules, CA).  Prior to injection, 
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the sample was diluted to 20 mg/mL in 10 mM ammonium acetate (pH 8.5).  Approximately 
4 mg of total protein was analyzed in the complete 2D separation run. 
4.2.3 Anion exchange fractionation 
The first dimension of the 2D separation was performed using a Waters Biosuite Q 10 
μm anion exchange column, which is 7.5 cm long and has an ID of 7.5 mm.  A Waters 600E 
quaternary gradient LC pump was used to produce the anion exchange gradient.  The pump is 
connected to a Valco 6-port valve (VICI, Houston, TX) with a 200 μL sample loop, which is 
used to perform injections onto the column.  Detection was performed using an Applied 
Biosystems 785A UV absorbance detector (Foster City, CA) set at 280 nm. 
For anion exchange separations, mobile phase A was 10 mM ammonium acetate, 
adjusted to pH 8.5 with ammonium hydroxide.  Mobile phase B was 1M ammonium acetate, 
adjusted to pH 8.5 with ammonium hydroxide.  The gradient program is as follows: after 
sample injection, a linear gradient from 0% to 50% B was run over 60 minutes, followed by a 
linear ramp to 75% B over 5 minutes.  The mobile phase composition was held at 75% B for 
20 minutes, and then returned to 100% A.   The flow rate through the column was 0.5 
mL/min. 
After passing through the UV detector, the effluent from the anion exchange column 
was sent to a Waters Fraction Collector II, which allowed automated collection of fractions 
in polypropylene centrifuge tubes.  Fractions were collected every 3 minutes, beginning as 
soon as the sample was injected, for a volume of 1.5 mL per fraction.  A total of 20 fractions 
were collected.  After collection, fractions were flash-frozen using liquid nitrogen and were 
placed in a SpeedVac Concentrator (Thermo-Electron, Bellefonte, PA), which was pumped 
down to pressures between 10-2 to 10-3 Torr using an Edwards double-stage rotary vacuum 
pump (Wilmington, MA).  Once the fractions had been lyophilized to dryness, they were 
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reconstituted in 50 μL of a solution of 50 mM ammonium bicarbonate in deionized water and 
vortexed.  After all lyophilized protein had dissolved, 25 μL was transferred from each 
fraction to a corresponding Waters CapLC sample vial to be used for intact protein LC-MS 
analysis.  50 μL of additional ammonium bicarbonate buffer was added to these sample vials, 
which brought their total volume up to 75 μL.   The 25 μL of the reconstituted anion 
exchange fractions remaining in the microcentrifuge tubes was left in place to be digested 
using trypsin. 
4.2.4 Trypsin digest of fractions 
The procedure for trypsin digestion of fractions was based upon the recommended in-
solution digest protocol provided with the RapiGest SF acid-labile surfactant.  The advantage 
of using RapiGest over standard protein denaturants, such sodium dodecyl sulfate or urea, is 
that RapiGest does not modify peptides or suppress endoprotease activity, and it can be 
easily removed after use by hydrolysis under acidic conditions.21  Slight modifications were 
made to the standard procedure to account for the expected quantity of protein in each 
fraction.  The exact procedure used is given below. 
RapiGest SF powder was re-constituted by adding 150 μL of 50 mM ammonium 
bicarbonate to 1 mg of powder in a glass vial, then vortexing to mix.  3 μL of the RapiGest 
solution was added to each of the centrifuge tubes containing the re-constituted anion 
exchange fractions, and all tubes were vortexed.  The fractions were incubated in a 
convection oven at 80º C for 15 minutes, vortexing periodically.  The fractions were then 
centrifuged for 4 minutes at 12 krpm.  1 μL of 100 mM dithiothreitol was added to each 
fraction, and they were again vortexed to mix.  They were incubated at 60º C for 30 minutes, 
and then centrifuged for 4 minutes at 12 krpm.  1 μL of 200 mM iodoacetamide was added to 
each fraction and vortexed.  They were incubated in the dark at room temperature for 30 
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minutes, and were then centrifuged for 4 minutes at 12krpm.  10 μL of a 0.1 μg/μL solution 
of TPCK-modified trypsin in 50 mM ammonium bicarbonate was added to each fraction and 
vortexed.  They were then incubated overnight at 37º C.  The next morning, the fractions 
were removed from the convection oven and were centrifuged at 12 krpm for 4 min.  40 μL 
of deionized water and 4 μL of 10% trifluoroacetic acid were added to each fraction to 
quench the enzymatic reaction and to hydrolyze the RapiGest.  The fractions were vortexed 
and then incubated at 37º C for 45 minutes.  They were then centrifuged for 10 minutes at 13 
krpm.  The supernatant of each fraction, which totaled just over 80 μL, was transferred to 
CapLC sample vials for LC-MS/MS analysis. 
4.2.5 Intact protein separation using gradient UHP-RPLC-MS 
4.2.5.1 LC instrumentation and run conditions 
The second-dimension separations of intact proteins were performed using gradient 
ultra-high pressure reversed phase liquid chromatography (UHP-RPLC).  The instrument 
used to perform the separation was the same as the pre-loaded gradient pump described in 
section 3.2.5.1, with one exception.  The high pressure 4-port union, where the column, 
splitter capillary, CapLC pump and hydraulic amplifier pump are interfaced, was replaced 
with a lower dead-volume version.  A comparison of the old and new 4-port unions is shown 
in Figure 4-4.  The new union has a much smaller internal volume, which reduces the delay 
between when a run is started and when the first peaks begin to elute from the column.  The 
parameters used for performing runs were identical to those specified previously, with the 
exception of the UHPLC pump flow rate, which was increased to 4 μL/min.  The column 
used for the separations was a 50 μm ID capillary, 15 cm in length, packed with 1.8 μm 
bridged-ethyl hybrid silica particles modified with a C18 stationary phase.  The particles 
have 300 Å pores, which are suited for use with large molecules such as intact proteins.  The 
 
132
column was operated at a pressure of approximately 1,600 bar (23,000psi).  The flow rate 
through the column was approximately 400 nL/min, giving a split ratio of approximately 
10:1. 
For reversed phase separations of intact proteins, mobile phase A was deionized 
water with 0.2% (v/v) formic acid.  Mobile phase B was acetonitrile with 0.2% (v/v) formic 
acid.  Runs were performed using a linear gradient from 10% to 60% MP B over 30 minutes, 
followed by a 5 minute hold at 60%B, and then a return to initial conditions.  The CapLC 
autosampler loaded 2.5 μL of sample onto the gradient storage loop for each run.  Based on 
the split ratio, the volume of sample injected onto the column was approximately 250 nL. 
4.2.5.2 MS instrumentation and run conditions 
The outlet of the reversed-phase capillary column was coupled to a fused silica nano-
electrospray emitter using a Waters Universal Nanoflow Sprayer.  The sprayer has a zero 
dead volume union which allows the column to be coupled end-to-end with the emitter.  
Since the union is made of stainless steel, it also serves as an electrical contact to the fluid 
inside the emitter.  Electrospray can be produced by applying an elevated electrical potential 
(the “capillary voltage” from the MS) anywhere on the sprayer. The nano-electrospray 
emitter, marketed under the name NanoEase Emitter, was obtained from Waters Corporation.  
It is a 20 μm ID / 90 μm OD fused silica capillary, sheathed by and bonded to a 100 μm ID / 
360 μm OD fused silica capillary.  Approximately 2 cm of un-sheathed 90 μm OD capillary 
protrudes from the larger capillary at the outlet end of the emitter.  The outlet end of the 
capillary is not tapered; the 90 μm diameter of the capillary is small enough that a stable 
Taylor cone forms at the end of the emitter when operating at flow rates of 200 nL/min or 
higher.  A gentle sheath flow of room-temperature nitrogen gas can be applied around the 
emitter tip in order to improve the stability of the Taylor cone.  The tip of the emitter was 
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placed a few millimeters away from the sample cone of the mass spectrometer and was 
oriented perpendicular to its orifice.  The emitter-to-cone distance was manually optimized to 
give the best signal.   
On-line positive ion mode electrospray - time of flight MS was performed using a 
Micromass LCT instrument (Waters Corp.).  A capillary voltage of +2900 V, a sample cone 
voltage of +35 V, and an extraction cone voltage of +2 V were used for runs in this 
experiment.  The source temperature was set at 100 ºC.  Mass spectra were acquired at a 
frequency of 2 Hz over a mass range from 550-1600 Da for the duration of the runs.  All 
mass spectra were acquired using the software package MassLynx 4.0 (Waters Corp.). 
4.2.6 Protein digest separation using gradient UHP-RPLC-MS 
4.2.6.1 LC instrumentation and run conditions 
Like the intact protein separations, the separations of protein digests were also 
performed using gradient ultra-high pressure reversed phase liquid chromatography (UHP-
RPLC).  A second preloaded gradient UHPLC pump, identical to the one described 
previously, was used to inject the sample and generate the gradient.  The column differed 
slightly from the one used for intact protein separations.  It was a 50 μm ID capillary, 30 cm 
in length, packed with 1.5 μm bridged-ethyl hybrid silica particles modified with a C18 
stationary phase.  The particles have 145 Å pores, which are suited for use with smaller 
molecules such as peptides.  The column was operated at a pressure of approximately 1,600 
bar (23,000psi); the flow rate through the column was around 150 nL/min.  Since the 
UHPLC pump was operated at 4 μL/min, the split ratio was approximately 26:1. 
For reversed phase separations of protein digests, mobile phase A was deionized 
water with 0.2% (v/v) formic acid.  Mobile phase B was acetonitrile with 0.2% (v/v) formic 
acid.  Runs were performed using a linear gradient from 1% to 50% MP B over 30 minutes, 
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followed by a 5 minute hold at 50%B, and then returned to initial conditions in 1 minute.  
The CapLC autosampler loaded 1 μL of sample onto the gradient storage loop for each run.  
Based on the split ratio, the volume of sample injected onto the column was approximately 
40 nL. 
4.2.6.2 MS instrumentation and run conditions 
The outlet of the reversed-phase capillary column was coupled to a fused silica nano-
electrospray emitter using the same Waters Universal Nanoflow Sprayer described in section 
4.2.5.2.  Due to the reduced flow rate as compared to the column used for protein 
separations, it was necessary to use a pulled-tip emitter as opposed to the blunt-ended 
NanoEase emitter.  Thus, a fused silica Pico-Tip emitter was purchased from New Objective 
(Woburn, MA).  This nano-electrospray emitter has an inner diameter of 20 μm, which tapers 
to 10 μm at the tip.  It does not have an electrically conductive coating, since the voltage is 
still applied through the metal junction of the sprayer. 
On-line positive ion mode electrospray - time of flight MS and MS/MS were 
performed using a Waters Q-TOF micro.  All mass spectra were acquired using a capillary 
voltage of +2000 V, a sample cone voltage of +30 V, and an extraction cone voltage of +2 V, 
with the source temperature set at 100 ºC.  For the first set of runs of the protein digest 
fractions, peptide mass fingerprinting (PMF) was used.  Therefore, the instrument was 
operated in TOF-only mode, with the quadrupole set to allow all ions to pass to the TOF 
mass analyzer.   Mass spectra were acquired at a frequency of 1.67 Hz over a mass range 
from 450-1600 Da for the duration of the runs. 
The protein digest fractions were separated and analyzed a second time, using a data-
directed analysis (DDA) method obtain MS/MS spectra of the peptides as they eluted from 
the column.  The workflow of the DDA experiment is as follows.  Initially, the mass 
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spectrometer runs a survey scan over the mass range from 450-1600 Da, in which the 
quadrupole is set to pass all ions to the TOF analyzer and the collision energy is set at its 
default low-energy value (7 V) so that ions are not fragmented.  If no peaks above a threshold 
of 25 counts/second are detected, the instrument continues running survey scans at a 
frequency of 0.91 Hz.  When the intensity of a peak exceeds a set threshold, the instrument 
switches to MS/MS mode.  This sets the quadrupole to allow only ions with a m/z that 
matches the above-threshold peak to pass to the TOF analyzer.  The collision energy is 
increased in order to induce fragmentation, and the resulting fragment ions between 200-
1800 Da are detected.  In order to obtain good quality MS/MS spectra, the collision energy is 
stepped through four different voltages, each with a scan time lasting 1.1 seconds, including 
a 0.1 second inter-scan delay time.  The precise values of the collision energy depend on the 
m/z of the precursor ion, and are set using a collision energy profile table (shown in Table 
4-1).   After all MS/MS scans are complete (4.4 seconds after initiating the first scan), the 
instrument returns to performing survey scans, and continues to do so until another peak 
exceeds the threshold.  The instrument is set to be able to trigger MS/MS on two precursor 
ions simultaneously. This allows data to be obtained on two co-eluting peptides.  In order to 
avoid acquiring redundant data, the instrument is programmed not to switch to MS/MS mode 
on any peaks already analyzed within the last 60 seconds.  To prevent MS/MS from being 
triggered on isotope peaks of the same component, a mass range of +/- 2.3 Da from the main 
peak is also excluded for the same period of time. 
4.2.7 Data analysis 
Data analysis for this experiment consisted of two steps.  First, data from the top 
down and bottom up portions of the experiment were worked up independently, in order to 
produce a list of the intact protein masses detected and of the proteins identified using 
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peptide database searching.  Then, it was possible to consider the data from the experiment as 
a whole, by attempting to match intact protein masses with protein identities. 
4.2.7.1 Intact protein data workup 
Data workup for the intact protein separations was performed using the methods 
described in Section 3.2.7.  Maximum entropy de-convolution was performed on all mass 
spectra within the LC-MS chromatograms using AutoME.  Parameters for the de-convolution 
were set as follows: the time segment width was 6 seconds, the output spectrum resolution 
was 1Da, the range of masses in the output spectrum was 5,000-80,000 Da, and the 
maximum number of iterations was 50.  2D chromatograms and protein peak lists were both 
generated from the AutoME-processed data. 
4.2.7.2 Protein digest data workup 
LC-MS data from the runs of the trypsin-digested fractions were collected and 
analyzed using two different methods: peptide mass fingerprinting (PMF) and data directed 
analysis (DDA) MS/MS.  A different data workup method is necessary for each of these 
methods.  In order to identify proteins from the PMF data, peak lists were generated which 
contain the mass and charge of all components in each chromatogram above a user-defined 
threshold.  Although this can be performed manually, typically an add-on package to 
MassLynx 4.0 called ProteinLynx was used to generate the peaks lists.  ProteinLynx uses an 
algorithm which detects peaks, recognizes their charge state via a de-convolution routine 
known as MaxEnt3, and records the information in a peak list file.  Once the lists were 
generated, the web-based database search program Aldente 
(http://www.expasy.org/tools/aldente/) was used to match the masses with those of peptides 
that would be expected from tryptic digests of known E. coli proteins listed in the Swiss-Prot 
protein knowledgebase (http://us.expasy.org/sprot/).  Numerous parameters can be specified 
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to define the criteria which Aldente uses to perform the search.  A detailed list of the search 
parameters used for this experiment is provided in Table 4-2.  Based on the output of the 
search, a list of proteins possibly present in the sample was produced.  Aldente assigns each 
protein a score which indicates the probability that the identification is correct.   
 The runs performed using DDA MS/MS were analyzed up using ProteinLynx Global 
Server 2 (PLGS2, Waters Corp.), which is a software package that automates processing of 
LC-MS data for proteomics.  Unlike Aldente, which requires the user to generate a peak list, 
PLGS2 allows LC-MS/MS data acquired in MassLynx to be loaded directly into the 
program.  Generally, data analysis using PLGS2 is performed with two components: the data 
preparation tool and workflow designer.  The data preparation tool automates noise 
reduction, de-isotoping, and centroiding of the mass spectra acquired during the runs.  In 
essence, this generates data equivalent to the peak list used by Aldente.  The workflow 
designer allows automation of databank search queries using the processed mass spectra.  A 
variety of parameters must be specified; they are shown in Table 4-3.  As with Aldente, data 
were searched against the Swiss-Prot E. coli database, and the end result was a list of proteins 
which were identified as being present in the sample.  Each protein is assigned a probability 
score, along with other statistics. 
4.2.7.3 Comparison of intact protein and peptide data 
The intact protein and peptide data analyses generated two lists: one with intact 
protein masses, and the other with the names of proteins identified and a predicted mass for 
each protein.  It was then necessary to correlate one list with the other and thereby associate 
intact protein masses with a protein identity.  In some cases, this was as simple as comparing 
the predicted mass of an identified protein with the intact protein mass list from the same 
anion exchange fraction and finding a near-exact (within 5 Da) match.  When no exact match 
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was apparent, but the difference between the observed mass of a protein and a peptide-
predicted mass was within several hundred Daltons, the mass difference was checked against 
the Delta Mass database of common post-translational modifications 
(http://www.abrf.org/index.cfm/dm.home).  If a logical match was found, it was recorded as 
a possible PTM of the identified protein.     
4.3 Results and discussion 
From the standpoint of chromatography, this experiment can be thought of as two 
distinct 2D separations: one in which the sample is intact proteins throughout, and the other 
in which the sample begins as proteins which are digested to peptides between the first and 
second dimensions.  Thus, the chromatographic results from these two separations are 
reported and discussed in separate sections.  From the viewpoint of proteomics, however, the 
mass spectral data from the top-down and bottom-up analyses are complementary.  Thus, 
they are presented here as a single entity; where possible, data from the two techniques were 
correlated in order to reveal information not evident from either technique alone.   
4.3.1 Anion exchange fractionation: chromatographic results 
The first step in the hybrid top-down/bottom-up analysis was to fractionate the E. coli 
protein extract using anion exchange chromatography.  The chromatogram for a 60-minute 
gradient separation of the sample is shown in Figure 4-5.  It reveals a complex pattern of 
incompletely resolved peaks, which is expected due to the complexity of the sample.  A total 
of 20 fractions were collected.  Although the largest peak appears in the last fraction, it is 
unlikely that it and some of the other late-eluting components are actually proteins, based on 
observations from previous 2D-LC runs of this sample (Chapter 3).  This is plausible because 
UV absorbance detection at 280 nm is not selective to proteins; other smaller molecules may 
exhibit substantial absorbance at this wavelength.  
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The Waters Biosuite Q 10 μm AXC column, 7.5 mm ID x 7.5 cm long, was used to 
perform the separation, as opposed to the custom-packed long anion exchange column.  The 
long column would have generated greater resolution and thus allowed a larger number of 
distinct fractions to be collected, which would improve the total peak capacity of the 2D 
separation.  The tradeoff for increased resolution is longer total analysis time.  Given the fact 
that each anion exchange fraction is divided into two parts, each of which must be run using 
RPLC-MS, the increase in total analysis time would have been substantial.  Thus, the 
separation provided by the short AXC column was judged to be adequate for this initial 
evaluation of the top down / bottom up approach to proteomics. 
4.3.2 Intact protein separation: chromatographic results 
Following the anion exchange separation, the fractions were lyophilized, re-
constituted in a smaller volume of solvent, and then divided into two equal parts.  For the 
portion of the fractions used for intact protein analysis, no further modification of the 
proteins was performed.  Ultra-high pressure RPLC was used to separate the proteins, with 
the outlet of the column coupled to on-line ESI-TOF-MS.  The chromatograms which 
resulted from the RPLC separations were combined to generate a 2D chromatogram, two 
versions of which are shown in Figure 4-6.  The chromatogram in Figure 4-6A was produced 
using the total ion current data from the LC-MS runs, whereas Figure 4-6B is a base peak 
intensity chromatogram generated using the same LC-MS data after de-convolution by 
AutoME.  As noted in Chapter 3, AutoME de-convolution eliminates much of the 
background noise from non-protein components in the sample.  Particularly notable is its 
removal of the non-protein contaminant peak which appears at a reversed-phase retention 
time of approximately 14 minutes in all fractions (see section 3.3.3 for explanation).  
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In terms of chromatographic performance, the proteins seem to be spread over a 
relatively wide range of the 2D separation space.  Peaks are observed in all 20 of the anion 
exchange fractions, though they are less abundant in the earliest and latest fractions.  The 
second-dimension peak capacity seems to be diminished somewhat as compared to the runs 
performed in Chapter 3.  This is due to the fact that the gradient length was decreased from 
60 minutes to 30 minutes in order to reduce the total analysis time.  The first dimension peak 
capacity is estimated to be 2/3 of the total number of fractions containing peaks, to account 
for some peaks being split between fractions as explained in Section 3.3.3.  This gives a 
value of 13.  The second-dimension peak capacity is estimated as being 75.  Thus the total 
peak capacity of the 2D separation is approximately 975.  As demonstrated in Chapter 3, it 
would easily be possible to improve this peak capacity by using a longer anion exchange 
column and gradient in the first dimension and by increasing the gradient length in the 
second dimension. 
The AutoME processed data were used to generate a list of proteins detected in the E. 
coli protein extract sample.  The number of proteins detected in each fraction is illustrated as 
a histogram in Figure 4-7.  The chart shows that a relatively small number of proteins eluted 
from the anion exchange column in the first several fractions.  The majority of the proteins, 
however, were relatively evenly distributed between fractions 6-19.  This suggests that most 
proteins are well-retained by the anion exchange column, which contrasts favorably with 
many of the runs performed in Chapter 3, where the first few anion exchange fractions often 
appeared to contain more proteins than any other fractions.  The improvement in retention is 
probably due to the change in initial buffer concentration from 25 mM to 10 mM.  Although 
not a dramatic reduction, the decrease in ionic strength is evidently sufficient to allow a 
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substantial number of proteins to be retained by the anion exchange column which would 
otherwise have eluted near the column void time.    
4.3.3 Protein digest separation: chromatographic results 
The proteins in the second portion of the anion exchange fractions were first 
denatured using an acid-labile surfactant to expose the entire peptide backbone.  They were 
then chemically reduced with dithiothreitol in order to cleave disulfide bonds, and alkylated 
using iodoacetamide to prevent disulfide bonds from re-forming.  They were then digested 
using trypsin, an enzyme which cleaves the peptide backbone at lysine and arginine residues.  
Once the digestion was complete, the surfactant was degraded by acid hydrolysis, and the 
fractions were ready for analysis.  They were separated using gradient UHP-RPLC; the outlet 
of the column was coupled to an ESI-Q-TOF mass spectrometer. 
Two runs of each trypsin-digested fraction were performed, which were identical in 
terms of chromatographic conditions but differed in the mode in which the mass 
spectrometer was operated.   In the first set of runs, the MS was operated in TOF-only mode, 
in order to obtain the MW of the peptides to enable protein identification using peptide mass 
fingerprinting.  For the second set of runs, data-directed MS/MS analysis was used to switch 
between a survey MS scan and MS/MS mode for fragmentation of detected ions.  These 
modes result in LC-MS chromatograms that are substantially different in appearance, as 
illustrated Figure 4-8.  For runs of the same anion exchange fraction, the PMF mode (Figure 
4-8A) seems to produce a much higher resolution chromatogram than the MS/MS mode 
(figure 4-6B1).  This is not due to superior chromatographic performance, since both runs 
were run on the same column under identical conditions.  Instead, it is an issue of sampling 
frequency.  The PMF experiment uses a constant sampling rate of 1.67 Hz; thus, a typical 
 
142
peak with a base width of 8 seconds will be sampled 13 times by the mass spectrometer, 
which yields a relatively smooth chromatographic trace.   
In MS/MS, the sampling frequency for the survey scan varies throughout the run due 
to the data-directed workflow.  If no MS/MS scans are being performed, the survey scan 
sampling rate is one point every 1.1 seconds (0.91 Hz).  When one MS/MS scan is active, the 
survey scan sampling frequency drops to one point every 4.4 seconds (0.23 Hz).  With two 
MS/MS scans active simultaneously, the sampling frequency decreases to one point every 8.8 
seconds (0.11 Hz).  Thus, assuming a peak width around 8 seconds, many peaks will only be 
sampled once or twice in MS survey mode.  This is inadequate to generate a chromatogram 
where peaks can be clearly discerned, which is the case in Figure 4-8B1.  MS/MS also 
produces two additional “channels” of data which contain the spectra in which selected ions 
were fragmented to discern the peptide sequence.  These channels are shown in Figure 4-8B2 
and B3, which plot the total intensity of fragment ions as a function of time.  The data appear 
in 4-scan “bursts”, interspersed with areas of no signal.  This reflects the fact that MS/MS 
scans are discontinuous – one ion is selected and analyzed using MS/MS for 4 scans, after 
which the instrument returns to MS survey mode, selects a different ion, and the process 
continues.  The intensity-vs.-time representation of MS/MS data has limited practical use, 
however, since only by observing the full mass spectra can peptide sequence information be 
obtained. 
Since the PMF runs produced visually superior chromatograms, they were combined 
to produce a 2D base-peak chromatogram of the peptide separation, which is shown in Figure 
4-9.  Unlike the intact protein data, no special de-convolution is necessary to produce the BPI 
chromatogram.  This is because peptides are smaller molecules than proteins, and when 
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ionized by electrospray they generally exist predominantly in only one charge state.  
Therefore, MassLynx can generate a BPI chromatogram by simply plotting the intensity of 
the most abundant ion as a function of time. 
One feature of the 2D chromatogram which is immediately evident is that the 
reversed-phase separation of peptides produces sharper peaks (or “bands”, as they appear in 
the 2D chromatogram) than a separation of intact proteins.  This is because peptides are 
generally more uniform in terms of chemical properties than proteins, and are also less likely 
to exhibit non-ideal interactions with the stationary phase, which often cause proteins to elute 
as broadened or asymmetrical peaks.  The peak capacity of the second dimension of the 2D 
peptide separation is estimated to be 180; since the anion exchange peak capacity is 
unchanged at 13, the total peak capacity is about 2,300.  Although the peak capacity is about 
2.5 times higher than that of the intact protein separation, the complexity of the mixture has 
increased to an even greater extent.  It has been reported that the average number of tryptic 
peptides expected to be produced per E. coli protein is around 13.22  Since the increase in 
peak capacity is 5 times less than this value, the intact protein separation would be expected 
to offer better resolution of the components in the sample than the peptide separation.  This 
conclusion is supported by a visual comparison of the experimental data.  In the most 
crowded region of the 2D peptide chromatogram (Figure 4-9), more peptides appear to co-
elute with or are poorly resolved from their nearest neighbors than is the case for the 2D 
protein separation (Figure 4-6).  Therefore, from a chromatographic standpoint, there is an 
advantage to working with intact proteins rather than protein digests. 
4.3.4 Top down / bottom up E. coli proteome analysis: mass spectral results 
A sensitive and accurate means of detecting and identifying proteins is as important 
to the success of a proteomic analysis as the separation method used to resolve the sample 
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into its components.  Mass spectrometry and the interpretation of mass spectral data is the 
technique used in this experiment which enables identification and characterization of 
proteins.  Thus, it is important to consider the results of the E. coli analysis presented in this 
chapter from the perspective of mass spectrometry, as well as from a chromatographic one.   
4.3.4.1 Proteins detected using intact protein, PMF, and MS/MS methods 
The simplest means of assessing the results of the top down / bottom up E. coli 
proteome analysis is to examine the total number of proteins detected by each of the methods 
used to analyze the sample.  Intact protein LC-MS data was de-convoluted using AutoME 
and a list of intact protein masses detected in the sample was generated.  All duplicates and 
adducts were removed, which resulted in a total of 233 proteins.  For the peptide LC-MS 
data, two different data analysis methods were used – PMF and MS/MS – both of which 
employed a database searching approach to identify tryptic peptides originating from known 
E. coli proteins.  After all duplicate proteins were removed from the final lists, PMF 
identified 256 proteins and MS/MS identified 159.  Based on these data alone, it would seem 
that PMF was the most successful technique.  However, this simple comparison of numbers 
of proteins detected does not take into account the accuracy of the identifications, or to what 
extent the techniques complement one another. 
In order to determine how many of the detected proteins were found by multiple 
methods, all three protein lists were combined and sorted in order of protein MW.  For the 
intact protein data, the MW data came from the observed protein masses; for the peptide 
data, the MWs predicted by the database search program were used.  The lists were then 
surveyed to find masses which were within 5 Da of one another (a conservative estimate for 
the mass accuracy of the intact protein data).  Matching masses were recorded as proteins 
found using multiple techniques.  A Venn diagram which displays the overlap of the number 
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of proteins found by all three methods is shown in Figure 4-10A.  Of the possible total of 510 
distinct proteins found, only 25 (4%) were detected by all three techniques.  The overlap 
between PMF and intact protein data was 31/233, or 13%.  The overlap between MS/MS and 
intact protein data was about twice as high, at 64/233, or 27%.  The overlap between MS/MS 
and PMF data was approximately the same, at 68/256, or 27%. 
Since the goal of the experiment was to correlate top-down and bottom-up 
techniques, it was necessary to decide which bottom-up data set to use for further 
comparisons.  Although PMF produced a higher total number of protein identifications than 
MS/MS, fewer of its proteins matched with those found using the top-down method.  This 
reduced percentage of overlap implies that PMF may have produced a higher number of false 
protein identifications than MS/MS.  This is not difficult to believe, since PMF relies on 
peptide MW alone to identify peptides.  The accuracy of PMF is very sensitive to the mass 
accuracy of the instrument used to acquire the data, which in the case of this experiment was 
prone to drift of up to 200 ppm (0.2 Da for a 1 kDa peptide) due to reliance on external 
calibration.  MS/MS, on the other hand, employs the study of fragmentation patterns of 
selected ions, which is an inherently more discriminating process and is less prone to false 
identifications, in spite of limited mass accuracy.  It was therefore determined that the 
MS/MS dataset would be used for further correlations between top-down and bottom up 
analyses.  A simplified version of the Venn diagram showing only the overlap between these 
two methods is shown in Figure 4-10B.  Complete tables were produced which list all 
proteins detected by both methods (Table 4-4), as well as those found only in intact protein 
(Table 4-5) and MS/MS (Table 4-6) datasets.  Descriptive names of the identified proteins 
are provided in the appendix of this dissertation. 
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4.3.4.2 Assessment of overlap between top-down and bottom-up methods 
One discouraging feature of the results presented in this chapter is the relatively low 
overlap (approximately 27%) between the number of intact proteins detected and proteins 
identified based on bottom-up peptide analysis.  Although low, this value is comparable to 
those reported by similar studies found in the literature.17, 18, 23  Still, it is worthwhile to 
consider the factors which may contribute to the observed lack of overlap.  The simplest 
explanation is that many proteins may not have been detected by both the top-down and the 
bottom-up approach.  This is particularly likely for low-abundance proteins, where the 
protein is near the detection limit.  In the MS/MS runs, some proteins may also have been 
missed due to a low scan frequency.  If a peptide happened to elute from the column just 
after the instrument began to perform MS/MS on other ions, the new peptide might have 
finished eluting by the time the instrument returned to survey scan mode.  The probability of 
missing components in MS/MS analyses could be reduced by increasing the peak capacity of 
the LC x LC separation, by using a mass spectrometer with a higher scan rate and duty cycle, 
or by performing replicate runs of each sample. 
Another factor that may contribute to the low overlap is the fact that there is an 
inherent difference in selectivity for top-down and bottom-up approaches.  This is made clear 
by examining the MW distribution histogram shown in Figure 4-11.  From the graph, it is 
immediately apparent that a larger number of intact proteins were detected than were found 
using MS/MS.  However, the more significant aspect of the data is the fact that the 
distribution of the proteins identified by MS/MS is shifted toward higher masses than the 
intact protein data.  No masses above 60 kDa were found in the intact data, whereas proteins 
up to 111 kDa were found using MS/MS.  Numerically, the average MW for the intact 
protein data is 21.0 kDa and the median is 18.6 kDa, whereas for the MS/MS data the 
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average is 33.1 kDa and the median is 29.2 kDa.  Interestingly, the values from the MS/MS 
data are much closer to – although still lower than – the theoretically predicted 35.1 kDa 
average and 30.6 kDa median calculated from all known E. coli proteins (see Section 3.3.4). 
The differences in the MW distributions can be explained by considering the nature 
of the two techniques.  Generally speaking, small intact proteins (MW < 30 kDa) are ionized 
and detected more readily using electrospray-MS than larger proteins.  Conversely, MS/MS 
may favor detection of high MW proteins.  This is because, for a given concentration of 
protein, more peptides are produced when a large protein is enzymatically digested than a 
small one.  The probability of detecting one or more of these peptides in a bottom-up analysis 
is higher than finding one of the comparatively few peptides produced by a digest of a 
smaller protein.  Thus, top down analysis may be biased toward small proteins, whereas 
bottom-up may be biased toward larger proteins. 
4.3.4.3 Detection of post-translational modifications  
A final possible reason for the low degree of overlap – and also an important feature 
of the data in its own right – is the presence of post-translational modifications (PTMs).  In 
this experiment, when an exact match was found between an observed intact protein MW and 
the predicted MW of a protein identified by the bottom-up method, it was viewed as 
confirmation that the identification was correct.  Some predicted protein masses already 
incorporated certain PTMs, such as removal of a signal sequence of approximately 20 amino 
acids from the N-terminus of the protein.  However, many of the proteins in this sample are 
likely to have PTMs which are not recorded in the databases used for bottom-up protein 
identification.  In some cases, consideration of other PTMs improved the correlation between 
top-down and bottom up data.  Table 4-7 shows nine proteins which were found using both 
intact protein and peptide MS/MS analyses when certain common modifications were 
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considered, such as acetylation, phosphorylation, and removal (or non-removal) of the N-
terminal methionine.  The PTMs listed in the table cannot be assigned with absolute 
confidence, since the only evidence for their presence is the difference in mass between the 
observed and predicted protein MW.  Nevertheless, the ability to detect possible PTMs 
demonstrates that the hybrid top down / bottom up technique can give information about the 
proteins present in the sample which neither method could provide on its own.   
Although common post-translational modifications could be assigned based on 
differences between observed and predicted protein MW, it was not possible to identify the 
entire range of PTMs that may occur or to discern multiple PTMs on the same protein.  If 
these modifications could be detected, however, the actual overlap between the top-down and 
bottom-up data might be substantially higher than was determined in this experiment.  To 
improve chances of unambiguously determining PTMs additional improvements would be 
required – such as significantly higher resolution and mass accuracy, and/or MS/MS of intact 
proteins.  Another daunting challenge is determining the location of PTMs on a protein.  
Various MS/MS techniques have been used to locate specific PTMs within peptides.24, 25 
Such methods are relatively early in development for use at the intact protein level, 
however.26  Thus, characterization of post-translational modifications remains a difficult, yet 
significant, aspect of the development of top-down / bottom-up proteomics. 
4.3.5 Visualization of LC-MS data using 2D chromatospectra 
In addition to the chromatographic and proteomic analyses already described, 
chromatospectra were used as a supplementary means of examining the data generated in this 
experiment.  In essence, a chromatospectrum is a plot analogous to a 2D chromatogram, 
except one of the axes contains MS data.  In this experiment, chromatospectra were applied 
to visualization of AutoME-de-convoluted intact protein data.  Since it was desirable to 
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display the results from an entire LC x LC separation in one plot, it was necessary to 
combine all of the data from one of the dimensions into a single data set.  Because the peak 
capacity of the reversed-phase separation is higher than for the anion exchange separation, 
the data from all anion exchange fractions were combined and placed in a table containing 
reversed-phase retention time, protein MW, and intensity. 
Once the data was properly formatted, a chromatospectrum was generated using an 
Igor Pro function written by John Eschelbach.  The details of this custom-programmed 
function have been described elsewhere.27  When applied to the data gathered in this 
experiment, the resulting 2D plot is shown in Figure 4-12.  The chromatospectrum shows 
reversed-phase retention time on the X-axis and protein MW on the Y-axis, with component 
intensity represented by color, with blue being the lowest intensity and black the highest.  
The apparent “peak capacity” given by the MS dimension is truly spectacular – for this 
analysis, a range from 5,000 to 60,000 Da is displayed, and the data were de-convoluted to a 
resolution of 1 Da.  This yields an effective peak capacity of 55,000, which, when multiplied 
by the reversed-phase peak capacity of 75, gives a total peak capacity of 4.1 million.  It is 
important to note that, on its own, a mass spectrometer would not be able to resolve 
anywhere near 55,000 proteins in a single mass spectrum, at least with current technology.  
In fact, due to the occurrence of ionization suppression and the fact that spectra are more 
complex preceding de-convolution, the practical peak capacity for ESI-TOF-MS of proteins 
is probably closer to 10.  Nonetheless, when intact protein mass spectrometry is used as a 
part of a LC x LC analysis, it allows a very detailed visualization of the data to be produced. 
A chromatospectrum with a peak capacity over 4 million could not be adequately 
displayed on a standard sheet of paper, because the width of each data point would be too 
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small to be visually discerned.  Thus, Figure 4-12 was generated using 100 Da bins, which 
reduces the visually observable peak capacity to 41,000.  Although a large reduction from 4.1 
million, this is still high compared to a typical LC x LC chromatogram.  To access the higher 
resolution data, a specific region of the chromatospectrum can be displayed using a smaller 
bin size.  This is illustrated using the area inside the dashed rectangle, which is expanded in 
Figure 4-13.  The bin size in this chromatospectrum was 1 Da.  The expanded view reveals 
much more detail, which was not evident in the lower-resolution chromatospectrum.  With 
the increased resolution, peaks separated by only a few tens of Daltons can be clearly 
discerned. 
   It is important to consider what practical uses chromatospectra might serve in a 
proteomic analysis.  One logical application for “low-resolution”, full mass range 
chromatospectra would be in making comparisons between samples.  Since protein mass 
measurement is not subject to nearly as much drift as chromatographic retention times, a 
chromatospectrum would have an advantage over a 2D chromatogram in terms of 
reproducibility in one of its dimensions.  Higher resolution chromatospectra could also prove 
useful in detecting multiple forms of a protein.  As seen in Figure 4-13, proteins with 
multiple forms appear as parallel bands separated by tens or hundreds of Daltons.  These 
could be due to a number of post-translational modifications, which are of great interest in 
proteomic studies.  The visual nature of the chromatospectrum makes it easy to detect such 
patterns within the data. 
4.4 Conclusions 
In this chapter, a hybrid top-down / bottom-up approach was shown to be a successful 
means of studying the proteome of E. coli.  LC x LC coupled to mass spectrometry was the 
fundamental technique used to carry out the analysis.  The LC dimensions were coupled off-
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line, which allowed fractions from the first dimension, anion exchange, to be divided in two 
parts.  One set of fractions were analyzed as intact proteins using UHP-RPLC-MS; this 
served as the top-down portion of the experiment.  The second set was digested using trypsin 
and analyzed using UHP-RPLC-MS/MS; this represented the bottom-up portion of the 
analysis.  Data from the two workflows were analyzed and compared in order to match intact 
proteins detected with proteins identified using database searching of peptide MS/MS 
spectra.  In so doing, numerous post-translational modifications were revealed which were 
not predicted by the peptide databank entries. 
Although numerous E. coli proteins were successfully characterized using the method 
described in this chapter, the technique does suffer from certain shortcomings.  First, the total 
number of proteins detected – approximately 200 – is well under 1/10th of the total proteins 
expected to be produced by E. coli.  Clearly, no strategy used to date has been able to 
successfully characterize all of the proteins produced by any organism, though greater 
numbers of identifications have been reported elsewhere.22  As discussed, the number of 
proteins characterized could be improved by performing a higher resolution anion exchange 
separation, collecting more fractions, and lengthening the reversed-phase gradients.  Making 
these improvements would, however, substantially increase the analysis time.  Unfortunately, 
the existing method is already relatively slow, due to the time required to analyze 20 
fractions off-line using both top-down and bottom-up methods.  In order to increase the 
number of fractions analyzed without suffering an unreasonable increase in analysis time, a 
substantial change in approach would be necessary.  It was this fact which motivated a switch 
to on-line LC x LC, which will be described in the next chapter. 
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4.6 Tables 
 
 
 
 
 
 
 
 
 
 
 
 
 
m/z range Collision 
energy 1 (V) 
Collision 
energy 2 (V) 
Collision 
energy 3 (V) 
Collision 
energy 4 (V) 
400.00-500.00 20 22 24 26 
500.01-600.00 22 24 26 28 
600.01-700.00 24 26 28 30 
700.01-800.00 26 28 30 32 
800.01-900.00 28 30 32 34 
900.01-up 30 32 34 36 
 
Table 4-1: Collision energy profile used for MS/MS experiments 
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Parameter  Value 
Database UniProt KB / Swiss-Prot 
Taxon Escherichia coli 
Protein MW range 0-285,000 
Protein pI range: 0.00-14.00 
Include varsplice yes 
Include fragment yes 
Enzyme trypsin 
Missed cleavage 1 
Resolution monoisotopic 
Ion mode [M] 
PTM observed / by similarity 
Max PTM per peptide 2 
Modifications CAM C – C2H4ON – fixed 
 MSO M – O – variable 
Shift max (Da) 0.00 
Slope max (ppm) 200 
Internal error (ppm) 25 
pValue max 1 x 10-3 
Random try max 100,000 
Random fine min 3,000 
Peptide: Scoring missed cl 0.50 
Peptide: Scoring intensity 1.00 
Peptide: Scoring C-term R 1.00 
Peptide: Scoring C-term K 1.00 
Peptide: Scoring C-term L 1.00 
Protein: Scoring Coverage 1.00 
Protein: Scoring MW 1.00 
Protein: Scoring pI 1.00 
 
Table 4-2: Parameters used to perform peptide mass fingerprinting database searching using 
Aldente (http://www.expasy.org/tools/aldente/) 
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Data processing parameter Value 
Mass Accuracy No lockspray calibration 
Noise reduction (electrospray survey and 
MS/MS) 
Adaptive 
Perform de-isotoping Yes 
Deisotoping type Slow (MaxEnt 3) 
Maximum iterations 50 
  
Workflow template parameter  Value 
Search engine type PLGS 
Databanks SWISSPROT_NCBI-1.0 
Species E. coli 
Peptide tolerance 50 ppm 
Fragment tolerance 0.3 Da 
Estimated calibration error 0.005 Da 
Molecular weight range 0-100,000 Da 
pI range 0-14 
Minimum peptides to match 1 
Maximum hits 200 
Primary digest reagent Trypsin 
Secondary digest reagent None 
Missed cleavages 2 
Fixed modifications Carbamidomethyl C 
Variable modifications Oxidation M 
Validate Yes 
Filter None 
 
Table 4-3: Parameters used to perform LC-MS/MS data workup using ProteinLynx Global 
Server 2.0 (Waters)  Data processing parameters control how the MS spectra were processed 
prior to database searching; workflow template parameters control how the MS/MS database 
search is performed 
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Ref 
# 
Protein Peptides 
matched 
Coverage 
% 
Predicted 
MW 
Observed 
MW 
AXC 
Fraction 
RT 
1 CSPC_ECOLI 2 43 7271 7272 3 18.18 
2 CSPE_ECOLI 1 18 7332 7333 2 19.05 
3 YJBJ_ECOLI 5 59 8325 8326 6 17.43 
4 HDEB_ECOLI 1 16 9065 9062 10 17.50 
5 PTHP_ECOLI 1 35 9119 9119 8 20.64 
6 RS15_ECOLI 2 42 10138 10142 6 20.53 
7 CH10_ECOLI 2 25 10387 10387 14 19.69 
8 FETP_ECOLI 1 26 10821 10822 10 19.00 
9 YGIW_ECOLI 2 27 11976 11977 10 19.40 
10 YEGP_ECOLI 1 17 12024 12026 8 16.14 
11 RL7_ECOLI 1 10 12164 12162 16 28.25 
12 GRCA_ECOLI 3 35 14284 14285 10 19.60 
13 YCCU_ECOLI 2 27 14701 14701 8 26.74 
14 OSMC_ECOLI 3 41 14957 14955 9 21.51 
15 RS6_ECOLI 1 8 15316 15316 16 18.64 
16 NDK_ECOLI 2 28 15332 15333 13 24.18 
17 HNS_ECOLI 2 15 15408 15410 12 21.22 
18 SODC_ECOLI 1 5 15739 15737 9 16.31 
19 USPA_ECOLI 2 36 15935 15934 18 25.46 
20 YJGK_ECOLI 2 11 16865 16867 12 20.92 
21 TPX_ECOLI 3 35 17704 17704 12 26.72 
22 PTGA_ECOLI 4 30 18120 18121 14 23.59 
23 OSMY_ECOLI 11 60 18161 18162 8 16.74 
24 BFR_ECOLI 2 16 18495 18494 19 24.94 
25 FABA_ECOLI 3 20 18838 18842 17 20.28 
26 FTNA_ECOLI 1 8 19424 19425 12 21.62 
27 YFBU_ECOLI 1 5 19536 19537 13 24.28 
28 AHPC_ECOLI 5 35 20630 20628 14 24.29 
29 WRBA_ECOLI 6 46 20714 20712 17 23.68 
30 SODF_ECOLI 2 15 21135 21136 10 24.20 
31 RPIA_ECOLI 1 4 22860 22863 12 24.22 
32 KAD_ECOLI 6 35 23586 23587 9 22.21 
33 RPE_ECOLI 2 8 24554 24553 19 25.34 
34 ARTI_ECOLI 5 27 25042 25042 7 21.01 
35 FABG_ECOLI 1 5 25560 25561 8 24.84 
36 ARGT_ECOLI 1 6 25785 25785 7 20.71 
37 DEOD_ECOLI 3 20 25819 25818 15 25.87 
38 FLIY_ECOLI 2 10 26068 26069 8 21.24 
39 HISJ_ECOLI 1 6 26233 26233 7 20.41 
40 TPIS_ECOLI 1 5 26972 26972 13 22.98 
41 UDP_ECOLI 2 14 27028 27029 13 25.58 
42 KDUD_ECOLI 7 28 27070 27067 16 27.75 
43 FABI_ECOLI 1 6 27733 27735 10 25.40 
44 GPMA_ECOLI 7 31 28425 28427 10 23.70 
45 RBSB_ECOLI 18 75 28474 28476 6 21.33 
46 EFTS_ECOLI 4 20 30292 30293 14 22.59 
 
Table 4-4: E. coli proteins identified by both intact protein and peptide MS/MS analyses. 
(Table is continued and term definitions are included on the following page).
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Ref 
# 
Protein Peptides 
matched 
Coverage 
(%) 
Predicted 
MW (Da) 
Observed 
MW (Da) 
AXC 
Fraction 
RT 
(min) 
47 HCHA_ECOLI 3 13 31059 31062 12 23.62 
48 YTFG_ECOLI 3 9 32126 32127 6 22.43 
49 MDH_ECOLI 10 35 32337 32338 8 25.74 
50 DGAL_ECOLI 12 51 33368 33371 7 21.91 
51 PROX_ECOLI 1 7 33727 33727 7 20.81 
52 CYSK_ECOLI 4 21 34358 34359 13 23.88 
53 ASPG2_ECOLI 1 4 34593 34593 9 21.41 
54 TALB_ECOLI 7 21 35088 35090 11 25.71 
55 TALA_ECOLI 4 18 35659 35660 10 23.30 
56 6PGL_ECOLI 2 9 36308 36304 18 20.36 
57 GLPQ_ECOLI 5 19 38200 38201 14 20.79 
58 ALF_ECOLI 3 9 39016 39014 15 23.37 
59 MALE_ECOLI 4 12 40707 40709 9 22.31 
60 EFTU_ECOLI 11 35 43182 43188 16 22.84 
61 GLYA_ECOLI 8 24 45317 45320 12 23.22 
62 UGPB_ECOLI 2 7 46124 46126 7 21.51 
63 TNAA_ECOLI 16 45 52773 52775 11 24.21 
64 DPPA_ECOLI 1 5 57407 57406 7 23.71 
 
Table 4-4: (Table is continued from the previous page) E. coli proteins identified by both 
intact protein and peptide MS/MS analyses.  Heading terms are defined as follows: Ref #: 
Internal reference number; see below. Protein: SwissProt database entry name; Peptides 
matched: number of tryptic peptides identified using ESI-q-TOF MS/MS analysis; 
Coverage %: percent coverage of predicted protein sequence based on peptides matched; 
Predicted MW: average protein mass calculated from predicted protein sequence in 
SwissProt database entry; Observed MW: de-convoluted molecular weight of protein 
determined by ESI-TOF MS; AXC Fraction: anion exchange fraction number; RT: intact 
protein reversed-phase retention time.   
 
A descriptive name of all proteins in this table is provided in the appendix of this 
dissertation, listed by Ref #.
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MW Frac. RT MW Frac. RT MW Frac. RT MW Frac. RT 
5064 10 17.40 11691 12 25.02 19490 11 19.11 30979 9 24.01 
5458 2 15.05 11745 12 22.72 19572 15 21.67 31094 12 23.32 
5474 2 13.95 11896 2 16.75 19685 14 21.69 31234 2 19.95 
5591 3 15.08 11911 6 16.33 19729 11 24.61 31658 19 26.94 
5760 17 21.78 12205 16 28.95 19892 12 14.12 32262 10 26.20 
6318 6 19.23 12220 16 28.65 19951 14 22.49 32899 20 26.14 
6856 10 17.40 12294 16 28.45 19963 14 24.09 33271 9 23.61 
6867 2 16.95 12424 16 23.14 20112 17 23.18 33827 17 25.18 
6945 18 24.36 12692 12 25.92 20324 10 20.70 34375 13 23.68 
7136 16 21.14 13003 13 17.78 20453 14 23.29 34486 17 23.08 
7151 7 13.81 13111 14 21.99 20472 7 22.71 36489 17 24.18 
7349 14 17.99 13520 8 22.14 20603 15 25.87 38704 10 23.20 
8157 10 24.80 13737 10 20.60 20888 6 20.43 40990 12 28.13 
8275 11 10.31 13757 8 23.44 20945 6 20.33 41258 14 25.29 
8342 6 17.33 14085 12 21.72 20994 19 23.54 42150 17 22.88 
8393 18 22.96 14102 12 21.52 21151 10 23.80 42852 10 26.30 
8536 6 19.23 14151 19 29.15 21222 19 26.64 43543 11 21.21 
8670 12 21.92 14297 10 20.40 21574 16 26.34 43555 11 21.01 
8749 16 20.44 14364 8 17.84 21666 19 27.85 45010 6 21.03 
9005 7 17.51 14442 6 19.23 21738 2 22.15 49317 6 20.73 
9078 10 17.10 14528 20 27.14 21760 13 23.78 50264 11 23.41 
9094 10 17.30 14607 10 20.10 22082 16 25.74 51349 14 27.19 
9161 10 18.20 14662 17 29.59 22297 9 26.91 52670 15 26.67 
9283 4 17.57 14939 12 20.72 22973 4 22.17 57689 17 26.88 
9386 11 20.21 15291 15 23.27 23457 10 19.70 58727 12 23.42 
9461 7 16.71 15709 11 23.41 23531 6 20.63    
9477 7 16.51 15946 18 26.16 23783 19 22.64    
9577 8 17.74 16099 7 19.51 23858 11 23.41    
9705 7 16.61 16155 17 28.29 23906 13 25.08    
9737 11 18.01 16284 16 24.44 24175 13 25.88    
9755 11 17.61 16659 18 22.76 24532 10 21.80    
9802 6 20.13 16958 9 25.21 24572 12 24.82    
9827 7 19.41 17036 14 22.09 24971 4 21.47    
9838 13 19.78 17057 6 19.43 24985 2 21.25    
9903 12 20.12 17317 15 23.47 25863 8 20.84    
9967 12 19.82 17523 18 20.76 26313 13 26.58    
10314 6 19.43 17647 16 24.34 26959 8 24.44    
10602 13 20.38 17791 4 22.17 27029 13 25.58    
10615 6 20.83 17980 12 26.52 28549 7 21.61    
10651 2 19.95 18082 2 19.85 28578 7 21.71    
10779 11 20.11 18178 8 16.54 28679 6 21.93    
10919 16 24.04 18214 6 21.83 28702 8 21.74    
11035 19 22.44 18248 8 21.64 28864 6 22.53    
11157 14 22.99 18389 9 17.11 29296 10 24.60    
11224 9 21.11 18795 17 27.18 29364 12 23.22    
11400 9 17.11 18963 10 25.50 29389 6 23.63    
11496 15 21.67 19199 12 23.02 30206 6 22.13    
11674 12 26.72 19408 12 21.72 30417 6 23.33    
 
Table 4-5: E. coli proteins detected by intact protein analysis only.  Heading terms are 
defined as follows: MW: de-convoluted molecular weight of protein determined by ESI-TOF 
MS; Frac.: anion exchange fraction number; RT: reversed-phase retention time (in minutes)
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Ref
# 
Protein Prd 
MW 
Pep 
mtc 
% 
Cov 
Ref 
# 
Protein Prd 
MW 
Pep 
mtc 
% 
Cov 
65 RL29_ECOLI 7273 1 22 113 DHAS_ECOLI 40018 1 5 
66 YCCJ_ECOLI 8524 1 16 114 PGK_ECOLI 40987 14 55 
67 RL28_ECOLI 8875 1 13 115 SUCC_ECOLI 41393 6 24 
68 DBHB_ECOLI 9226 2 33 116 AGP_ECOLI 43560 1 3 
69 DBHA_ECOLI 9535 4 58 117 AAT_ECOLI 43573 2 6 
70 RL25_ECOLI 10693 2 10 118 DEOB_ECOLI 44370 2 6 
71 RL24_ECOLI 11185 1 17 119 SURA_ECOLI 45078 1 3 
72 IHFA_ECOLI 11354 1 10 120 ENO_ECOLI 45524 7 28 
73 RL21_ECOLI 11564 1 12 121 IDH_ECOLI 45757 2 5 
74 RS10_ECOLI 11736 2 23 122 ACEA_ECOLI 47522 2 5 
75 RL18_ECOLI 12770 1 8 123 CISY_ECOLI 48015 3 10 
76 GLRX4_ECOLI 12879 1 11 124 TIG_ECOLI 48193 3 9 
77 YJGF_ECOLI 13480 2 48 125 SYS_ECOLI 48414 2 7 
78 RL11_ECOLI 14744 2 17 126 ATPB_ECOLI 50194 1 3 
79 RL15_ECOLI 14980 2 18 127 DLDH_ECOLI 50557 1 2 
80 SKP_ECOLI 15692 2 20 128 KPYK2_ECOLI 51226 2 8 
81 RL9_ECOLI 15769 5 40 129 6PGD_ECOLI 51481 2 9 
82 RL13_ECOLI 16019 1 14 130 ALDA_ECOLI 52142 9 22 
83 ASNC_ECOLI 16888 1 7 131 ASPA_ECOLI 52356 2 5 
84 RL10_ECOLI 17580 1 7 132 DCEA_ECOLI 52685 6 16 
85 YBAY_ECOLI 17682 1 9 133 YHJJ_ECOLI 53050 1 3 
86 PPIB_ECOLI 18153 2 20 134 ATPA_ECOLI 55222 5 11 
87 RL6_ECOLI 18773 3 24 135 OPGG_ECOLI 55365 2 8 
88 RS7_ECOLI 19888 1 10 136 GLPK_ECOLI 56100 20 50 
89 NUSG_ECOLI 20400 1 8 137 ALDB_ECOLI 56306 2 5 
90 CLPP_ECOLI 21563 1 10 138 CH60_ECOLI 57198 11 28 
91 YRBC_ECOLI 21733 1 7 139 PUR9_ECOLI 57329 2 6 
92 RL3_ECOLI 22244 1 10 140 PPCK_ECOLI 59643 8 27 
93 ALKH_ECOLI 22284 4 25 141 RS1_ECOLI 61158 4 13 
94 SODM_ECOLI 22966 1 4 142 G6PI_ECOLI 61530 3 7 
95 CRP_ECOLI 23640 2 12 143 SYD_ECOLI 65913 1 2 
96 GLRX2_ECOLI 24350 1 6 144 GLMS_ECOLI 66763 2 4 
97 RL1_ECOLI 24598 3 16 145 DNAK_ECOLI 68984 7 15 
98 GLNH_ECOLI 24963 6 33 146 HTPG_ECOLI 71423 2 4 
99 RS3_ECOLI 25852 1 5 147 TKT1_ECOLI 72212 2 5 
100 YBGI_ECOLI 26892 1 8 148 PNP_ECOLI 77101 3 5 
101 UDP_ECOLI 27028 2 14 149 EFG_ECOLI 77450 18 39 
102 DEOC_ECOLI 27734 2 11 150 MASZ_ECOLI 80357 1 2 
103 FARR_ECOLI 28273 1 3 151 MAO2_ECOLI 82417 4 9 
104 SUCD_ECOLI 29646 1 33 152 CATE_ECOLI 84163 6 9 
105 DAPD_ECOLI 29892 1 3 153 PFLB_ECOLI 85226 2 2 
106 KDUI_ECOLI 31076 3 16 154 SYFB_ECOLI 87378 2 4 
107 GLTI_ECOLI 31229 2 11 155 ACON2_ECOLI 93498 3 4 
108 KDGK_ECOLI 33962 3 15 156 ADHE_ECOLI 95996 2 3 
109 G3P1_ECOLI 35401 13 48 157 SYV_ECOLI 108192 1 1 
110 USPE_ECOLI 35576 1 6 158 GABT_ECOLI 45775 1 3 
111 YGHZ_ECOLI 38832 1 8 159 IF3_ECOLI 20564 2 13 
112 SERC_ECOLI 39652 1 3      
 
Table 4-6: E. coli proteins detected by peptide MS/MS analysis only.  Heading term 
definitions are the same as in Table 4-4 (abbreviated versions used). A descriptive name of 
all proteins in this table is provided in the appendix of this dissertation, listed by Ref #. 
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Ref 
# 
Protein Pept 
mtch 
Cov 
% 
AXC 
Frac. 
RT Pred. 
MW 
Obs. 
MW 
ΔMW Assigned 
modification 
66 YCCJ_ECOLI 1 16 18 22.96 8524 8393 -131 Met loss 
67 RL28_ECOLI 1 13 7 17.51 8875 9005 130 No Met loss 
68 DBHB_ECOLI 2 33 10 17.30 9226 9094 -131 Met loss 
69 DBHA_ECOLI 4 58 8 17.74 9535 9577 42 Acetylation 
70 RL25_ECOLI 2 10 2 19.95 10693 10651 -43 No acetylation 
72 IHFA_ECOLI 1 10 9 21.11 11354 11224 -130 Met loss 
79 RL15_ECOLI 2 18 12 20.72 14980 14939 -42 No acetylation 
82 RL13_ECOLI 1 14 7 19.51 16019 16099 80 Phosphorylation 
129 6PGD_ECOLI 2 9 14 27.19 51481 51349 -132 Met loss 
 
Table 4-7: Additional E. coli proteins possibly identified by both intact protein and peptide 
MS/MS analyses when certain common post-translational modifications were considered.  
Heading term definitions are the same as in Table 4-4 (in abbreviated form), with the 
addition of the following: ΔMW: Difference in MW calculated by subtracting Predicted MW 
from Observed MW; Assigned modification: post-translational modification of the protein 
assigned based on delta-mass information.  A descriptive name of all proteins in this table is 
provided in the appendix of this dissertation, listed by Ref #. 
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4.7 Figures 
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Peak list table     Database search program 
 
     Protein ID: ALBU_BOVIN 
Figure 4-1: Overview of peptide mass fingerprinting (PMF) method. An LC-MS separation 
of a peptide mixture is performed (A); mass spectra for all major components are generated 
(B) and their m/z and charge state are recorded in a peak list (C).  The peak list is searched 
against a database (D), which produces an identification of the protein(s)
m/z charge state 
488.49 2+ 
722.27 2+ 
395.21 2+ 
653.30 2+ 
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473.86 3+ 
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…. … 
(+ others) 
A 
B 
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Figure 4-2: Overview of bottom-up protein identification using DDA MS/MS of peptides.  
An LC-MS separation of a peptide mixture is performed (A); MS survey mode is used to 
detect major components (B).  These components are then selected and fragmented by CID; 
the resulting MS/MS spectra can be used to sequence the peptides.  The peptide sequences 
are searched against a database (D), which identifies the protein(s).
Database searching program  Protein ID: ALBU_BOVIN 
A 
B 
C
D
(CID) 
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Figure 4-3: Overview of instrumentation and procedure used for hybrid top-down / bottom-
up LC x UHPLC-MS analysis of complex protein mixtures 
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Figure 4-4: Comparison of the old high pressure 4-port union (A & B) with the new one (C & 
D).  The new union has a much lower internal dead volume, which reduces the delay between 
the start of the run and when the first peaks appear.  Both unions use the same 1/32” fittings 
to hold fused silica capillary.  A complete diagram of the pump can be found in Figure 3-4. 
A 
B D
C
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Figure 4-5: First dimension anion exchange separation of the E. coli protein extract.  The run 
was performed using a 60 minute linear gradient from 10 to 500 mM ammonium acetate (pH 
8.5).  Detection was UV absorbance at 280 nm.  A total of 20 fractions were collected. 
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Figure 4-6: 2D chromatograms from an off-line AXC x RPLC separation of intact E. coli 
proteins.  (A) was generated using the TIC data; (B) is a base peak chromatogram for the 
same run, generated using AutoME de-convoluted data.  Run conditions are defined in the 
text. 
A 
B 
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Figure 4-7: Number of proteins found in each anion exchange fraction for the 2D separation 
of the E. coli protein extract. 
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Figure 4-8: Comparison of PMF and MS/MS chromatograms of the same E. coli protein 
digest sample.  (A) Is the chromatogram from the PMF experiment; (B1) is the survey 
chromatogram from the MS/MS experiment.  (B2) and (B3) are chromatographic 
representations of the two MS/MS channels from the same run as (B1); they indicate when 
MS/MS was performed and the total ion intensity of the component being scanned. Run 
conditions are defined in the text.
A: PMF chromatogram 
B1: MS/MS survey chromatogram 
B2: MS/MS channel 1 
B3: MS/MS channel 2 
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Figure 4-9: 2D chromatogram of an off-line AXC x RPLC separation of peptides from 
trypsin-digested E. coli proteins.  The chromatogram was generated using the UHP-RPLC 
runs from the PMF experiment.  Run conditions are defined in the text. 
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Figure 4-10: Venn diagrams illustrating overlap of E. coli proteins detected using bottom up 
(PMF and MS/MS) and top-down (intact protein) analyses.  (A) Compares all three of the 
methods; (B) is a simplified diagram comparing only intact protein and MS/MS strategies  
B 
A 
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Figure 4-11: Molecular weight distribution of E. coli proteins detected from the intact protein 
and peptide MS/MS data 
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Figure 4-12: “Low-resolution” chromatospectrum of the full dataset from a 2D AXC x RPLC 
separation of intact E. coli proteins.  Data from all anion exchange fractions were summed.  
MW Range: 5-60 kDa, RT range: 13-32 min, bin size: 100 Da.  Total data points: 104,550.  
The area within the box is expanded in Figure 4-13. 
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Figure 4-13: “High-resolution” chromatospectrum of a selected time/mass window (see 
Figure 4-12) from a 2D AXC x RPLC separation of intact E. coli proteins.  MW Range: 9-10 
kDa, RT range: 15-23 min, bin size: 1 Da.  Total data points: 80,000. 
CHAPTER 5: On-line LC x LC-MS of intact proteins, followed by peptide LC-MS/MS: 
an extension of the top down / bottom up method 
 
5.1 Introduction 
The work described in Chapter 4 demonstrated that a hybrid of top down and bottom 
up proteomics methods can provide useful information when analyzing a complex sample.  
However, the data obtained suggested that the technique needed higher chromatographic 
resolution of intact proteins prior to digestion in order to reduce the complexity of the 
fractions and improve the success of peptide identification using MS/MS.  To do so without 
an unreasonable increase in analysis time necessitates a substantial change in approach.  On-
line LC x LC is a logical option, because it can substantially reduce analysis time while 
maintaining or improving separation performance.  A switch to on-line coupling of 
dimensions is not without tradeoffs, however.  It requires substantially more careful 
optimization of the timing of each dimension than off-line methods.  Also, as discussed 
previously, it is not yet practical to use ultra-high pressure separations in on-line LC x LC.  
In spite of the drawbacks, it was judged that there were sufficient advantages to merit moving 
to an on-line approach.   
In this chapter, a method is reported which uses on-line LC x LC for intact protein 
separations, followed by fraction collection and bottom-up protein analysis.  This technique 
differs from the research presented in Chapter 4 in two main ways: first, the intact protein 
separation is carried out using on-line coupling of dimensions as opposed to off-line, and 
second, fraction collection and trypsin digestion occur after two dimensions of LC separation 
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as opposed to just one.  Bottom-up analysis of peptides using LC-MS/MS remains a part of 
the technique; however, the coupling between the top-down and bottom-up portion of the 
analysis is still off-line via fraction collection.  The methods which were developed were 
applied to analysis of the E. coli proteome.  Results from these studies are presented and 
compared with the findings from the off-line LC x LC method reported in Chapter 4. 
5.2 Experimental methods 
5.2.1 Overview 
An overview of the instrumentation and procedure used to perform an on-line 2D 
separation of intact proteins and bottom-up analysis of protein digests is shown in Figure 5-1.  
The first dimension of the on-line LC x LC separation is performed using gradient anion 
exchange chromatography.  The effluent from the anion exchange column enters a 10-port 
switching valve.  The valve directs the AXC column effluent to the front of one of two 
reversed-phase columns, which serve as the second dimension of the 2D separation.  Any 
proteins eluting from the AXC column are trapped at the front of the RPLC column until the 
valve is switched, at which point they are eluted using a reversed-phase gradient.  The valve 
is switched multiple times over the course of a 2D run, which allows the second dimension to 
sample the first multiple times.  For some experiments, a small portion of the effluent from 
the reversed-phase column was diverted to an ESI-quadrupole mass spectrometer to obtain 
intact protein MW information.  For all runs, the majority of the effluent was sent to a UV 
absorbance detector, then to a fraction collector.  For the bottom-up portion of the 
experiment, the fractions are lyophilized in a vacuum centrifuge, and then digested using 
trypsin to produce peptides.  They are then analyzed using capillary RPLC-MS/MS and the 
resulting spectra are searched against a database in order to identify the proteins present in 
the sample. 
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5.2.2 Chemicals and samples 
Chemicals used for LC mobile phase were ammonium acetate, formic acid and 
trifluoroacetic acid (ACS reagent grade), which were purchased from Sigma-Aldrich (St. 
Louis, MO), and ammonium hydroxide (ACS reagent grade) and acetonitrile (HPLC grade), 
which were purchased from Fisher Scientific (Fair Lawn, NJ).  Deionized water was purified 
using a Barnstead Nanopure System (Boston, MA).  Chemicals used in the trypsin digest 
procedure were: ammonium bicarbonate (Sigma-Aldrich, St. Louis, MO), RapiGest SF acid-
labile surfactant (Waters Corporation, Milford, MA), dithiothreitol (Research Products 
International, Mt. Prospect, IL), iodoacetamide (Sigma-Aldrich), TPCK-modified trypsin 
(Pierce, Rockford, IL), and trifluoroacetic acid (Sigma-Aldrich). 
The samples which were analyzed consisted of both standard proteins and cellular 
protein extracts.  The standard proteins – lysozyme, ribonuclease A, cytochrome C, 
myoglobin, β-lactoglobulin, bovine serum albumin, and ovalbumin – were purchased from 
Sigma-Aldrich and were used as received.  The Escherichia coli protein extract analyzed in 
this experiment was the same sample described in Chapter 4.  Prior to injection, the sample 
was diluted to 20 mg/mL in 10 mM ammonium acetate (pH 8.5). 
5.2.3 Evaluation of commercial columns for RPLC of intact proteins 
In previous chapters, all reversed-phase separations of proteins were performed using 
capillary columns operated at ultra-high pressures.  It was not possible to use these columns 
in an on-line LC x LC system because automated switching valves which could be operated 
at pressures above 1400 bar (20 kpsi) were not available.  Also, it was desired to collect 
fractions from the effluent of the second dimension columns.  Therefore, even if suitable 
switching valves were available, the capillary columns used in UHPLC would not be 
practical because they operate at flow rates which are too low for fraction collection.  
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Consequently, it was necessary to use conventional-diameter, conventional-pressure reversed 
phase HPLC columns.  Therefore, two different commercial RPLC columns were evaluated 
under controlled conditions before selecting a column to use for on-line 2D separations of 
complex samples.  The goal of these tests was to determine if satisfactory separations could 
be attained, and which type of column offered the best performance. 
Reversed-phase columns marketed as appropriate for protein separations were 
obtained from Waters Corporation.  The first column was the Waters Biosuite pPhenyl 10 
μm, which is 7.5 cm long x 4.6 mm ID.  It is packed with 10 μm polymeric particles with 
1000 Å pores, which are the same base particle as those found in the Biosuite AXC column.  
The particles are bonded with phenyl functional groups to give the stationary phase a 
hydrophobic surface.  The second column was a Waters Symmetry300 C4, which is 5 cm 
long x 4.6 mm ID and is packed with 5 μm silica particles with 300 Å pores.  The bonded 
stationary phase contains n-butyl groups.  A Waters 600E quaternary gradient LC pump was 
used to produce the reversed-phase gradients.  The pump is connected to a Valco 6-port valve 
(VICI, Houston, TX) with a sample loop, which is used to perform injections onto the 
column.  Detection was performed using an Applied Biosystems 785A UV absorbance 
detector (Foster City, CA) set at 280 nm. 
Columns were tested using a mixture of 7 standard proteins.  Each was dissolved at a 
concentration of 0.1 mg/mL in starting mobile phase; the sample injection amount was 
typically 20 μL.  In addition to the standard protein sample, the E. coli protein extract was 
also used to evaluate the performance of the columns with a more complex mixture.  The 
mobile phase composition and gradient program for the separations were varied in order to 
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determine the method which gave the best performance; specific run conditions are described 
with the results presented in Section 5.3.   
5.2.4 On-line LC x LC: instrumentation 
Once an RPLC column was selected, the on-line LC x LC system was constructed.  A 
diagram illustrating the components of the system and how they are operated is shown in 
Figure 5-2.  All fluidic connections are made using 0.005” (127 μm) ID PEEK tubing.  The 
first dimension of the 2D separation is performed using anion exchange chromatography.  
Initially, the Waters Biosuite Q 10 μm AXC column (7.5 cm x 7.5 mm ID) was used.  In 
order to improve resolution, it was later replaced with the custom-packed long anion 
exchange column (111 cm x 6.6 mm ID).  Sample is injected onto the first dimension column 
using a Valco 6-port valve (VICI, Houston, TX) with a sample loop.  The anion exchange 
gradient is generated by a Waters 600E quaternary gradient LC pump. 
The effluent from the AXC column enters a two-position, 10-port valve (Cheminert 
C2H-1000EH, VICI).  From there, it is directed onto the head of the first of two identical 
reversed-phase columns (labeled column 1 in Figure 5-2A).  Since the mobile phase from the 
AXC column is 100% aqueous, all proteins are retained at the front of the reversed-phase 
column.  The residual anion exchange mobile phase passes through the column and back into 
the 10-port valve, where it is diverted to waste.  At the same time as sample is being loaded 
onto column 1, the inlet of RPLC column 2 is connected to a second LC pump.  This pump, 
which is a Hewlett Packard model 1050 HPLC (Agilent, Santa Clara, CA), is used to 
generate gradients to elute proteins from the RPLC columns.  After a set period of time – 
typically 30 minutes – the 10-port valve is switched, which directs the effluent of the AXC 
column to RPLC column 2.  Meanwhile, the proteins which had previously been loaded onto 
RPLC column 1 are eluted using a gradient generated by the second LC pump.  In order to 
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perform a full 2D run, the process of loading one column while eluting the other is repeated 
multiple times until all components have eluted from the AXC column and have been 
separated on one of the RPLC columns. 
In the first run performed on the 2D system, all of the effluent from the RPLC column 
being eluted was directed to a UV absorbance detector set at 215 nm (Applied Biosystems 
785A, Foster City, CA) and then to a fraction collector (Waters Fraction Collector II).  In 
later analyses, approximately 1/20th of the RPLC column effluent was diverted to a Waters 
ZQ mass spectrometer for on-line ESI-MS analysis.  The mass spectrometer was operated 
using a standard z-spray source in the positive ion mode, with a capillary voltage of +3000V 
and a sample cone voltage of +35V.  Data were acquired at a rate of 1 sample/sec over a 
range of 450-1600 m/z.  The ZQ uses a single quadrupole mass analyzer, which gives lower 
resolution than a TOF instrument, although it is adequate for measuring intact protein MW.  
The instrument was calibrated regularly using a solution of sodium formate. 
5.2.5 On-line LC x LC: software control and timing 
In order for the LC x LC system to work properly, the timing of many components 
must be precisely controlled.  This was accomplished using a computerized control program 
called a virtual instrument (VI) written in-house using LabVIEW 6.1 (National Instruments, 
Austin, TX).  This program coordinated the timing of the sample injection, valve switch 
events, gradient start signals, data acquisition, and fraction collection.  Although the 
LabVIEW program controls the timing of the entire LC x LC analysis, two other software 
programs were used for data acquisition.  A modified version of Stripchart Recorder XP 
(another custom LabVIEW VI, written by Matthew Monroe) was used to record the signal 
from the UV detector, and MassLynx 4.1 (Waters Corp.) was used to acquire LC-MS data. 
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5.2.6 On-line LC x LC: run conditions 
For the anion exchange separation, mobile phase A was 10 mM ammonium acetate, 
adjusted to pH 8.5 with ammonium hydroxide.  Mobile phase B was 1M ammonium acetate, 
adjusted to pH 8.5 with ammonium hydroxide.  For the first 2D separation, which used UV 
detection only, reversed-phase mobile phase A was deionized water with 0.1% trifluoroacetic 
acid, and B was acetonitrile with 0.1% trifluoroacetic acid.  When MS detection was used, 
the ion pairing agent was changed to 0.2% formic acid, since TFA is known to cause ion 
suppression in ESI-MS.1 
Selection of run lengths and gradient profiles is a more complex process for on-line 
LC x LC than for off-line.  This is because the second dimension separations must be much 
faster than the first so that the effluent of the first dimension can be sampled multiple times 
over the course of the 2D run.2  Since the second dimension separation speed is the limiting 
factor for the length of the entire analysis, it was desired to keep the RPLC run time as low as 
possible.  Evaluations of the RPLC columns had determined that a good compromise 
between speed and resolution was reached when they were operated at a flow rate of 0.5 
mL/min and with a turn-around time of 30 minutes between runs.  In order to allow for a 
post-gradient column wash and full re-equilibration to initial conditions within this time 
period, a reversed-phase gradient length of 20 minutes was used.  The length of the anion 
exchange gradient was set so that an adequate number of fractions could be transferred from 
the first dimension to the second.  For the short anion exchange column, it was desired to 
transfer a total of 10-12 fractions, so a 300 minute anion exchange gradient was used.  The 
flow rate was set at 0.1 mL/min to keep the gradient volume near the same as previous runs 
using this column.  For the long anion exchange column, it was decided to analyze a total of 
30 fractions, so the gradient length was increased to 900 minutes.  The flow rate used for this 
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column was also 0.1 mL/min.  Several different anion exchange and reversed-phase gradient 
profiles were used for the LC x LC runs reported in this chapter.  AXC gradient profiles are 
displayed in Table 5-1 and Table 5-2; reversed-phase gradient profiles are displayed in Table 
5-3 and Table 5-4.  The specific profile used for a given 2D run is reported with the results in 
Section 5.3. 
5.2.7 Fraction collection, lyophilization, and trypsin digest 
Some of the 2D runs reported in this chapter were performed solely to investigate the 
capabilities of the online LC x LC system for intact protein separations.  In these runs, no 
fractions were collected, and bottom-up proteome analysis was not performed.  For the one 
run in which fraction collection was performed, the goal was to spread the proteins out over 
as many fractions as possible, and to avoid collecting fractions in empty regions of the 
chromatogram.  In trial runs of reversed-phase separations of the E. coli protein extract, no 
protein peaks were typically observed before 7 minutes into the gradient or after 23 minutes.  
Therefore, the fraction collector was programmed to delay starting the collection of fractions 
until 7 minutes after the start of every reversed-phase gradient, and to change tubes every 1.5 
minutes until 23.5 min.  This yielded 11 fractions per reversed-phase run, with a volume of 
0.75 mL each.  A total of 11 reversed phase runs were performed over the course of the 2D 
separation, so the total number of fractions collected was 121.  Once all fractions were 
collected, they were flash-frozen using liquid nitrogen and then lyophilization was performed 
using a vacuum centrifuge as described in Section 4.2.4.  Once completely dry, the fractions 
were reconstituted using 25 μL of 50 mM ammonium bicarbonate.  The proteins in the 
fractions were then reduced, alkylated, and digested using trypsin according to the procedure 
explained in Section 4.2.4.  
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5.2.8 LC-MS/MS of protein digests 
Capillary LC was performed using a conventional-pressure CapLC pump (Waters 
Corp.).  A diagram of the instrument is shown in Figure 5-3.  Its operation is quite 
straightforward compared to the stored-gradient UHPLC pump described previously.  The 
autosampler injects the desired amount of sample onto the column, and then a real-time 
gradient is generated to elute the sample components.  The column used was a Waters 
Symmetry C18, which is 15 cm long and has an ID of 320 μm.  It is packed with 5 μm silica 
particles with 100 Å pores which are bonded with a C18 stationary phase.  Although referred 
to as a capillary column, its inner diameter is several times larger than the custom-packed 
capillary columns described previously in this dissertation.  Typical flow rates used with this 
column were 5-10 μL/min; therefore, fluidic connections between system components could 
be made with 0.0025” (67 μm) ID PEEK tubing without causing excessive band broadening. 
For the RPLC peptide separations, mobile phase A was deionized water with 0.2% 
formic acid and mobile phase B was HPLC-grade acetonitrile with 0.2% formic acid.  A 30 
minute gradient from 1-30% B was used to separate the peptides, followed by a 5 minute 
column wash at 75% B, after which the mobile phase was returned to 1% B.  Typically 10 μL 
of sample were injected onto the column.  This is a large volume of sample relative to the 
column diameter; however, it was necessary in order to obtain adequate MS/MS signal 
intensity for sample components over a wide range of concentrations. 
For experiments in which UV detection was performed, the outlet of the column was 
coupled to a CapLC photodiode array (PDA) detector, which is an integrated part of the 
CapLC instrument.  This detector allows UV absorbance to be monitored over a range of 
wavelengths from 190 - 400 nm.  The detector flow cell has an internal volume of 250 nL, 
which is small enough to prevent significant band broadening from harming the resolution of 
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peaks as they pass through the cell.  The effluent from the detector was coupled to the inlet of 
the Q-TOF Micro mass spectrometer (Waters Corp.).  For those experiments in which UV 
detection was not performed, the outlet of the column was connected directly to the MS.  The 
MS was operated using a standard z-spray source in the positive ion mode, with a capillary 
voltage of +3000V and a sample cone voltage of +40V.  The MS source temperature was 
100º C and the desolvation gas flow rate and temperature were set at 250 L/hr and 120º C, 
respectively.  MS/MS analysis of the components eluting from the column were performed 
using a data-directed analysis (DDA) method.  The workflow of the DDA experiment was 
the same as described in Section 4.2.6.2. 
5.2.9 Data analysis 
For the LC x LC intact protein separation in which no MS data were acquired, a 2D 
chromatogram was generated using UV absorbance data.  For the other LC x LC runs, 2D 
chromatograms were generated from the LC-MS data which was de-convoluted using 
AutoME as described in Section 3.2.7.  AutoME processing parameters were set as follows: 
the time segment width was 6 seconds, the output spectrum resolution was 1Da, the range of 
masses in the output spectrum was 5,000-80,000 Da, and the maximum number of iterations 
was 50.  The de-convoluted data were also used to generate a list of the molecular weights of 
intact proteins found in the sample.  ProteinLynx Global Server 2.0 (Waters Corp.) was used 
to process LC-MS/MS data from runs of the trypsin-digested fractions and to search the 
MS/MS spectra against the SwissProt database.   A more detailed account of this process can 
be found in Section 4.2.7.2. 
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5.3 Results and discussion 
5.3.1 Evaluation of commercial columns for RPLC of intact proteins 
Reversed-phase separations of intact proteins are sometimes associated with negative 
attributes such as asymmetrical peak shape, poor sample recovery, and sample carryover 
between runs.3-7  These occurrences may be due to undesired interactions between the 
proteins and chemical moieties in the stationary phase, such as residual silanol groups on 
silica particles or metal contaminants.8  Since the chemistry of the stationary phase can have 
a substantial impact on separation quality, two different types of reversed-phase columns 
were tested to assess their performance for protein separations.  The first column – the 
Waters Biosuite pPhenyl – contained methacrylate-based polymeric particles bonded with a 
phenyl stationary phase.  The second – a Waters Symmetry300 – contained silica particles 
with a C4 stationary phase. 
The columns were first evaluated using a mixture of seven standard proteins, which 
are listed in Section 5.2.2.  Separations were performed using 15 and 30 minute gradients 
from 10-70% acetonitrile with 0.1% trifluoroacetic acid.  Chromatograms from these runs are 
shown in Figure 5-4.  Peak capacities were computed for all of the separations and are 
displayed along with the chromatograms in the figure.  For both columns, peak capacity 
increased by approximately 45% when the gradient was lengthened from 15 to 30 minutes.  
Of the two columns, the Symmetry offers better chromatographic performance – it gives 
peak capacities approximately 50% higher than the Biosuite column for equivalent gradient 
lengths.  This is not surprising, since the Symmetry column contains 5 μm particles while the 
Biosuite column uses 10 μm particles.  The columns were also evaluated by performing 
separations of an E. coli protein extract using a 15 minute gradient, as shown in Figure 5-5.  
Due to the complexity of the sample, neither column is able to resolve the components into 
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individual peaks.  However, the chromatogram produced by the Symmetry column does 
show more detail, due to a smaller average peak width. 
In general, these data suggest that the Symmetry column produces higher resolution 
separations of proteins than the Biosuite column.  However, closer examination of the 
chromatograms in Figure 5-4 reveals a concern related to the performance of the Symmetry 
column.  The Biosuite column produces seven distinct, relatively symmetrical peaks, plus 
one minor peak, which is most likely a contaminant from one of the protein standards.  Thus, 
the number of major peaks matches the number of components in the sample.  The 
chromatograms from the Symmetry column show four sharp peaks, two somewhat broader 
peaks, and a variety of other peaks too small to be one of the main sample components.  
Thus, one of the seven proteins in the sample appears to be missing from the chromatogram.  
Also, some of the peaks are somewhat asymmetrical.  These observations indicate that non-
ideal interactions with some of the proteins may be occurring with the silica-based Symmetry 
column.  Therefore, the polymer-based Biosuite column was selected to be used for the 
second dimension of the on-line 2D system, because of the likelihood that it will produce 
more consistent separations of a wide range of proteins. 
5.3.2 On-line LC x LC of intact proteins: chromatographic results 
Once the reversed-phase columns had been selected and the on-line LC x LC 
instrument was prepared, a 2D separation of the E. coli protein extract was performed.  
Anion exchange run conditions for this separation are specified in Table 5-1; reversed-phase 
run conditions are in Table 5-3.  For this run, no MS detector was used; only UV absorbance 
data were obtained for the separation.  The UV data were used to generate a 2D 
chromatogram, which is shown in Figure 5-6.  Peaks in the chromatogram appear to be 
spread over a relatively wide range of the separation space, although the last two anion 
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exchange fractions contained relatively few proteins.  The peak capacity of this separation 
was estimated to be approximately 300, which is low compared to LC x LC separations 
reported in previous chapters.  The loss in peak capacity can be attributed to the low number 
of anion exchange fractions and the reduced peak capacity of the reversed-phase separation 
as compared to runs performed using ultra-high pressure LC.  From a proteomic standpoint, 
however, better use is made of the available peak capacity, since 121 fractions were collected 
during the run, all of which were subsequently digested and analyzed using a bottom-up 
method.  This is 6 times more fractions than were collected and analyzed in the off-line LC x 
LC experiment reported in Chapter 4.  Another advantage of this method is the substantial 
increase in speed.  The entire 2D separation was performed in approximately 6 hours; an 
equivalent separation would have taken several days to complete using the off-line method. 
A second LC x LC separation of the E. coli protein extract was performed using 
electrospray mass spectrometry as the detection method.  Anion exchange run conditions for 
this separation are specified in Table 5-1; reversed-phase run conditions are in Table 5-4.  In 
order to assess the reproducibility of the online 2D separation, this run was performed in 
duplicate.  Chromatograms for both of the runs are shown in Figure 5-7.  Protein peaks 
appear to be more well-defined in these chromatograms than in the UV chromatogram 
(Figure 5-6) due to the greater sensitivity and selectivity of electrospray mass spectrometry 
toward intact proteins, particularly when maximum entropy de-convolution is used to process 
the data as described in Section 3.2.7.  The peak capacity is essentially unchanged from the 
previous LC x LC run, which is expected since the gradient lengths were the same.  
Reversed-phase retention times were shifted lower by several minutes because the gradient 
was altered slightly and the acidic modifier was changed from trifluoroacetic acid to formic 
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acid.  Based on a visual comparison of the two chromatograms, reproducibility of the 2D 
separation appears to be relatively good.  Most peaks appear in the same position and have 
approximately equal intensity.  There are some instances, however, where a peak appears to 
have shifted to an adjacent anion exchange fraction, or to be split between two fractions in 
one chromatogram while appearing in only one fraction in the other.  Although it is difficult 
to ascertain the cause of these shifts with certainty, it is possible that a slight change in the 
pH of the anion exchange mobile phase between 2D runs is responsible for the retention time 
drift.  No fraction collection was performed with these 2D separations.   
A third on-line LC x LC separation was carried out using the long AXC column as 
the first dimension.  As before, the run was performed in duplicate.  Anion exchange run 
conditions for this separation are specified in Table 5-2; reversed-phase run conditions are in 
Table 5-4.  The improved resolution contributed by the longer anion exchange column 
increased the peak capacity of the 2D separation to approximately 900.  As before, the 
general appearance of the two replicate chromatograms is similar, indicating that 
reproducibility is fairly good.  Closer inspection does reveal that a substantial number of 
components shifted to adjacent anion exchange fractions, lending more evidence to the 
hypothesis that a drift in pH of the anion exchange mobile phase is causing a shift in 
retention of the proteins.  Again, no fraction collection was performed following these 2D 
separations.  If it had been, the total number of fractions collected could have been well over 
300, which illustrates the potential of the technique to divide the complex sample into fine 
segments before bottom-up protein analysis. 
5.3.3 On-line LC x LC of intact proteins: mass slice chromatograms 
In the process of comparing chromatograms from replicate 2D runs, a useful way of 
visually representing LC x LC-MS data was developed.  The data can be divided into 
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segments based on mass ranges and then displayed as a series of 2D chromatograms.  For 
example, one chromatogram could be generated using only components with a mass between 
5 and 15 kDa, a second between 15 and 25 kDa, and so on.  The data from the 2D separation 
of the E. coli protein extract shown in Figure 5-8A was processed using custom-written 
functions in Igor Pro (Wavemetrics, Lake Oswego, OR) to divide the data into 11 kDa mass 
ranges.  The resulting data were displayed as a series of 2D plots shown in Figure 5-9, which 
are termed “mass slice chromatograms.”  The plots are analogous to a selected ion 
chromatogram (SIC) for LC-MS data, except they are presented in 2D format and contain a 
range of masses as opposed to a single mass.  The first chromatogram on the page, Figure 
5-9A, shows the full mass range data (3000-80,000 kDa).  The remaining seven 
chromatograms, Figure 5-9B-H, display the same data divided into mass slices.  The result is 
that the number of components which appear in any individual 2D chromatogram is reduced.  
Some of the mass slice chromatograms contain more peaks than others; this is because a 
large portion of the E. coli proteins detected have a mass between 10-35 kDa.  Note that all 
peaks present in the full mass range chromatogram (A) can be found in one of the mass slice 
chromatograms (B-H). 
The main use for the mass-slice chromatograms is anticipated to be in comparing sets 
of LC x LC data.  When attempting to compare two peaks in a crowded chromatogram, it is 
often difficult to be certain whether the same components have been selected, especially 
considering the fact that retention times may have shifted slightly.  When the chromatogram 
is divided into mass slices and only peaks within the same mass range are compared, the 
number of interfering peaks is reduced, which increases the reliability of the comparison.  
Also, mass-slice chromatograms may reveal peaks which are not visible in full mass range 
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chromatograms.  This would be the case if two peaks with different masses co-eluted in 
terms of retention times on both the first and second LC dimensions.  While such peaks could 
not be distinguished in a full-mass-range chromatogram, they would appear as separate 
components in the mass slice chromatograms.  Finally, it should be noted that mass slices are 
not limited to ~10 kDa segments.  The data could be divided into much finer bins (for 
example, 1kDa or 100Da) in order to further simplify comparison between chromatograms.  
5.3.4 RPLC-MS/MS of peptides: chromatographic results 
After the LC x LC separation with fraction collection was performed, fractions were 
digested using trypsin to produce peptides.  The peptides in each fraction were separated and 
analyzed using LC-MS/MS.  Due to the large number of fractions to be run – 121 in total – it 
was necessary to use instrumentation capable of automated, relatively fast runs.  It was 
therefore decided to use a conventional-pressure (350 bar / 5000 psi) capillary LC system, 
which offered reduced separation performance compared to the stored gradient UHPLC 
system, but substantially faster sample throughput due to more reliable automation. 
Two chromatograms from a RPLC separation of one of the trypsin-digested LC x LC 
fractions are shown in Figure 5-10.  The first chromatogram, Figure 5-10A, displays UV 
absorbance at 193 nm.   This was found to be the most sensitive wavelength for detection of 
peptides.  The peak capacity for this separation was estimated to be 55, which is 3 times less 
than the peak capacity obtained using gradient UHPLC reported in Chapter 4.  The loss of 
peak capacity is not surprising, given that this column uses 5 μm particles, as opposed to the 
1.5 μm particles used for UHPLC.  The complexity of the sample somewhat exceeds the 
resolving capabilities of the column, as is indicated by numerous overlapping peaks 
distributed throughout the chromatogram and the absence of regions of flat baseline. 
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The second chromatogram from the same run, shown in Figure 5-10B, displays the 
base peak intensity from the MS survey scan.  Due to the low sampling rate associated with 
data-directed MS/MS, the resolution of the chromatogram is poor.  This makes it nearly 
impossible to correlate specific peaks in the UV chromatogram with peaks in the MS 
chromatogram.  Protein identification was still possible, since it is based on the quality of the 
MS/MS spectra rather than chromatographic resolution.  Nevertheless, better coverage of the 
proteins in the sample might have been obtained if a higher resolution separation were 
performed, because it would increase the number of different peptides that could be sampled 
using MS/MS. 
5.3.5 Top-down / bottom-up E. coli proteome analysis: mass spectral results 
To assess the effectiveness of the on-line LC x LC separation when applied to the 
field of proteomics, the MS data were analyzed using automated maximum entropy de-
convolution (AutoME, Waters Corp.) to generate a list of the intact protein masses found in 
the sample.  Likewise, the MS/MS data from the trypsin-digested fractions were searched 
against the SwissProt database of known E. coli proteins using ProteinLynx Global Server 
2.0 (Waters Corp.) in order to identify the proteins which were detected.  The results were 
compared with previous analyses, to determine if the on-line LC x LC approach offered any 
benefit in terms of increased number of proteins detected and identified.  The overlap 
between the proteins detected using top-down (intact protein MS) and bottom-up (peptide 
MS/MS) analyses was also assessed, to determine if the increased fractionation offered by 
LC x LC helped improve the correlation between the methods. 
5.3.5.1 Comparison with previous experiments 
The simplest comparison to make involving proteomic datasets is between proteins 
that have been identified by database searching.  This is because each protein is assigned a 
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unique name and identifying code; a comparison between two lists can be made simply by 
checking to see if a protein present in one list is also present in the other.  Thus, the proteins 
identified using MS/MS data in this experiment were compared in this manner with those 
identified from the off-line LC x LC experiment reported in Chapter 4.  A Venn diagram 
illustrating the correlation between the proteins identified in each experiment is shown in 
Figure 5-11A.  Encouragingly, the overlap is relatively high – 72% of the proteins identified 
using MS/MS in Chapter 4 were also found using the methods reported in this chapter.  
Moreover, the total number of proteins identified increased from 159 to 241 in moving from 
the off-line to the on-line LC x LC separation.  This is evidence that the larger number of 
fractions collected allowed better MS/MS coverage of the proteins in the sample.  Table 5-5 
lists the 127 “new” proteins that were not found in Chapter 4 but were identified by peptide 
MS/MS database searching using the method reported in this chapter. 
The fact that the overlap between the two methods was not 100%, in spite of an 
increased total number of proteins detected, indicates that protein identifications via MS/MS 
can be somewhat hit-or-miss.  For example, if a peptide starts to elute from the RPLC 
column when other ions are being analyzed using MS/MS, but finishes eluting before the 
MS/MS scans are complete, it may never be subjected to fragmentation and therefore cannot 
be used to identify the protein from which it originated.  A means of improving the 
correlation further would be to return to UHPLC for peptide separations.  This would 
improve resolution of peaks, which would allow a greater portion of the peptides to be 
analyzed using MS/MS.  
5.3.5.2 Overlap between intact protein masses and identified proteins 
Unlike comparing lists of proteins which have been uniquely identified, there is some 
ambiguity associated with matching proteins in two different lists based on their molecular 
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weights.  One reason for this uncertainty is that an arbitrary error margin must be assigned to 
account for mass error.  Also, when comparing experimentally measured intact protein 
masses to predicted protein MW values, there is no way of knowing in advance if the 
predicted mass accounts for all post-translational modifications. Nonetheless, this is the only 
method by which the correlation between top-down and bottom-up data collected in this 
experiment could be assessed.  A direct comparison of the proteins found in the same 
fractions using the top-down and bottom-up methods was not possible, since intact protein 
MS data was not collected for the 2D separation in which fractions were analyzed using the 
bottom-up approach (Figure 5-6).  However, intact protein MS data was collected in a later 
LC x LC separation of the same sample under nearly identical conditions (Figure 5-7).  This 
allowed a reasonable assessment of the overlap between top-down and bottom-up analyses to 
be made, which is illustrated using a Venn diagram in Figure 5-11B.  The overlap between 
intact proteins and proteins identified by MS/MS was determined to be 40%.  This is a 
moderate increase from the overlap of 27% obtained in Chapter 4.  Thus, some improvement 
in the correlation between top-down and bottom-up data was gained due to the extra 
resolution provided by LC x LC separation prior to fractionation.  As discussed in Chapter 4, 
the remaining 60% of non-overlapping proteins may be due in part to post-translational 
modifications not predicted in the protein databases, or different selectivity of electrospray-
MS for intact proteins as compared to peptides. 
A final comparison was made between the total number of intact proteins detected 
using on-line LC x LC with the short AXC column (Figure 5-7) versus the long AXC column 
(Figure 5-8).  By increasing the column length, the total number of intact proteins detected 
increased from 233 to 299.  Thus, the longer anion exchange column provided a relatively 
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modest 28% increase in total number of intact proteins detected.  It is likely that this increase 
would have been greater if the long anion exchange column were sampled more frequently 
by the second dimension, in order to take advantage of more of the resolution which it is 
capable of generating. 
5.4 Conclusions 
  The data generated in this experiment demonstrated that on-line LC x LC can be 
successfully used in the context of a hybrid top-down / bottom-up proteomic experiment.  
The number of intact proteins detected and proteins identified using MS/MS data both 
increased modestly as compared to the off-line LC x LC approach.  The relatively small 
gains in proteins detected illustrates the fact that “digging deeper” into the proteome of an 
organism becomes exponentially more difficult the farther down one attempts to probe, due 
to the large range of protein concentrations that are present.  Ultimately, the number of 
proteins which can be detected is largely dependent on the sensitivity and dynamic range of 
the mass spectrometer.  MS instruments which are substantially more sensitive than the ones 
used in this study are commercially available at the present time, and future improvements in 
this area will doubtless result in further advances in the field of proteomics. 
A more significant improvement demonstrated in this chapter was the increase in 
analysis speed achieved by using on-line LC x LC for separations of intact proteins.  An 
analysis which previously required several days to complete could be performed in just a few 
hours, and was completely automated once the sample was injected.  Moreover, the 
sensitivity and the resolution of the technique was maintained to an adequate degree, such 
that the number of proteins detected and identified remained the same or improved as 
compared to off-line separations.  The bottom-up portion of the analysis, which was still 
performed off-line using fraction collection, remained relatively time-consuming.  
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Nevertheless, an improvement in speed of one portion of the method represents a significant 
step toward making the technique more practical for day-to-day proteomics research. 
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5.6 Tables 
 
 
 
Time (min) % B 
0 0 
10 5 
300 50 
350 50 
355 0 
 
Table 5-1: AXC gradient profile used with the short anion exchange column.  MP A was 
0.01M ammonium acetate, pH 8.5.  MP B was 1M ammonium acetate, pH 8.5. 
 
 
 
 
 
Time (min) % mobile phase B 
0 0 
30 5 
900 50 
1050 50 
1071 0 
 
Table 5-2: AXC gradient profile used with the long anion exchange column.  Mobile phase A 
was 0.01M ammonium acetate, pH 8.5.  Mobile phase B was 1M ammonium acetate, pH 8.5 
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Time (min) % mobile phase B 
0 10 
1 20 
6.25 35 
19 50 
20 70 
21 70 
22 10 
 
Table 5-3: RPLC gradient profile for LC x LC separations with UV detection only.  Mobile 
phase A was 0.1% (v/v) trifluoroacetic acid in deionized water.  Mobile phase B was 0.1% 
(v/v) trifluoroacetic acid in acetonitrile. 
 
 
 
 
 
Time (min) % mobile phase B 
0 5 
2 20 
20 50 
21 70 
22 5 
23 70 
24 5 
 
Table 5-4: RPLC gradient profile for LC x LC separations with UV and MS detection.  
Mobile phase A was 0.2% (v/v) formic acid in deionized water.  Mobile phase B was 0.2% 
(v/v) formic acid in acetonitrile. 
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Ref
# 
Protein Prd 
MW 
Pep 
mtc 
% 
Cov 
Ref 
# 
Protein Prd 
MW 
Pep 
mtc 
% 
Cov 
160 RL30_ECOLI 6411 1 24 208 YCAC_ECOLI 23100 1 5 
161 YDCH_ECOLI 6470 1 18 209 ENGB_ECOLI 23561 1 5 
162 RL31_ECOLI 7871 1 20 210 YLIJ_ECOLI 23713 2 17 
163 IF1_ECOLI 8118 1 25 211 TRAT1_ECOLI 23809 1 2 
164 YODD_ECOLI 8579 2 57 212 NARL_ECOLI 23927 2 12 
165 GLRX3_ECOLI 9006 1 30 213 YCEH_ECOLI 24177 1 6 
166 YCIN_ECOLI 9386 1 24 214 PYRH_ECOLI 25839 1 5 
167 RS20_ECOLI 9553 1 13 215 CPXR_ECOLI 26312 1 6 
168 RS17_ECOLI 9573 1 23 216 RS2_ECOLI 26612 1 6 
169 YIIU_ECOLI 9635 4 58 217 YGGE_ECOLI 26635 2 7 
170 HDEA_ECOLI 9741 2 59 218 HDHA_ECOLI 26779 1 5 
171 YHCO_ECOLI 10796 1 22 219 LPXA_ECOLI 28080 1 8 
172 YGIN_ECOLI 11532 1 9 220 PANB_ECOLI 28237 2 9 
173 THIO_ECOLI 11675 1 11 221 TRPA_ECOLI 28724 1 7 
174 BOLA_ECOLI 11994 1 15 222 YEHZ_ECOLI 30204 1 6 
175 YDEI_ECOLI 12025 1 12 223 ALSB_ECOLI 30385 2 10 
176 PHNA_ECOLI 12345 1 15 224 NADE_ECOLI 30637 1 5 
177 GLNB_ECOLI 12425 1 10 225 THTM_ECOLI 30681 2 14 
178 RL19_ECOLI 13002 1 13 226 DKGA_ECOLI 31110 2 11 
179 YCFF_ECOLI 13241 1 14 227 AGAY_ECOLI 31294 1 2 
180 YJBR_ECOLI 13519 1 8 228 YJJW_ECOLI 31491 1 2 
181 RL16_ECOLI 14281 1 12 229 PANC_ECOLI 31598 1 4 
182 YHHA_ECOLI 14738 1 14 230 YBBN_ECOLI 31791 1 4 
183 YAEH_ECOLI 15096 1 9 231 YTFQ_ECOLI 32126 3 13 
184 USPG_ECOLI 15935 1 18 232 GLSA1_ECOLI 32903 3 16 
185 FUR_ECOLI 16795 3 27 233 RSEB_ECOLI 33294 1 4 
186 YHBC_ECOLI 16821 1 7 234 ACCD_ECOLI 33322 1 7 
187 DKSA_ECOLI 17528 1 8 235 THIB_ECOLI 34207 1 4 
188 BCP_ECOLI 17634 1 13 236 PTNAB_ECOLI 34916 1 4 
189 GREA_ECOLI 17641 1 7 237 ACCA_ECOLI 35110 3 12 
190 PPIA_ECOLI 18077 1 14 238 QOR_ECOLI 35172 1 4 
191 SSPB_ECOLI 18262 1 7 239 RPOA_ECOLI 36512 2 9 
192 MOAB_ECOLI 18534 1 7 240 TDH_ECOLI 37239 1 1 
193 LRP_ECOLI 18756 1 7 241 ALF1_ECOLI 37978 2 7 
194 SSB_ECOLI 18844 1 8 242 GALM_ECOLI 38190 1 7 
195 HSLV_ECOLI 18962 1 6 243 GCST_ECOLI 40016 4 15 
196 YAJQ_ECOLI 19047 2 17 244 IADA_ECOLI 41084 1 3 
197 ATPD_ECOLI 19332 2 22 245 YQHD_ECOLI 42097 1 4 
198 APT_ECOLI 19859 2 23 246 FABB_ECOLI 42613 1 2 
199 WCAF_ECOLI 19962 1 3 247 RIR2_ECOLI 43386 2 9 
200 YDJA_ECOLI 20059 1 9 248 TOLB_ECOLI 43602 1 2 
201 RL5_ECOLI 20170 1 12 249 ASTC_ECOLI 43665 1 5 
202 EFP_ECOLI 20460 1 6 250 ODO2_ECOLI 43880 5 15 
203 GMHA_ECOLI 20815 1 8 251 ISCS_ECOLI 45090 1 3 
204 YDJY_ECOLI 21740 1 2 252 DEGP_ECOLI 46829 2 6 
205 GRPE_ECOLI 21798 1 7 253 PURA_ECOLI 47214 1 5 
206 FKBB_ECOLI 22085 2 11 254 GLMM_ECOLI 47412 2 6 
207 RL4_ECOLI 22087 1 12 255 DHE4_ECOLI 48581 1 6 
 
Table 5-5: E. coli proteins identified by peptide MS/MS analyses, which were not detected in 
Chapter 4.  (This table is continued and the heading terms are defined on the following page). 
 
200
 
 
 
 
 
 
Ref
# 
Protein Prd 
MW 
Pep 
mtc 
% 
Cov 
Ref 
# 
Protein Prd 
MW 
Pep 
mtc 
% 
Cov 
256 ACCC_ECOLI 49321 1 3 272 SYQ_ECOLI 63347 1 2 
257 KPYK1_ECOLI 50729 2 7 273 DHSA_ECOLI 64422 1 2 
258 GABD_ECOLI 51720 2 10 274 ODP2_ECOLI 65965 1 2 
259 GLNA_ECOLI 51773 4 15 275 YEJA_ECOLI 67521 1 1 
260 IMDH_ECOLI 52022 3 13 276 TKT2_ECOLI 73043 3 8 
261 SYN_ECOLI 52439 1 2 277 OPDA_ECOLI 77167 2 5 
262 PEPD_ECOLI 52784 1 2 278 CATA_ECOLI 80024 3 6 
263 SYE_ECOLI 53816 4 11 279 TRAD1_ECOLI 81489 1 1 
264 NORR_ECOLI 55236 1 1 280 CLPB_ECOLI 95585 6 7 
265 AHPF_ECOLI 56177 1 2 281 SYA_ECOLI 96032 3 7 
266 PUR1_ECOLI 56357 3 6 282 AMPN_ECOLI 98788 4 5 
267 SYK2_ECOLI 57695 2 5 283 CAPP_ECOLI 99063 1 2 
268 USHA_ECOLI 58209 1 2 284 ODP1_ECOLI 99537 1 1 
269 FUMA_ECOLI 60167 3 7 285 SYI_ECOLI 104166 5 10 
270 YTFM_ECOLI 62527 1 1 286 ODO1_ECOLI 105062 3 5 
271 MAO1_ECOLI 63197 1 2      
 
Table 5-5: (Table is continued from previous page) E. coli proteins identified by peptide 
MS/MS analyses, which were not detected in Chapter 4.  Heading terms are defined as 
follows: Ref #: Internal protein reference number; see below. Protein: SwissProt database 
entry name; Prd MW: average protein mass calculated from predicted protein sequence in 
SwissProt database entry; Pep mtc: number of tryptic peptides identified using ESI-q-TOF 
MS/MS analysis; % Cov: Percent coverage of predicted protein sequence based on peptides 
matched. 
 
A descriptive name of all proteins in this table is provided in the appendix of this 
dissertation, listed by Ref #. 
 
201
5.7 Figures 
 
 
 
 
 
 
Figure 5-1: Overview of instrumentation and procedure used for top-down LC x LC-MS and 
bottom-up LC-MS/MS analysis of complex protein mixtures 
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Figure 5-2: Diagram illustrating operation of the on-line LC x LC system.  Fluidic 
connection lines are colored to illustrate flow paths through the system.  The 10-port 
switching valve can be in one of two positions, A or B.  In position A, the effluent from the 
AXC column is directed to RPLC column 1, and sample components are trapped at the head 
of the column.  Meanwhile, RPLC column 2 is eluted by a reversed-phase gradient produced 
by LC pump 2.  When the gradient is finished, the valve is switched to position B, which 
causes the effluent of the AXC column to be directed to column 2, and allows the sample 
components on column 1 to be eluted. 
Position A: load column 1, elute column 2  
Position B: load column 2, elute column 1 
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Figure 5-3: Diagram of the conventional pressure CapLC-MS system used to perform 
bottom-up proteomic analyses.  The UV detector was a photodiode array, which is built into 
the CapLC system.  It is shown as a separate component in this diagram for clarity. 
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Figure 5-4: Comparison of separations of seven standard proteins at 0.1 mg/mL using 
polymeric (A, B) and silica-based (C, D) RPLC columns.  The gradient went from 10 to 70% 
ACN with 0.1% TFA over the specified length of time (15 or 30 minutes).
A: Biosuite, 15 min gradient 
B: Biosuite, 30 min gradient 
C: Symmetry, 15 min gradient 
D: Symmetry, 30 min gradient 
Peak capacity = 13 
Peak capacity = 21 
Peak capacity = 31 
Peak capacity = 20 
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Figure 5-5: Comparison of separations of an E. coli protein extract using polymeric (A) and 
silica-based (B) RPLC columns.  The gradients used were: (A): 10-70% ACN over 7.5 min; 
(B): 10-70% ACN over 15 min; (C): 20-60%ACN over 15 min; (D): 20-80% ACN over 15 
min.  0.1% TFA was in all mobile phases throughout the runs. 
A: Biosuite, E. coli extract 
B: Symmetry, E. coli extract 
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Figure 5-6: UV absorbance chromatogram from an online LC x LC separation of the E. coli 
protein extract.  Detection was performed at a wavelength of 215 nm.  A total of 121 
fractions were collected.  Anion exchange run conditions are specified in Table 5-1; 
reversed-phase run conditions are specified in Table 5-3. 
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Figure 5-7: 2D chromatograms from replicate on-line LC x LC separations of the E. coli 
protein extract using the short AXC column.  The chromatograms were generated using 
AutoME-de-convoluted data and are displayed using an identical color-scale range.  Run 
conditions are specified in the text. 
A 
B 
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Figure 5-8: 2D chromatograms from replicate on-line LC x LC separations of the E. coli 
protein extract using the long AXC column.  The chromatograms were generated using 
AutoME-de-convoluted data and are displayed using an identical color-scale range.  Run 
conditions are specified in the text. 
A 
B 
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Figure 5-9: Mass slice 2D chromatograms of the E. coli protein extract. Chromatogram (A) 
shows the full-mass range data; the other seven chromatograms (B-H) display 11 kDa 
segment “mass slices” of the same data.   
A (full range) B 
C D 
E F 
G H 
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Figure 5-10: Chromatograms displaying UV absorbance (A) and MS base peak intensity (B) 
for the RPLC separation of peptides from a trypsin digest of LC x LC fraction F8 (see Figure 
5-6). 
A 
B 
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Figure 5-11: Venn diagrams illustrating overlap between proteins found using different 
analysis methods.  (A) compares the number of proteins identified using MS/MS from off-
line LC x LC (Chapter 4) and on-line LC x LC (Chapter 5).  (B) illustrates the overlap 
between proteins detected using intact protein LC x LC-MS versus those identified using LC-
MS/MS of the peptide fractions. 
A 
B 
CHAPTER 6: LC x LC-MS for differential analysis of the proteome of yeast grown 
under different conditions 
 
6.1 Introduction 
The objective of proteomics is to determine meaningful biological information by 
analyzing the entire complement of proteins expressed by an organism.  Qualitative 
proteomics – which involves determining the identities of the proteins in a sample – has been 
the focus of the methods reported in this dissertation thus far.  While this is a useful means of 
gaining understanding of many fundamental biological processes, in many cases it is also 
important to know how two or more samples differ in terms of the quantity of the various 
proteins they contain.  For example, the rapidly developing field of biomarker discovery 
relies in part on the detection of patterns of change in protein expression in order to allow 
faster, more accurate diagnosis of disease.1-4  It is therefore often necessary to compare the 
amounts of various proteins produced by a healthy organism or tissue to those from an 
organism with a specific disease.  Methods designed to address this type of challenge fall 
within the field of differential proteomics.5, 6 
Most differential proteomics performed to date has been carried out using gel 
electrophoresis.6  A typical experiment is performed by separating the samples to be 
compared on 2D gels under identical conditions.  The proteins are stained, and images of the 
gels are captured and converted to digital form.  Image manipulation and analysis is 
performed to overlay matching spots and to detect spots which differ substantially in 
intensity.  These regions of the gel are then excised, and in-gel digestion is performed on the 
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proteins.  The peptides which are released are then analyzed using bottom-up methods such 
as MALDI-TOF-MS or LC-ESI-TOF-MS followed by database searching to identify the 
proteins which differed in quantity between samples.  While effective, this approach is 
subject to all of the shortcomings of gel electrophoresis, such as poor resolution of some 
proteins, the lack of dynamic range associated with staining methods, and the requirement of 
substantial manual labor.  More recently, alternative approaches for differential proteomics 
have been demonstrated which employ strategies based on LC-MS or multidimensional LC-
MS.1, 6  The majority of these techniques are based on bottom-up proteomics.  Frequently, 
they involve some form of isotopic labeling in order to differentiate one sample from another 
using mass spectrometry,7, 8 although some label-free methods have been reported.9 
 In the research presented in this chapter, multidimensional liquid chromatography 
coupled to mass spectrometry was used to perform a differential analysis of several samples 
of soluble proteins extracted from Saccharomyces cerevisiae (bakers yeast), a unicellular 
eukaryote which has been extensively used as a model organism in the fields of cellular 
biology and biochemistry.10, 11  Differences in protein expression were brought about by 
culturing yeast on different growth media and by harvesting protein at different stages in its 
growth cycle.  LC x LC-MS analyses of intact proteins from the yeast cultures were then 
used to detect variances in protein expression between the samples.  Proteins which were 
found to be up- or down-regulated in one or more of the samples were digested using trypsin 
and were identified via bottom-up LC-MS/MS.  Most of the analytical techniques used are 
similar to those described in Chapter 5.  Thus, the focus of this chapter is on the application 
of the hybrid top down / bottom up method to differential proteomics. 
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6.2 Experimental 
6.2.1 Overview 
An overview of the method used to perform differential proteomic analysis of S. 
cerevisiae is shown in Figure 6-1.  Protein extracts from yeast cultures grown under different 
conditions were separated using on-line LC x LC.  The effluent from the second dimension 
was split such that a small portion was used to perform on-line electrospray-TOF MS, while 
the majority was collected in fractions.  The intact protein LC x LC-MS data were used to 
generate 2D mass-slice chromatograms.  The mass slice chromatograms from the different 
samples were compared, and proteins which increased or decreased significantly in intensity 
were selected for further analysis.  The proteins in these fractions were digested using 
trypsin, and then separated and detected using capillary RPLC-MS/MS.  The resulting 
MS/MS spectra were searched against a database of known yeast proteins in order to identify 
the proteins present in the fractions.  The specific proteins which were detected to be up- or 
down-regulated were identified by matching their observed MW from the intact protein MS 
data with the predicted MWs from the peptide data. 
6.2.2 Chemicals and samples 
The chemicals used in this experiment were the same as those described in Chapter 5.  
The yeast protein extract samples were prepared from cultures of S. cerevisiae by researchers 
at Waters Corporation (Milford, MA).  To induce differences in protein expression, the yeast 
was cultured using growth media with different carbon sources and the proteins were 
harvested at different phases of growth.  One culture was grown on glycerol medium and 
harvested at log-growth phase.  A second was grown on glucose medium and was harvested 
at log-growth phase.  The third was grown on glucose medium and was harvested at 
stationary phase.  Soluble proteins were extracted from each of the yeast cultures according 
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to a procedure which has been described previously.12  The final extract samples contained 
cytosolic yeast proteins in 25 mM ammonium bicarbonate, along with several protease 
inhibitors.  The concentration of protein in the extracts was measured using a Coomassie Plus 
Bradford assay kit (Pierce, Rockford, IL) using bovine serum albumin as a standard. Based 
on this assay, the concentration of protein in the glycerol/log phase sample was 13.5 mg/mL; 
in the glucose/log phase sample it was 11.0 mg/mL, and in the glucose/ stationary phase 
sample it was 10.5 mg/mL.  All solutions were diluted to a concentration of 10.0 mg/mL with 
anion exchange mobile phase A and were spiked with bovine heart cytochrome C at a 
concentration of 10 ng/mL to serve as an internal standard. 
6.2.3 Intact protein LC x LC-MS  
The instrumentation used for the on-line LC x LC-MS separations of intact proteins 
was identical to that which is described in Section 5.2.6.  Most of the chromatographic 
conditions were also similar, though slight modifications were made to the anion exchange 
and reversed phase gradients in order to improve the distribution of the yeast proteins over 
the available separation space.  Mobile phase compositions and gradient profiles are provided 
in Table 6-1 and Table 5-4.  A total of 30 reversed-phase separations were performed in 
every LC x LC run.  Fraction collection was initiated 2 minutes after the start of each 
reversed phase gradient, and fractions were switched every 45 seconds using an automated 
fraction collector until 16 fractions had been collected, at which point collection was 
suspended until 2 minutes after the start of the next gradient.  For each LC x LC run, a total 
of 480 fractions, 0.75 mL each, were collected in 1 mL 96-well microtiter plates.  After 
collection, the fractions were stored at -20º C until needed. 
A total of six LC x LC separations were performed.  The first three runs were carried 
out in order to analyze differences in protein expression between the three yeast samples.  
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The log-phase glycerol-medium sample was analyzed first, followed by the log-phase 
glucose-medium sample and the stationary-phase glucose-medium sample.  After these runs 
were complete, the glycerol log-phase sample was analyzed three additional times using the 
same LC x LC-MS method.  These replicate runs served to assess the run-to-run 
reproducibility, and thereby to verify the technique’s applicability to differential analysis of 
complex mixtures of proteins. 
6.2.4 Intact protein data processing 
The focus of this experiment was to selectively identify proteins which were up or 
down-regulated in one of the yeast samples, rather than to detect and identify as many 
proteins as possible.  Therefore, the intact protein LC x LC-MS data were examined to detect 
proteins that changed in intensity between different yeast samples.  The yeast culture grown 
on glycerol medium was compared to the sample grown on glucose medium (both samples 
harvested at logarithmic phase), and the yeast culture harvested at logarithmic growth phase 
was compared to the sample harvested at stationary phase (both samples were grown on 
glucose media). 
In order to compare the abundance of proteins in the samples, LC x LC-MS data were 
first processed using automated maximum entropy de-convolution (AutoME) according to 
the parameters specified in Chapter 5.  The resolution for maximum entropy de-convolution 
was set at 2 Da as opposed to 1 Da to reduce processing time.  The de-convoluted data were 
used to generate 2D chromatograms using custom functions written for the data analysis 
software package Igor Pro (WaveMetrics, Lake Oswego, Oregon).  The bovine heart 
cytochrome C peak, an internal standard added to each of the yeast samples, was located in 
each chromatogram and its area was measured.  These peak areas were used to standardize 
the intensities of all other peaks for all three yeast samples.  The standardized chromatograms 
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were displayed using the same z-axis range (color scale) in order to allow accurate 
comparisons between samples.  The maximum intensity was selected such that some of the 
tallest peaks are off-scale; this made lower intensity peaks more visible.  In cases where the 
intensity of the largest peaks needed to be compared, the chromatograms were re-scaled 
appropriately.  2D mass-slice chromatograms spanning a range of 1 kDa each were generated 
as described in Section 5.3.3.  The mass slice chromatograms from two different yeast 
samples were then visually compared.  Any protein which was observed to increase or 
decrease significantly in intensity was noted by recording the mass slice in which it was 
found and the LC x LC fraction in which it was most intense. 
The de-convoluted intact protein data were also used for quantitative analysis of the 
samples.  Custom-written Igor Pro functions were used to identify components in the LC x 
LC-MS data and to determine their intensity, 2D retention time, and mass.  The intensity of a 
component was calculated by summing its intensity (as reported by maximum entropy de-
convolution) for all consecutive time segments in which it appeared.  This included summing 
components which were spread over multiple anion exchange fractions.  The 2D retention 
time and mass of each component were set as the values determined from the time segment at 
the apex of the peak.  To compare the intensity of components in different samples, an 
additional Igor Pro function was used to tabulate components with matching mass (+/- 150 
ppm), anion exchange retention time (+/- 2 fractions) and reversed-phase retention time (+/- 
2 min).  
6.2.5 Protein digestion and peptide LC-MS/MS  
After reviewing the intact protein data, fractions that contained proteins which were 
up- or down-regulated between samples were selected for further analysis.  These fractions 
were thawed, digested using trypsin as described in Chapter 5, and then analyzed using 
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capillary RPLC-MS/MS.  The chromatographic run conditions and mass spectrometer 
settings were the same as described in Chapter 5, except that a custom-packed 8 cm x 150 
μm ID capillary column with 1.5 μm bridged-ethyl hybrid C18-modified particles (Waters) 
was used to perform the RPLC separations.  The LC flow was split prior to entering the 
column.  Approximately 1 μL/min flowed through the column and 4 μL/min flowed to waste 
via a splitter capillary.  The outlet of the RPLC capillary was directly connected to an 
uncoated fused silica nanospray emitter with a 20 μm ID and a 10 μm tip (New Objective, 
Woburn, MA).  Spray voltage was applied through a zero dead volume union incorporated 
into the nanoflow sprayer (Waters Corporation).  MS/MS scans were performed in data 
directed analysis mode, using the same parameters as described in Chapter 5. 
6.2.6 Peptide data processing 
The peptide LC-MS/MS data were processed using ProteinLynx Global Server 2.3 
(Waters Corporation).  MS and MS/MS data were background subtracted using adaptive 
mode, de-isotoped using the MaxEnt 3 algorithm, and centroided.  The MS/MS spectra were 
then searched against a database of known yeast proteins from the Swiss-Prot protein 
knowledgebase release 54.2 (http://us.expasy.org/sprot).  A fixed modification of 
carboxyamidomethylcysteine and a variable modification of methionine oxidation were used 
in the search parameters. 
After the database search was complete, the proteins identified at the peptide level 
were compared with the intact proteins detected in the corresponding fractions.   A match 
was considered to have been found when the MW of a protein identified from the peptide 
MS/MS data, as given in its Swiss-Prot database entry, corresponded with the MW of an 
intact protein found in the same fraction.  Although in many cases the MW correspondence 
was precise, a tolerance of +/- 500 Daltons was allowed to account for the possible presence 
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of post-translational modifications not incorporated into the MW reported in the database.  
This wide mass range is justified by the fact that not only the mass but also the 2D retention 
time needed to be the same in order for a match to be considered valid. 
6.3 Results 
6.3.1 Reproducibility of intact protein LC x LC-MS analysis 
Three replicate LC x LC-MS runs of the yeast protein extract grown on glycerol 
medium were used to assess the reproducibility of the method.  Full-mass-range 2D 
chromatograms from the separations of these samples are shown in Figure 6-2.  As expected, 
the general pattern of peaks is quite similar in all three chromatograms.  Closer inspection 
reveals that some retention time drift did occur, both in the anion exchange and reversed 
phase dimensions.  This may be due to slight changes in the composition of the anion 
exchange and reversed phase mobile phases due to evaporation of volatile buffer 
components, since runs were performed over the course of three days.  Since this drift affects 
all peaks approximately equally, it does not significantly hamper visual comparison of the 
chromatograms. 
In terms of peak intensity, most peaks appear to be relatively consistent from run to 
run, although a few peaks vary noticeably.  Since reproducible peak intensity is important 
when performing relative quantification, the extent of the variation was investigated further 
by generating a log-log intensity scatter plot, which is shown in Figure 6-3.  In this plot, 
proteins are represented as points on an x-y plane, where the x-coordinate is the intensity of a 
given protein measured in one 2D run and the y coordinate is its intensity in another run.  
Since three replicate runs were performed, but only two intensities can be plotted as a single 
point, a total of three different sets of coordinates were plotted on the same graph: run 1 vs. 
run 2, run 2 vs. run 3, and run 2 vs. run 3.  In order to better visualize the full range of the 
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data, a logarithmic scale is used on both axes.  For replicate runs of a sample, an ideal 
distribution would be a plot in which all points fall along the line y = x, displaying no run-to-
run variation in intensity.  The data shown in Figure 6-3 follow this trend relatively closely 
(±10-20%) for proteins with high intensity.  For lower intensity proteins, however, the 
variability is significantly higher – over 10-fold for proteins with an intensity of 500, which 
was the limit of detection for this method.  The shape of the distribution is relatively close to 
that of a simple linear equation, y = ± (mx + b), plotted on a log-log scale.  This equation 
takes into consideration a constant noise component, b, and a response factor uncertainty 
component, m.  Several different forms of this equation are plotted in Figure 3, which 
incorporate a greater or lesser proportion of the experimentally-measured protein intensity 
data points depending on the m and b values which are selected.  The equation y = 1.2x + 
104.4 was determined to contain 96.5% of the experimental data points from the replicate runs 
of the glycerol-medium yeast protein extract; thus it was judged to be an acceptable threshold 
for determining whether a difference in protein intensity was significant for runs of different 
samples. 
6.3.2 Detection and relative quantification of differentially expressed proteins using 
intact protein LC x LC-MS data 
Full-mass-range 2D chromatograms from the separation of the three different yeast 
protein extracts are shown in Figure 6-4.  As with the replicate runs, there are substantial 
similarities between the patterns of peaks in the chromatograms.  This is expected, since all 
of the samples originate from the same organism, and therefore largely carry the same 
complement of proteins.  There is some retention time drift between chromatograms, 
particularly in the anion exchange dimension, but it does not substantially hamper visual 
comparison of the peaks.  It is also apparent from the data that the intensities of many peaks 
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are substantially different from one chromatogram to the next.  Furthermore, some peaks 
appear to be present in one or two of the chromatograms, but are completely absent from 
others.  Although it is possible to observe some intensity changes in the full-mass-range 
chromatograms, many may be missed due to the presence of overlapping peaks.  
To facilitate visual comparison of peak intensity from one sample to the next, mass 
slice chromatograms were used.  Figure 6-5 shows three representative mass slice 
chromatograms with a 1kDa mass range which were used to compare glucose versus glycerol 
yeast protein samples.  Figure 6-6 depicts mass slice chromatograms for the comparison 
between logarithmic growth phase and stationary growth phase samples.  Some of the mass 
slice chromatograms contained no detectable peaks, or no peaks which were noted to change 
intensity.  However, many chromatograms did have components which changed intensity 
between samples, or components which were present in one chromatogram but completely 
absent from another.  When this was the case, the LC x LC fraction in which the component 
was most abundant was recorded.  Once all mass slice chromatograms had been analyzed, a 
total of 164 fractions (out of a total of 1440) had been selected for further analysis in order to 
attempt to identify the proteins using bottom-up LC-MS/MS. 
Although visual comparison of the mass slice chromatograms allowed facile selection 
of fractions containing proteins of interest, it did not provide a quantitative estimate of 
change between samples.  Additionally, it did not address whether an observed difference in 
peak intensity was significant.  Therefore, log-log intensity scatter plots were generated using 
the de-convoluted peak intensities for the two relevant comparisons: 1) proteins from yeast 
grown on glucose and glycerol media, and 2) proteins from yeast harvested at log and 
stationary growth phase.  Only those peaks which had been selected for further analysis 
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based on the mass-slice chromatograms and were also successfully identified based on the 
peptide LC-MS/MS data (Section 6.2.6) were included in the scatter plots.  Both of these 
plots are shown on the same axes in Figure 6-7.  Also included in the plot is the data from the 
replicate runs of the glycerol sample, and the curve associated with a 96.5% confidence 
interval.  Points from the glucose/glycerol and log/stationary comparisons which fall outside 
of the curve are considered significantly different, which means the protein was present at 
different abundances in the two samples.   
Although it was straightforward to determine whether the change in abundance of a 
protein was significant for components which were detected in both samples, a substantial 
number of components were found in only one of two samples.  Since an intensity value of 
zero cannot be displayed on a log-log plot, these components could not be assessed for 
significance of differential expression.  To work around this issue, the missing proteins were 
assigned an intensity of 500 – which is the approximate limit of detection for the method – 
for the sample in which they were not found.  Thus, for a protein detected in only one 
sample, its intensity must meet the threshold for statistical significance as if it were present in 
the second sample at an abundance equivalent to the limit of detection.  Over the entire 
intensity range, a total of 52 proteins satisfied the criteria for statistical significance for 
change in abundance at the 96.5% threshold.  Of these, 30 proteins were from the 
glucose/glycerol comparison and 22 from the log/stationary comparison. 
6.3.3 Identification of differentially expressed proteins using peptide LC-MS/MS data 
Those fractions which had been selected for “bottom-up” analysis in order to identify 
the proteins they contained were lyophilized, digested using trypsin, and analyzed using 
capillary RPLC-MS/MS.  The MS/MS data from these runs were searched against the Swiss-
Prot database of known yeast proteins using ProteinLynx Global Server 2.3.  This generated 
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a list of proteins present in the fractions.  A total of 230 unique yeast proteins were identified 
in all of the fractions which were analyzed; however, many of these proteins were not those 
which were detected as being up- or down-regulated from the LC x LC-MS data.  After a 
fraction-by-fraction comparison of the list of identified proteins with the list of proteins 
which changed intensity, a total of 76 matches were found.   Thus, of the total 164 
differentially expressed proteins which were “searched for” by LC-MS/MS analysis, 
approximately 46% were successfully identified.  As stated previously, 52 of these proteins 
met the criteria for statistical significance of differential expression.  These proteins are listed 
in Table 6-3 (glucose vs. glycerol comparison) and Table 6-4 (logarithmic vs. stationary 
comparison).  Also included in the tables are the proteins’ Swiss-Prot accession number 
(http://us.expasy.org/sprot), ordered locus gene name (http://www.yeastgenome.org), MW, 
intensity, and the extent to which they were up- or down-regulated, expressed as a “fold-
change”, which was calculated by dividing the intensity of the more abundant protein by the 
intensity of the less abundant protein. 
6.4 Discussion 
The fact that a substantial portion of the intact proteins which were detected as being 
differentially expressed were not successfully identified is clearly a limitation of this method.  
Nonetheless, the observed portion of successful identifications (46%) is in line with or better 
than the typical success rate of correlating top-down and bottom-up proteomic data, as 
reported in the literature2, 12, 13 and in Chapters 4 and 5 of this dissertation.  Many of the same 
factors which prevent higher overlap from being achieved in other studies are likely also at 
work in this experiment.  These include difficulty detecting low abundance proteins, 
differences in selectivity of electrospray ionization towards intact proteins and peptides, and 
the presence of post translational modifications not predicted in protein database entries.  The 
 
224
last of these reasons can be viewed as both an obstacle to be overcome and as a potential 
source of useful information.  Once a correlation between intact protein MW and an 
identified protein is established, the mass shift provides a means of probing the modified 
state of the protein to determine which PTMs may be present.  As enhanced top-down 
proteomics methods are developed, it is anticipated that correlating intact proteins detected 
with proteins identified by bottom-up methods will become more routinely feasible, which 
will allow more constructive data regarding PTMs to be obtained. 
Of the differentially expressed yeast proteins which were successfully identified, 
many are involved in metabolic pathways.  It is logical to expect that such proteins would be 
well-represented in this study, since two of the samples were grown on different media, 
which would be anticipated to cause differences in metabolic processes within the yeast 
cells.14  Likewise, the transition from logarithmic to stationary growth phase is associated 
with a saturation of the growth medium and a depletion of the readily available carbon 
source, which would also be expected to induce changes in metabolism.15   
Figure 6-8 and Figure 6-9 visually illustrate the major metabolic pathways of yeast, 
and highlight the metabolic proteins which were differentially expressed in the 
glucose/glycerol (Figure 6-8) and log/stationary (Figure 6-9) comparisons.  In Figure 6-8, it 
is particularly notable that numerous enzymes which are involved in the citric acid cycle are 
up-regulated in the yeast grown on glycerol media.  Yeast is unable to derive energy from 
glycerol via fermentation to ethanol, as is possible with glucose, and therefore must use the 
citric acid cycle.  It is therefore logical that enzymes involved in this cycle would be present 
in larger quantities in the glycerol sample than in glucose.  Conversely, some proteins are up-
regulated in the glycerol sample.  For example, the protein phosphoglycerate mutase 1 
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(PMG1) is known to be unnecessary for growth on glycerol, which explains the fact that it 
was detected as being more abundant in the glucose sample.16   
Aside from proteins directly involved in metabolic pathways of yeast, several other 
proteins which were detected as being differentially expressed can be associated with 
biochemical changes caused by growing yeast under different conditions.  For instance, 
mitochondrial matrix factor 1 (MMF1) and its homologue HMF1, were detected as being up-
regulated in the glycerol sample.  These proteins are known to be essential for the growth of 
yeast on non-fermentable carbon sources, such as glycerol.17  Likewise, the protein 
alanine:glyoxylate aminotransferase 1 (AGX1), which is involved in the biosynthesis of 
glycine, was detected as being more abundant in the glycerol sample.  This observation 
correlates with the fact that expression of this protein is known to be repressed when yeast is 
grown on a glucose-containing medium.18  A final example is NADPH dependent 
methylglyoxal reductase (GRE2), which catalyzes the reduction of methyl glyoxal, a 
cytotoxic compound.  This protein was found to be up-regulated in the sample harvested at 
stationary phase, which is logical given that accumulation of waste products is likely to occur 
when the growth medium reaches saturation with yeast cells.19 
Some of the proteins which were detected as being differentially expressed in the 
samples have no obvious link to changes which would be expected to occur due to 
differences in the growth medium or a shift from logarithmic growth to stationary phase.  
The expression of these proteins could be related to metabolic changes in an indirect manner.  
Alternatively, it is possible that some instances in which a protein was detected as being 
marginally up- or down-regulated were due to random variation between samples rather than 
biochemical changes.  Inclusion of biological replicates in future studies would improve 
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certainty in interpretation of the data.  Nevertheless, the fact that numerous well-documented 
changes in protein expression were detected using this method demonstrates its ability to 
reveal useful information when used for differential analysis of samples from a living 
organism. 
6.5 Conclusions 
Multidimensional liquid chromatography coupled to mass spectrometry shows 
significant potential as a method for differential proteomics studies.  The hybrid top-down / 
bottom-up workflow allows differentially expressed proteins to be detected at the intact 
protein level, which reduces sample complexity as compared to purely bottom-up analyses.  
The use of 2D mass-slice chromatograms facilitates visual comparison of the intact protein 
data, and reduces the potential for confusion of neighboring peaks.    Only fractions 
containing proteins observed to change in intensity between samples are subjected to further 
analysis by trypsin digest and LC-MS, which reduces the total workload.  While the method 
is not able to discern subtle changes in protein expression, changes of a reasonable 
magnitude are easily detected.  One area which requires further development is a reliable 
means of correlating data from the top-down and bottom-up portions of the experiment.  
Nevertheless, this label-free, gel-free approach to differential proteomics holds substantial 
advantages in terms of convenience and automation over more traditional methods.  
Therefore, variations of this method – and multidimensional LC in general – may see 
increasing application in real-world proteomic analyses. 
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6.8 Tables 
 
 
Time (min) % mobile phase B 
0 0  
20 7 
600 67 
675 67 
680 0 
 
Table 6-1: AXC gradient profile used for the first dimension of the on-line LC x LC 
separation performed using the long AXC column.  Mobile phase A was 0.01 M ammonium 
acetate, pH 9.0.  Mobile phase B was 1 M ammonium acetate, pH 9.0.  The flow rate was 0.2 
mL/min.  The total volume of sample injected was 225 μL per run; the mass of protein 
injected was 2.25 mg. 
 
 
 
 
Time (min) % mobile phase B 
0 5 
2 20 
5 30 
15 45 
15.5 90 
16 90 
16.5 5 
 
Table 6-2: RPLC gradient profile used for the second dimension of the on-line LC x LC 
separation.  Valve switch events in the 2D separation were separated by 20 minutes in order 
to allow for full re-equilibration with the starting mobile phase before the next sample was 
loaded.  Mobile phase A was 0.2% (v/v) formic acid in deionized water.  Mobile phase B was 
0.2% (v/v) formic acid in acetonitrile.  The flow rate was 1.0 mL/min. 
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Swiss-
Prot 
name 
Ordered 
locus name 
Description Pep. 
hits 
Intact 
mass 
Up-reg. 
in 
Fold 
change 
ACBP YGR037C Acyl-CoA binding protein 1 9930.17 Glucose 1.5 
TRX2 YGR209C Thioredoxin 2 2 11202.1 Glucose - 
GLRX1 YCL035C Glutaredoxin 1 4 12245.7 Glucose 21.6 
SODC YJR104C Superoxide dismutase Cu Zn 1 15722.9 Glucose 1.9 
YC026 YCL026C-B Uncharacterized protein YCL026C B 2 20906.2 Glucose 9.3 
TPIS YDR050C Triosephosphate isomerase 4 26666.3 Glucose 1.7 
MRS1 YIR021W Mitochondrial RNA splicing protein 
MRS1 
1 41078.3 Glucose 
13.5 
CYS3 YAL012W Cystathionine gamma lyase 5 42414.4 Glucose - 
OYE2 YHR179W NADPH dehydrogenase 2 7 44884.2 Glucose 9.6 
G6PI YBR196C Glucose 6 phosphate isomerase 24 61216.5 Glucose 1.3 
IPB2 YNL015W Protease B inhibitors 2 and 1 2 8459.56 Glycerol 8.6 
PROF YOR122C Profilin 1 13589.5 Glycerol 11.8 
HMF1 YER057C Protein HMF1 1 13775.5 Glycerol 4.7 
PMG1 YKL152C Phosphoglycerate mutase 1 8 27482.4 Glycerol 2.0 
YM71 YMR226C Uncharacterized oxioreductase 6 29071.6 Glycerol 5.3 
BMH1 YER177W Protein BMH1 10 30004.2 Glycerol 1.8 
BMH2 YDR099W Protein BMH2 10 30974.2 Glycerol 1.6 
SUCA YOR142W Succinyl CoA ligase, ADP forming 
subunit alpha 
4 33222.7 Glycerol 
15.5 
MDHM YKL085W Malate dehydrogenase, mitochondrial 5 33836.2 Glycerol 6.3 
ADH1 YOL086C Alcohol dehydrogenase 1 36646.2 Glycerol - 
TAL1 YLR354C Transaldolase 6 36951.3 Glycerol 10.7 
IDH2 YOR136W Isocitrate dehydrogenase NAD subunit 
2 
3 37802.1 Glycerol 
- 
RIR4 YGR180C Ribonucleoside diphosphate reductase 
small chain 2 
4 40130.7 Glycerol 
5.2 
MDHC YOL126C Malate dehydrogenase, cytoplasmic 2 40604.2 Glycerol - 
AGX1 YFL030W Alanine:glyoxylate aminotransferase 1 6 41778.4 Glycerol - 
AATC YLR027C Aspartate aminotransferase, 
cytoplasmic 
5 45893.4 Glycerol 
7.4 
CISY1 YNR001C Citrate synthase 7 49221.9 Glycerol 35.9 
GLYM YBR263W Serine hydroxymethyltransferase 3 51605.7 Glycerol - 
ALDH4 YOR374W K+ activated aldehyde dehydrogenase 15 53979.1 Glycerol - 
TKT1 YPR074C Transketolase 8 73677.7 Glycerol - 
 
Table 6-3: Proteins identified as being significantly differentially expressed in yeast grown 
on glucose medium versus glycerol medium (both samples were harvested during log-growth 
phase).  Heading terms are defined as follows: Swiss-Prot name: Swiss-Prot database entry 
name (all proteins have _YEAST suffix); Ordered locus name: Systematic gene name MW: 
Measured intact protein molecular weight; Pep. Hits: number of peptide MS/MS hits used to 
identify protein; Up-reg in.: Identity of the sample in which the protein was present at a 
higher abundance; Fold change: ratio of abundance in samples (more abundant / less 
abundant). ‘-‘ indicates that the protein was not detected in one of the samples, thus a fold 
change could not be calculated. 
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Swiss-
Prot 
name 
Ordered 
locus 
name 
Description Pep. 
hits 
Intact 
mass 
Up-reg 
in 
Fold 
change 
ACBP YGR037C Acyl-CoA binding protein 1 9930.17 Log 2.5 
CH10 YOR020C 10kDa Heat shock protein, mitochondrial 3 11283.9 Log 29.5 
HSP12 YFL014W 12kDa Heat shock protein 5 11604.6 Log 373.1 
YL364 YLR364W Glutaredoxin-like protein  2 12069 Log 5.1 
TBCA YOR265W Tubulin specific chaperone A 3 12248.4 Log - 
PNC1 YGL037C Nicotinamidase 2 24993.9 Log 17.9 
MRP8 YKL142W Uncharacterized protein MRP8 6 25004.8 Log - 
BMH1 YER177W Protein BMH1 10 29998.4 Log - 
BMH2 YDR099W Protein BMH2 10 30968.7 Log - 
G3P3 YGR192C Glyceraldehyde 3 phosphate 
dehydrogenase 3 
11 35617.8 Log 122.6 
CYS3 YAL012W Cystathionine gamma lyase 5 42414.4 Log 18.5 
PGK YCR012W Phosphoglycerate kinase 16 44652.7 Log - 
SODC YJR104C Superoxide dismutase Cu Zn 1 15719.6 Stat 1.5 
COFI YLL050C Cofilin 8 15809.9 Stat 1.9 
KGUA YDR454C Guanylate kinase 1 20901.8 Stat 7.1 
SODM YHR008C Superoxide dismutase Mn mitochondrial 4 23080.5 Stat 3.7 
PMG1 YKL152C Phosphoglycerate mutase 1 8 27477.9 Stat 6.8 
G3P1 YJL052W Glyceraldehyde 3 phosphate 
dehydrogenase 1 
11 35742.1 Stat - 
TAL1 YLR354C Transaldolase 6 36942.8 Stat 7.4 
DHOM YJR139C Homoserine dehydrogenase 11 38404.9 Stat 2.2 
MRS1 YIR021W Mitochondrial RNA splicing protein 
MRS1 
1 41070.4 Stat 1.4 
G6PI YBR196C Glucose 6 phosphate isomerase 24 61202.9 Stat 1.7 
 
Table 6-4: Proteins identified as being significantly differentially expressed in yeast 
harvested during log-growth phase versus stationary phase (both samples were grown on 
glucose medium).  Heading terms are defined as follows: Swiss-Prot name: Swiss-Prot 
database entry name (all proteins have _YEAST suffix); Ordered locus name: Systematic 
gene name; MW: Measured intact protein molecular weight; Pep. Hits: number of peptide 
MS/MS database hits used to identify protein; Up-reg in.: Identity of the sample in which the 
protein was more abundant; Fold change: ratio of abundance in samples (more abundant / 
less abundant). ‘-‘ indicates that the protein was not detected in one of the samples, thus a 
fold change could not be calculated. 
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6.9 Figures 
 
 
 
Figure 6-1: Overview of differential proteomics approach 
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Figure 6-2: 2D chromatograms from replicate online LC x LC separations of a protein extract 
from a yeast culture grown on glycerol medium, harvested during log-growth phase.
Run 1 
Run 2 
Run 3 
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Figure 6-3: Log-log plot comparing intensities of protein peaks in three replicate runs of a 
yeast protein extract.  Each black dot represents the intensity of a protein found in two 
different samples. The colored curves are linear equations which were determined to contain 
different portions of the points in the data set.  They are useful for assigning bounds for 
typical run-to-run variability as a function of peak intensity. 
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Figure 6-4: 2D chromatograms from online LC x LC separations of three yeast protein 
extracts.  The grid represents the time when fractions were switched.  Run conditions are 
defined in Table 6-3 and Table 6-4. 
A: glycerol log 
B: glucose log 
C: glucose stat 
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Glycerol medium, log phase 
 
Glucose medium, log phase 
 
Key: 
 
 
 
 
 
 
 
Protein intensity essentially unchanged 
 
Protein up-regulated in sample 
 
Protein down-regulated in sample 
 
Protein absent from sample 
 
Figure 6-5: Mass-slice chromatograms for comparison between yeast cultures grown on 
glucose medium and glycerol medium
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Glucose medium, log phase 
 
Glucose medium, stationary phase 
 
Key: 
 
 
 
 
 
 
 
Protein intensity essentially unchanged 
 
Protein up-regulated in sample 
 
Protein down-regulated in sample 
 
Protein entirely absent from sample 
 
Figure 6-6: Mass-slice chromatograms for comparison between yeast cultures harvested at 
log-growth phase and stationary phase 
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Figure 6-7: Log-log plot displaying differential peak intensity for both glucose vs. glycerol 
and log vs. stationary yeast protein extract comparisons.  The comparison data are overlaid 
upon the data from replicate runs of the glycerol sample.  The curve shown represents a 
“confidence interval” of 96.5%.  Points in the glucose/glycerol and log/stationary phase 
comparisons which fall outside the curve are considered to be significantly different, 
indicating a change in protein expression between the samples. 
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Figure 6-8: Yeast metabolic proteins differentially expressed in the samples cultured on 
glucose and glycerol media.  Proteins more abundant in the glucose sample are shown in 
blue, proteins more abundant in the glycerol sample are shown in red, and proteins not 
significantly different in abundance are shown in black.
Up-regulated in glucose medium 
Up-regulated in glycerol medium 
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Figure 6-9: Yeast metabolic proteins differentially expressed during logarithmic growth 
phase and stationary phase.  Proteins more abundant during log growth phase are shown in 
blue, proteins more abundant in stationary phase are shown in red, and proteins not 
significantly different in abundance are shown in black.  The protein shown in green has two 
isoforms; one isoform was more abundant in each sample. 
Up-regulated in log phase 
Up-regulated in stationary 
phase 
2 isozymes (one up-regulated 
in each sample) 
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APPENDIX 
A complete table of the E. coli proteins identified in Chapters 4 and 5 is provided 
below. Terms are as follows:  Ref #: number assigned in Table 4-4, Table 4-6, or Table 5-5; 
Protein: SwissProt database entry name; Description: SwissProt protein description 
Ref # Protein Description 
1 CSPC_ECOLI Cold shock-like protein cspC (CSP-C). 
2 CSPE_ECOLI Cold shock-like protein cspE (CSP-E). 
3 YJBJ_ECOLI UPF0337 protein yjbJ. 
4 HDEB_ECOLI Protein hdeB precursor (10K-L protein). 
5 PTHP_ECOLI Phosphocarrier protein HPr (Histidine-containing protein). 
6 RS15_ECOLI 30S ribosomal protein S15. 
7 CH10_ECOLI 10 kDa chaperonin (Protein Cpn10) (groES protein). 
8 FETP_ECOLI Probable Fe(2+)-trafficking protein. 
9 YGIW_ECOLI Protein ygiW precursor. 
10 YEGP_ECOLI UPF0339 protein yegP. 
11 RL7_ECOLI 50S ribosomal protein L7/L12 (L8). 
12 GRCA_ECOLI Autonomous glycyl radical cofactor. 
13 YCCU_ECOLI Uncharacterized protein yccU. 
14 OSMC_ECOLI Peroxiredoxin osmC (EC 1.11.1.15) (Osmotically-inducible protein C). 
15 RS6_ECOLI 30S ribosomal protein S6 [Contains: 30S ribosomal protein S6, fully 
modified isoform; 30S ribosomal protein S6, non-modified isoform]. 
16 NDK_ECOLI Nucleoside diphosphate kinase (EC 2.7.4.6) (NDK) (NDP kinase) 
17 HNS_ECOLI DNA-binding protein H-NS (Histone-like protein HLP-II) (Protein H1) 
18 SODC_ECOLI Superoxide dismutase [Cu-Zn] precursor (EC 1.15.1.1) 
19 USPA_ECOLI Universal stress protein A. 
20 YJGK_ECOLI Uncharacterized protein yjgK. 
21 TPX_ECOLI Thiol peroxidase (EC 1.11.1.-) (Scavengase P20). 
22 PTGA_ECOLI Glucose-specific phosphotransferase enzyme IIA component (EC 
2.7.1.-) 
23 OSMY_ECOLI Osmotically-inducible protein Y precursor. 
24 BFR_ECOLI Bacterioferritin (BFR) (Cytochrome b-1) (Cytochrome b-557). 
25 FABA_ECOLI 3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.60) 
26 FTNA_ECOLI Ferritin-1 (EC 1.16.3.1). 
27 YFBU_ECOLI UPF0304 protein yfbU. 
28 AHPC_ECOLI Alkyl hydroperoxide reductase subunit C (EC 1.11.1.15) 
(Peroxiredoxin) 
29 WRBA_ECOLI Flavoprotein wrbA (Trp repressor-binding protein). 
30 SODF_ECOLI Superoxide dismutase [Fe] (EC 1.15.1.1). 
31 RPIA_ECOLI Ribose-5-phosphate isomerase A (EC 5.3.1.6) (Phosphoriboisomerase 
A) 
32 KAD_ECOLI Adenylate kinase (EC 2.7.4.3) (ATP-AMP transphosphorylase) (AK). 
33 RPE_ECOLI Ribulose-phosphate 3-epimerase (EC 5.1.3.1) (Pentose-5-phosphate 3-
epimerase) (PPE) (R5P3E). 
34 ARTI_ECOLI Arginine-binding periplasmic protein 1 precursor. 
35 FABG_ECOLI 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100) (3-ketoacyl-
acyl carrier protein reductase). 
36 ARGT_ECOLI Lysine-arginine-ornithine-binding periplasmic protein precursor (LAO-
binding protein). 
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Ref # Protein Description 
37 DEOD_ECOLI Purine nucleoside phosphorylase deoD-type (EC 2.4.2.1) (PNP) 
(Inosine phosphorylase). 
38 FLIY_ECOLI Cystine-binding periplasmic protein precursor (CBP) (Protein fliY) 
39 HISJ_ECOLI Histidine-binding periplasmic protein precursor (HBP). 
40 TPIS_ECOLI Triosephosphate isomerase (EC 5.3.1.1) (TIM) (Triose-phosphate 
isomerase). 
41 UDP_ECOLI Uridine phosphorylase (EC 2.4.2.3) (UrdPase) (UPase). 
42 KDUD_ECOLI 2-deoxy-D-gluconate 3-dehydrogenase (EC 1.1.1.125) (2-keto-3-
deoxygluconate oxidoreductase). 
43 FABI_ECOLI Enoyl-[acyl-carrier-protein] reductase [NADH] (EC 1.3.1.9) (NADH-
dependent enoyl-ACP reductase). 
44 GPMA_ECOLI 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase (EC 
5.4.2.1) 
45 RBSB_ECOLI D-ribose-binding periplasmic protein precursor. 
46 EFTS_ECOLI Elongation factor Ts (EF-Ts). 
47 HCHA_ECOLI Chaperone protein hchA (Hsp31) (EcHsp31). 
48 YTFG_ECOLI Uncharacterized oxidoreductase ytfG (EC 1.-.-.-). 
49 MDH_ECOLI Malate dehydrogenase (EC 1.1.1.37). 
50 DGAL_ECOLI D-galactose-binding periplasmic protein precursor (GBP) (D-
galactose/D-glucose-binding protein) (GGBP). 
51 PROX_ECOLI Glycine betaine-binding periplasmic protein precursor. 
52 CYSK_ECOLI Cysteine synthase A (EC 2.5.1.47) (O-acetylserine sulfhydrylase A) (O-
acetylserine (Thiol)-lyase A) (CSase A) (Sulfate starvation-induced 
protein 5) (SSI5). 
53 ASPG2_ECOLI L-asparaginase 2 precursor (EC 3.5.1.1) (L-asparaginase II) (L- 
54 TALB_ECOLI Transaldolase B (EC 2.2.1.2). 
55 TALA_ECOLI Transaldolase A (EC 2.2.1.2). 
56 6PGL_ECOLI 6-phosphogluconolactonase (EC 3.1.1.31) (6-P-gluconolactonase) (Pgl). 
57 GLPQ_ECOLI Glycerophosphoryl diester phosphodiesterase precursor (EC 3.1.4.46) 
58 ALF_ECOLI Fructose-bisphosphate aldolase class 2 (EC 4.1.2.13)  
59 MALE_ECOLI Maltose-binding periplasmic protein precursor  
60 EFTU_ECOLI Elongation factor Tu (EF-Tu) (P-43). 
61 GLYA_ECOLI Serine hydroxymethyltransferase (EC 2.1.2.1) (Serine methylase) 
62 UGPB_ECOLI sn-glycerol-3-phosphate-binding periplasmic protein ugpB precursor. 
63 TNAA_ECOLI Tryptophanase (EC 4.1.99.1) (L-tryptophan indole-lyase) (TNase). 
64 DPPA_ECOLI Periplasmic dipeptide transport protein precursor 
65 RL29_ECOLI 50S ribosomal protein L29. 
66 YCCJ_ECOLI Uncharacterized protein yccJ. 
67 RL28_ECOLI 50S ribosomal protein L28. 
68 DBHB_ECOLI DNA-binding protein HU-beta (NS1) (HU-1). 
69 DBHA_ECOLI DNA-binding protein HU-alpha (NS2) (HU-2). 
70 RL25_ECOLI 50S ribosomal protein L25. 
71 RL24_ECOLI 50S ribosomal protein L24. 
72 IHFA_ECOLI Integration host factor subunit alpha (IHF-alpha). 
73 RL21_ECOLI 50S ribosomal protein L21. 
74 RS10_ECOLI 30S ribosomal protein S10. 
75 RL18_ECOLI 50S ribosomal protein L18. 
76 GLRX4_ECOLI Glutaredoxin-4 (Grx4) (Monothiol glutaredoxin). 
77 YJGF_ECOLI UPF0076 protein yjgF. 
78 RL11_ECOLI 50S ribosomal protein L11. 
79 RL15_ECOLI 50S ribosomal protein L15. 
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Ref # Protein Description 
80 SKP_ECOLI Chaperone protein skp precursor (Seventeen kilodalton protein) 
81 RL9_ECOLI 50S ribosomal protein L9. 
82 RL13_ECOLI 50S ribosomal protein L13. 
83 ASNC_ECOLI Regulatory protein asnC. 
84 RL10_ECOLI 50S ribosomal protein L10 (50S ribosomal protein L8). 
85 YBAY_ECOLI Uncharacterized lipoprotein ybaY precursor. 
86 PPIB_ECOLI Peptidyl-prolyl cis-trans isomerase B (EC 5.2.1.8) (PPIase B) 
87 RL6_ECOLI 50S ribosomal protein L6. 
88 RS7_ECOLI 30S ribosomal protein S7. 
89 NUSG_ECOLI Transcription antitermination protein nusG. 
90 CLPP_ECOLI ATP-dependent Clp protease proteolytic subunit precursor 
91 YRBC_ECOLI Protein yrbC precursor. 
92 RL3_ECOLI 50S ribosomal protein L3. 
93 ALKH_ECOLI KHG/KDPG aldolase [Includes: 4-hydroxy-2-oxoglutarate aldolase 
94 SODM_ECOLI Superoxide dismutase [Mn] (EC 1.15.1.1) (MnSOD). 
95 CRP_ECOLI Catabolite gene activator (cAMP receptor protein)  
96 GLRX2_ECOLI Glutaredoxin-2 (Grx2). 
97 RL1_ECOLI 50S ribosomal protein L1. 
98 GLNH_ECOLI Glutamine-binding periplasmic protein precursor (GlnBP). 
99 RS3_ECOLI 30S ribosomal protein S3. 
100 YBGI_ECOLI UPF0135 protein ybgI. 
101 UDP_ECOLI Uridine phosphorylase (EC 2.4.2.3) (UrdPase) (UPase). 
102 DEOC_ECOLI Deoxyribose-phosphate aldolase (EC 4.1.2.4) 
(Phosphodeoxyriboaldolase) 
103 FARR_ECOLI Fatty acyl-responsive regulator (P30 protein). 
104 SUCD_ECOLI Succinyl-CoA ligase [ADP-forming] subunit alpha (EC 6.2.1.5) 
105 DAPD_ECOLI 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase 
106 KDUI_ECOLI 4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase (EC 5.3.1.17)  
107 GLTI_ECOLI Glutamate/aspartate periplasmic-binding protein precursor. 
108 KDGK_ECOLI 2-dehydro-3-deoxygluconokinase (EC 2.7.1.45) 
109 G3P1_ECOLI Glyceraldehyde-3-phosphate dehydrogenase A (EC 1.2.1.12) (GAPDH-
A). 
110 USPE_ECOLI Universal stress protein E. 
111 YGHZ_ECOLI Uncharacterized protein yghZ. 
112 SERC_ECOLI Phosphoserine aminotransferase (EC 2.6.1.52) 
113 DHAS_ECOLI Aspartate-semialdehyde dehydrogenase (EC 1.2.1.11) (ASA 
dehydrogenase) 
114 PGK_ECOLI Phosphoglycerate kinase (EC 2.7.2.3). 
115 SUCC_ECOLI Succinyl-CoA synthetase beta chain (EC 6.2.1.5) (SCS-beta). 
116 AGP_ECOLI Glucose-1-phosphatase precursor (EC 3.1.3.10) (G1Pase). 
117 AAT_ECOLI Aspartate aminotransferase (EC 2.6.1.1) (Transaminase A) (ASPAT). 
118 DEOB_ECOLI Phosphopentomutase (EC 5.4.2.7) (Phosphodeoxyribomutase). 
119 SURA_ECOLI Chaperone surA precursor (Peptidyl-prolyl cis-trans isomerase surA) 
120 ENO_ECOLI Enolase (EC 4.2.1.11) (2-phosphoglycerate dehydratase)  
121 IDH_ECOLI Isocitrate dehydrogenase [NADP] (EC 1.1.1.42)  
122 ACEA_ECOLI Isocitrate lyase (EC 4.1.3.1) (Isocitrase) (Isocitratase) (ICL). 
123 CISY_ECOLI Citrate synthase (EC 2.3.3.1). 
124 TIG_ECOLI Trigger factor (TF). 
125 SYS_ECOLI Seryl-tRNA synthetase (EC 6.1.1.11) (Seryl-tRNA(Ser/Sec) synthetase) 
 
245
 
Ref # Protein Description 
126 ATPB_ECOLI ATP synthase subunit beta (EC 3.6.3.14) (ATPase subunit beta) 
127 DLDH_ECOLI Dihydrolipoyl dehydrogenase (EC 1.8.1.4) 
128 KPYK2_ECOLI Pyruvate kinase II (EC 2.7.1.40) (PK-2). 
129 6PGD_ECOLI 6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44). 
130 ALDA_ECOLI Aldehyde dehydrogenase A (EC 1.2.1.22) (Lactaldehyde 
dehydrogenase) 
131 ASPA_ECOLI Aspartate ammonia-lyase (EC 4.3.1.1) (Aspartase). 
132 DCEA_ECOLI Glutamate decarboxylase alpha (EC 4.1.1.15) (GAD-alpha). 
133 YHJJ_ECOLI Protein yhjJ precursor. 
134 ATPA_ECOLI ATP synthase subunit alpha (EC 3.6.3.14) (ATPase subunit alpha) 
135 OPGG_ECOLI Glucans biosynthesis protein G precursor. 
136 GLPK_ECOLI Glycerol kinase (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase) 
137 ALDB_ECOLI Aldehyde dehydrogenase B (EC 1.2.1.-). 
138 CH60_ECOLI 60 kDa chaperonin (Protein Cpn60) (groEL protein). 
139 PUR9_ECOLI Bifunctional purine biosynthesis protein purH 
140 PPCK_ECOLI Phosphoenolpyruvate carboxykinase [ATP] (EC 4.1.1.49) 
141 RS1_ECOLI 30S ribosomal protein S1. 
142 G6PI_ECOLI Glucose-6-phosphate isomerase (EC 5.3.1.9) (GPI) 
143 SYD_ECOLI Aspartyl-tRNA synthetase (EC 6.1.1.12) (Aspartate--tRNA ligase) 
144 GLMS_ECOLI Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 
145 DNAK_ECOLI Chaperone protein dnaK (Heat shock protein 70)  
146 HTPG_ECOLI Chaperone protein htpG (Heat shock protein htpG)  
147 TKT1_ECOLI Transketolase 1 (EC 2.2.1.1) (TK 1). 
148 PNP_ECOLI Polyribonucleotide nucleotidyltransferase (EC 2.7.7.8)  
149 EFG_ECOLI Elongation factor G (EF-G). 
150 MASZ_ECOLI Malate synthase G (EC 2.3.3.9) (MSG). 
151 MAO2_ECOLI NADP-dependent malic enzyme (EC 1.1.1.40) (NADP-ME). 
152 CATE_ECOLI Catalase HPII (EC 1.11.1.6) (Hydroxyperoxidase II). 
153 PFLB_ECOLI Formate acetyltransferase 1 (EC 2.3.1.54) (Pyruvate formate-lyase 1). 
154 SYFB_ECOLI Phenylalanyl-tRNA synthetase beta chain (EC 6.1.1.20)  
155 ACON2_ECOLI Aconitate hydratase 2 (EC 4.2.1.3) (Citrate hydro-lyase 2)  
156 ADHE_ECOLI Aldehyde-alcohol dehydrogenase 
157 SYV_ECOLI Valyl-tRNA synthetase (EC 6.1.1.9) (Valine--tRNA ligase) (ValRS). 
158 GABT_ECOLI 4-aminobutyrate aminotransferase (EC 2.6.1.19) 
159 IF3_ECOLI Translation initiation factor IF-3. 
160 RL30_ECOLI 50S ribosomal protein L30. 
161 YDCH_ECOLI Uncharacterized protein ydcH. 
162 RL31_ECOLI 50S ribosomal protein L31. 
163 IF1_ECOLI Translation initiation factor IF-1. 
164 YODD_ECOLI Uncharacterized protein yodD. 
165 GLRX3_ECOLI Glutaredoxin-3 (Grx3). 
166 YCIN_ECOLI Protein yciN. 
167 RS20_ECOLI 30S ribosomal protein S20. 
168 RS17_ECOLI 30S ribosomal protein S17. 
169 YIIU_ECOLI Uncharacterized protein yiiU. 
170 HDEA_ECOLI Protein hdeA precursor (10K-S protein). 
171 YHCO_ECOLI Uncharacterized protein yhcO. 
172 YGIN_ECOLI Protein ygiN. 
173 THIO_ECOLI Thioredoxin-1 (Trx-1) (Trx). 
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Ref # Protein Description 
174 BOLA_ECOLI Protein bolA. 
175 YDEI_ECOLI Uncharacterized protein ydeI precursor. 
176 PHNA_ECOLI Protein phnA. 
177 GLNB_ECOLI Nitrogen regulatory protein P-II 1. 
178 RL19_ECOLI 50S ribosomal protein L19. 
179 YCFF_ECOLI HIT-like protein ycfF. 
180 YJBR_ECOLI Uncharacterized protein yjbR. 
181 RL16_ECOLI 50S ribosomal protein L16. 
182 YHHA_ECOLI Uncharacterized protein yhhA precursor (ORFQ). 
183 YAEH_ECOLI UPF0325 protein yaeH. 
184 USPG_ECOLI Universal stress protein G. 
185 FUR_ECOLI Ferric uptake regulation protein (Ferric uptake regulator). 
186 YHBC_ECOLI UPF0090 protein yhbC. 
187 DKSA_ECOLI DnaK suppressor protein. 
188 BCP_ECOLI Putative peroxiredoxin bcp (EC 1.11.1.15) (Thioredoxin reductase) 
189 GREA_ECOLI Transcription elongation factor greA 
190 PPIA_ECOLI Peptidyl-prolyl cis-trans isomerase A precursor (EC 5.2.1.8) 
191 SSPB_ECOLI Stringent starvation protein B. 
192 MOAB_ECOLI Molybdenum cofactor biosynthesis protein B. 
193 LRP_ECOLI Leucine-responsive regulatory protein. 
194 SSB_ECOLI Single-stranded DNA-binding protein (SSB)  
195 HSLV_ECOLI ATP-dependent protease hslV (EC 3.4.25.-) (Heat shock protein hslV). 
196 YAJQ_ECOLI UPF0234 protein yajQ. 
197 ATPD_ECOLI ATP synthase delta chain (EC 3.6.3.14). 
198 APT_ECOLI Adenine phosphoribosyltransferase (EC 2.4.2.7) (APRT). 
199 WCAF_ECOLI Putative colanic acid biosynthesis acetyltransferase wcaF 
200 YDJA_ECOLI Protein ydjA. 
201 RL5_ECOLI 50S ribosomal protein L5. 
202 EFP_ECOLI Elongation factor P (EF-P). 
203 GMHA_ECOLI Phosphoheptose isomerase (EC 5.3.1.-) 
204 YDJY_ECOLI Uncharacterized protein ydjY precursor. 
205 GRPE_ECOLI Protein grpE (HSP-70 cofactor) (Heat shock protein B25.3) (HSP24). 
206 FKBB_ECOLI FKBP-type 22 kDa peptidyl-prolyl cis-trans isomerase (EC 5.2.1.8) 
207 RL4_ECOLI 50S ribosomal protein L4. 
208 YCAC_ECOLI Uncharacterized protein ycaC. 
209 ENGB_ECOLI Probable GTP-binding protein engB. 
210 YLIJ_ECOLI Uncharacterized GST-like protein yliJ. 
211 TRAT1_ECOLI TraT complement resistance protein precursor. 
212 NARL_ECOLI Nitrate/nitrite response regulator protein narL. 
213 YCEH_ECOLI Uncharacterized protein yceH (G20.3). 
214 PYRH_ECOLI Uridylate kinase (EC 2.7.4.-) (UK) (Uridine monophosphate kinase)  
215 CPXR_ECOLI Transcriptional regulatory protein cpxR. 
216 RS2_ECOLI 30S ribosomal protein S2. 
217 YGGE_ECOLI Uncharacterized protein yggE. 
218 HDHA_ECOLI 7-alpha-hydroxysteroid dehydrogenase (EC 1.1.1.159) (7-alpha-
HSDH). 
219 LPXA_ECOLI Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-
acyltransferase 
220 PANB_ECOLI 3-methyl-2-oxobutanoate hydroxymethyltransferase (EC 2.1.2.11) 
221 TRPA_ECOLI Tryptophan synthase alpha chain (EC 4.2.1.20). 
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222 YEHZ_ECOLI Uncharacterized protein yehZ precursor. 
223 ALSB_ECOLI D-allose-binding periplasmic protein precursor (ALBP). 
224 NADE_ECOLI NH(3)-dependent NAD(+) synthetase (EC 6.3.1.5)  
225 THTM_ECOLI 3-mercaptopyruvate sulfurtransferase (EC 2.8.1.2)  
226 DKGA_ECOLI 2,5-diketo-D-gluconic acid reductase A (EC 1.1.1.274) (2,5-DKG 
227 AGAY_ECOLI Tagatose-1,6-bisphosphate aldolase agaY (EC 4.1.2.-) (TBPA). 
228 YJJW_ECOLI Uncharacterized protein yjjW. 
229 PANC_ECOLI Pantoate--beta-alanine ligase (EC 6.3.2.1) (Pantothenate synthetase) 
230 YBBN_ECOLI Uncharacterized protein ybbN. 
231 YTFQ_ECOLI ABC transporter periplasmic-binding protein ytfQ precursor. 
232 GLSA1_ECOLI Glutaminase 1 (EC 3.5.1.2). 
233 RSEB_ECOLI Sigma-E factor regulatory protein rseB precursor. 
234 ACCD_ECOLI Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta 
235 THIB_ECOLI Thiamine-binding periplasmic protein precursor. 
236 PTNAB_ECOLI PTS system mannose-specific EIIAB component (EIIAB-Man)  
237 ACCA_ECOLI Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha 
238 QOR_ECOLI Quinone oxidoreductase (EC 1.6.5.5) (NADPH:quinone reductase)  
239 RPOA_ECOLI DNA-directed RNA polymerase alpha chain (EC 2.7.7.6) 
240 TDH_ECOLI L-threonine 3-dehydrogenase (EC 1.1.1.103). 
241 ALF1_ECOLI Fructose-bisphosphate aldolase class 1 (EC 4.1.2.13)  
242 GALM_ECOLI Aldose 1-epimerase (EC 5.1.3.3) (Mutarotase). 
243 GCST_ECOLI Aminomethyltransferase (EC 2.1.2.10)  
244 IADA_ECOLI Isoaspartyl dipeptidase (EC 3.4.19.-). 
245 YQHD_ECOLI Alcohol dehydrogenase yqhD (EC 1.1.1.-). 
246 FABB_ECOLI 3-oxoacyl-[acyl-carrier-protein] synthase 1 (EC 2.3.1.41)  
247 RIR2_ECOLI Ribonucleoside-diphosphate reductase 1 subunit beta (EC 1.17.4.1) 
248 TOLB_ECOLI Protein tolB precursor. 
249 ASTC_ECOLI Succinylornithine transaminase (EC 2.6.1.81)  
250 ODO2_ECOLI Dihydrolipoyllysine-residue succinyltransferase component  
251 ISCS_ECOLI Cysteine desulfurase (EC 2.8.1.7) (ThiI transpersulfidase)  
252 DEGP_ECOLI Protease do precursor (EC 3.4.21.-). 
253 PURA_ECOLI Adenylosuccinate synthetase (EC 6.3.4.4) (IMP--aspartate ligase) 
254 GLMM_ECOLI Phosphoglucosamine mutase (EC 5.4.2.10). 
255 DHE4_ECOLI NADP-specific glutamate dehydrogenase (EC 1.4.1.4) (NADP-GDH). 
256 ACCC_ECOLI Biotin carboxylase (EC 6.3.4.14) (Acetyl-CoA carboxylase subunit A) 
257 KPYK1_ECOLI Pyruvate kinase I (EC 2.7.1.40) (PK-1). 
258 GABD_ECOLI Succinate-semialdehyde dehydrogenase [NADP+] (EC 1.2.1.16) 
(SSDH). 
259 GLNA_ECOLI Glutamine synthetase (EC 6.3.1.2) (Glutamate--ammonia ligase). 
260 IMDH_ECOLI Inosine-5'-monophosphate dehydrogenase (EC 1.1.1.205)  
261 SYN_ECOLI Asparaginyl-tRNA synthetase (EC 6.1.1.22) (Asparagine--tRNA ligase) 
262 PEPD_ECOLI Aminoacyl-histidine dipeptidase (EC 3.4.13.3) (Xaa-His dipeptidase) 
263 SYE_ECOLI Glutamyl-tRNA synthetase (EC 6.1.1.17) (Glutamate--tRNA ligase) 
264 NORR_ECOLI Anaerobic nitric oxide reductase transcription regulator norR. 
265 AHPF_ECOLI Alkyl hydroperoxide reductase subunit F (EC 1.6.4.-) 
266 PUR1_ECOLI Amidophosphoribosyltransferase (EC 2.4.2.14)  
267 SYK2_ECOLI Lysyl-tRNA synthetase, heat inducible (EC 6.1.1.6)  
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268 USHA_ECOLI Protein ushA precursor [Includes: UDP-sugar hydrolase (EC 3.6.1.45) 
269 FUMA_ECOLI Fumarate hydratase class I, aerobic (EC 4.2.1.2) (Fumarase). 
270 YTFM_ECOLI Uncharacterized protein ytfM precursor. 
271 MAO1_ECOLI NAD-dependent malic enzyme (EC 1.1.1.38) (NAD-ME). 
272 SYQ_ECOLI Glutaminyl-tRNA synthetase (EC 6.1.1.18) (Glutamine--tRNA ligase) 
273 DHSA_ECOLI Succinate dehydrogenase flavoprotein subunit (EC 1.3.99.1). 
274 ODP2_ECOLI Dihydrolipoyllysine-residue acetyltransferase component of pyruvate 
275 YEJA_ECOLI Uncharacterized protein yejA precursor. 
276 TKT2_ECOLI Transketolase 2 (EC 2.2.1.1) (TK 2). 
277 OPDA_ECOLI Oligopeptidase A (EC 3.4.24.70). 
278 CATA_ECOLI Peroxidase/catalase HPI (EC 1.11.1.6) (Catalase-peroxidase) 
279 TRAD1_ECOLI Protein traD. 
280 CLPB_ECOLI Chaperone protein clpB (Heat-shock protein F84.1). 
281 SYA_ECOLI Alanyl-tRNA synthetase (EC 6.1.1.7) (Alanine--tRNA ligase) (AlaRS). 
282 AMPN_ECOLI Aminopeptidase N (EC 3.4.11.2) (Alpha-aminoacylpeptide hydrolase). 
283 CAPP_ECOLI Phosphoenolpyruvate carboxylase (EC 4.1.1.31) (PEPCase) (PEPC). 
284 ODP1_ECOLI Pyruvate dehydrogenase E1 component (EC 1.2.4.1). 
285 SYI_ECOLI Isoleucyl-tRNA synthetase (EC 6.1.1.5) (Isoleucine--tRNA ligase) 
286 ODO1_ECOLI 2-oxoglutarate dehydrogenase E1 component (EC 1.2.4.2) 
 
